AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40465313|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|69|198751799|Female|All other|2015-2019|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Malignant|297|198751799|Female|All other|2015-2019|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40190633|Female|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|39723250|Female|All other|2018|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Malignant|123|39723250|Female|All other|2018|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|33|39588700|Female|All other|2019|0.1|0.1|0.1
0-19|0.3|0.5|0.4|Malignant|154|39588700|Female|All other|2019|0.3|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|46|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40633964|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40465313|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40314778|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40221756|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40166969|Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|40165125|Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Anaplastic astrocytoma|2015-2019|~|~|~
0-19|0.1|0.1|0.1|Malignant|146|198751799|Female|Anaplastic astrocytoma|2015-2019|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40190633|Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|40166755|Female|Anaplastic astrocytoma|2017|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Anaplastic astrocytoma|2018|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39723250|Female|Anaplastic astrocytoma|2018|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Anaplastic astrocytoma|2019|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|39588700|Female|Anaplastic astrocytoma|2019|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Anaplastic oligodendroglioma|2015-2019|~|~|~
0-19|~|~|~|Malignant|~|198751799|Female|Anaplastic oligodendroglioma|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Anaplastic oligodendroglioma|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Anaplastic oligodendroglioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40633964|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40465313|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|40314778|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|102|40221756|Female|Astrocytoma, NOS|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|103|40166969|Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|40165125|Female|Astrocytoma, NOS|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Astrocytoma, NOS|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|386|198751799|Female|Astrocytoma, NOS|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|82|40190633|Female|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.2|0.2|Malignant|78|40166755|Female|Astrocytoma, NOS|2017|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|84|39723250|Female|Astrocytoma, NOS|2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Astrocytoma, NOS|2019|~|~|~
0-19|0.1|0.2|0.2|Malignant|70|39588700|Female|Astrocytoma, NOS|2019|0.1|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40633964|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40633964|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40465313|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40465313|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40314778|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40314778|Female|Choroid plexus|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40221756|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40221756|Female|Choroid plexus|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40166969|Female|Choroid plexus|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40166969|Female|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40165125|Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165125|Female|Choroid plexus|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|136|198751799|Female|Choroid plexus|2015-2019|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|35|198751799|Female|Choroid plexus|2015-2019|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|23|40190633|Female|Choroid plexus|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40190633|Female|Choroid plexus|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|40166755|Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40166755|Female|Choroid plexus|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|39723250|Female|Choroid plexus|2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39723250|Female|Choroid plexus|2018|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|39588700|Female|Choroid plexus|2019|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39588700|Female|Choroid plexus|2019|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|77|40165421|Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40633964|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40633964|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|40465313|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40465313|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40314778|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40314778|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40221756|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40221756|Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|40166969|Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40166969|Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|81|40165125|Female|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40165125|Female|Craniopharyngioma|2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|351|198751799|Female|Craniopharyngioma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|198751799|Female|Craniopharyngioma|2015-2019|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40190633|Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40190633|Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|79|40166755|Female|Craniopharyngioma|2017|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40166755|Female|Craniopharyngioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|39723250|Female|Craniopharyngioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39723250|Female|Craniopharyngioma|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39588700|Female|Craniopharyngioma|2019|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39588700|Female|Craniopharyngioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|40633964|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Diffuse astrocytoma|2015-2019|~|~|~
0-19|~|~|~|Malignant|~|198751799|Female|Diffuse astrocytoma|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Diffuse astrocytoma|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Diffuse astrocytoma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|215|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|186|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|204|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|219|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|204|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|175|40633964|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|40465313|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.4|Malignant|181|40314778|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|187|40221756|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.5|Malignant|212|40166969|Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.4|0.5|0.5|Malignant|191|40165125|Female|Embryonal/primitive/medulloblastoma|2015|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Embryonal/primitive/medulloblastoma|2015-2019|~|~|~
0-19|0.4|0.4|0.4|Malignant|801|198751799|Female|Embryonal/primitive/medulloblastoma|2015-2019|0.4|0.4|0.4
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.4|0.5|0.4|Malignant|178|40190633|Female|Embryonal/primitive/medulloblastoma|2016|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.4|0.5|0.4|Malignant|170|40166755|Female|Embryonal/primitive/medulloblastoma|2017|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.3|0.5|0.4|Malignant|154|39723250|Female|Embryonal/primitive/medulloblastoma|2018|0.3|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Embryonal/primitive/medulloblastoma|2019|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|39588700|Female|Embryonal/primitive/medulloblastoma|2019|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40465313|Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40465313|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40314778|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40314778|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40221756|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40221756|Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|Ependymoma variants|2015|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|61|198751799|Female|Ependymoma variants|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|198751799|Female|Ependymoma variants|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Ependymoma variants|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Ependymoma variants|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Ependymoma variants|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Ependymoma variants|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|72|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|40633964|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40465313|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40314778|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40221756|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40166969|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40165125|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Ependymoma/anaplastic ependymoma|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|401|198751799|Female|Ependymoma/anaplastic ependymoma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40190633|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40166755|Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|39723250|Female|Ependymoma/anaplastic ependymoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Ependymoma/anaplastic ependymoma|2019|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|39588700|Female|Ependymoma/anaplastic ependymoma|2019|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|30|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40633964|Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|53|40633964|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|+|40465313|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|36|40465313|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40314778|Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|21|40314778|Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40221756|Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|48|40221756|Female|Germ Cell Tumors|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40166969|Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|34|40166969|Female|Germ Cell Tumors|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165125|Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|46|40165125|Female|Germ Cell Tumors|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|96|198751799|Female|Germ Cell Tumors|2015-2019|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|235|198751799|Female|Germ Cell Tumors|2015-2019|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|40190633|Female|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|58|40190633|Female|Germ Cell Tumors|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Germ Cell Tumors|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40166755|Female|Germ Cell Tumors|2017|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|39723250|Female|Germ Cell Tumors|2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|40|39723250|Female|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Germ Cell Tumors|2019|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39588700|Female|Germ Cell Tumors|2019|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|59|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40633964|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40465313|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|40314778|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40221756|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|40166969|Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Glioblastoma|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|40165125|Female|Glioblastoma|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Glioblastoma|2015-2019|~|~|~
0-19|0.1|0.2|0.2|Malignant|301|198751799|Female|Glioblastoma|2015-2019|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.1|Malignant|55|40190633|Female|Glioblastoma|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|70|40166755|Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.1|Malignant|59|39723250|Female|Glioblastoma|2018|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Glioblastoma|2019|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|39588700|Female|Glioblastoma|2019|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|234|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|237|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|246|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|270|40382360|Female|Glioma malignant, NOS|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|298|40670476|Female|Glioma malignant, NOS|2009|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.7|Malignant|264|40633964|Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|+|40465313|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.9|0.8|Malignant|314|40465313|Female|Glioma malignant, NOS|2011|0.7|0.9|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|17|40314778|Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|228|40314778|Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.7|0.8|0.8|Malignant|305|40221756|Female|Glioma malignant, NOS|2013|0.7|0.8|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|18|40166969|Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|272|40166969|Female|Glioma malignant, NOS|2014|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Glioma malignant, NOS|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|279|40165125|Female|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|96|198751799|Female|Glioma malignant, NOS|2015-2019|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|1357|198751799|Female|Glioma malignant, NOS|2015-2019|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|23|40190633|Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|316|40190633|Female|Glioma malignant, NOS|2016|0.7|0.9|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|22|40166755|Female|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|316|40166755|Female|Glioma malignant, NOS|2017|0.7|0.9|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|21|39723250|Female|Glioma malignant, NOS|2018|0.0|0.1|0.1
0-19|0.5|0.7|0.6|Malignant|245|39723250|Female|Glioma malignant, NOS|2018|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Glioma malignant, NOS|2019|~|~|~
0-19|0.5|0.6|0.5|Malignant|209|39588700|Female|Glioma malignant, NOS|2019|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40670476|Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40465313|Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40465313|Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40314778|Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40314778|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40221756|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40221756|Female|Hemangioblastoma|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|40166969|Female|Hemangioblastoma|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40166969|Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40165125|Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165125|Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|80|198751799|Female|Hemangioblastoma|2015-2019|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|198751799|Female|Hemangioblastoma|2015-2019|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40190633|Female|Hemangioblastoma|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40190633|Female|Hemangioblastoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Hemangioblastoma|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39723250|Female|Hemangioblastoma|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39723250|Female|Hemangioblastoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Hemangioblastoma|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Hemangioblastoma|2019|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39865121|Female|Hemangioma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|40382360|Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40576293|Female|Hemangioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|40633964|Female|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40633964|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|40465313|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40465313|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40314778|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40314778|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40221756|Female|Hemangioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40221756|Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40166969|Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40166969|Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|40165125|Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165125|Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|271|198751799|Female|Hemangioma|2015-2019|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|198751799|Female|Hemangioma|2015-2019|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|40190633|Female|Hemangioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40190633|Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|40166755|Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40166755|Female|Hemangioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|39723250|Female|Hemangioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39723250|Female|Hemangioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|39588700|Female|Hemangioma|2019|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39588700|Female|Hemangioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Local Extensions from Regional Tumors|2015-2019|~|~|~
0-19|~|~|~|Malignant|~|198751799|Female|Local Extensions from Regional Tumors|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Local Extensions from Regional Tumors|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Local Extensions from Regional Tumors|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|198751799|Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40633964|Female|Meningioma|2010|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40633964|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40465313|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40465313|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40314778|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40314778|Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|40221756|Female|Meningioma|2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40221756|Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|40166969|Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40166969|Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|40165125|Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165125|Female|Meningioma|2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|345|198751799|Female|Meningioma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|198751799|Female|Meningioma|2015-2019|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|40190633|Female|Meningioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40190633|Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40166755|Female|Meningioma|2017|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40166755|Female|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|39723250|Female|Meningioma|2018|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39723250|Female|Meningioma|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|39588700|Female|Meningioma|2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39588700|Female|Meningioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|+|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|+|40576293|Female|Mixed glioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Mixed glioma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|198751799|Female|Mixed glioma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Mixed glioma|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Mixed glioma|2019|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|57|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|52|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|79|40576293|Female|Neoplasm, unspecified|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40633964|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40633964|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40465313|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|+|40465313|Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|74|40314778|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|40314778|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|75|40221756|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|40221756|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|80|40166969|Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40166969|Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|82|40165125|Female|Neoplasm, unspecified|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40165125|Female|Neoplasm, unspecified|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|296|198751799|Female|Neoplasm, unspecified|2015-2019|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|99|198751799|Female|Neoplasm, unspecified|2015-2019|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|55|40190633|Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|23|40190633|Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|53|40166755|Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|20|40166755|Female|Neoplasm, unspecified|2017|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|65|39723250|Female|Neoplasm, unspecified|2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|26|39723250|Female|Neoplasm, unspecified|2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|42|39588700|Female|Neoplasm, unspecified|2019|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|39588700|Female|Neoplasm, unspecified|2019|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Nerve sheath, benign and malignant|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|161|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40382360|Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|40633964|Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40633964|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40465313|Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40465313|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40314778|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40314778|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40221756|Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40221756|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40166969|Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40166969|Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|159|40165125|Female|Nerve sheath, benign and malignant|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165125|Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|561|198751799|Female|Nerve sheath, benign and malignant|2015-2019|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|198751799|Female|Nerve sheath, benign and malignant|2015-2019|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40190633|Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40190633|Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|123|40166755|Female|Nerve sheath, benign and malignant|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40166755|Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39723250|Female|Nerve sheath, benign and malignant|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39723250|Female|Nerve sheath, benign and malignant|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|39588700|Female|Nerve sheath, benign and malignant|2019|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39588700|Female|Nerve sheath, benign and malignant|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|40166969|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|40165125|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Neuroepithelial|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|+|198751799|Female|Neuroepithelial|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Neuroepithelial|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Neuroepithelial|2019|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|27|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|126|40165421|Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|140|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|34|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|135|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|144|40633964|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|+|40633964|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|154|40465313|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40465313|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40314778|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|17|40314778|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|162|40221756|Female|Neuronal/glial, neuronal|2013|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|22|40221756|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|161|40166969|Female|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|25|40166969|Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|172|40165125|Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|17|40165125|Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|815|198751799|Female|Neuronal/glial, neuronal|2015-2019|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|118|198751799|Female|Neuronal/glial, neuronal|2015-2019|0.0|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|186|40190633|Female|Neuronal/glial, neuronal|2016|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|29|40190633|Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|174|40166755|Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|22|40166755|Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|150|39723250|Female|Neuronal/glial, neuronal|2018|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|39723250|Female|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|136|39588700|Female|Neuronal/glial, neuronal|2019|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|21|39588700|Female|Neuronal/glial, neuronal|2019|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40633964|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40465313|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40314778|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40221756|Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40166969|Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40165125|Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|198751799|Female|Oligodendroglioma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|72|198751799|Female|Oligodendroglioma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40190633|Female|Oligodendroglioma|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|39723250|Female|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Oligodendroglioma|2019|~|~|~
0-19|~|~|~|Malignant|~|39588700|Female|Oligodendroglioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40633964|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40633964|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40465313|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40465313|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40314778|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40314778|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40221756|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40221756|Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|40166969|Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40166969|Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165125|Female|Other mesenchymal|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165125|Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|227|198751799|Female|Other mesenchymal|2015-2019|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|198751799|Female|Other mesenchymal|2015-2019|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|52|40190633|Female|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40190633|Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|40166755|Female|Other mesenchymal|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40166755|Female|Other mesenchymal|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|45|39723250|Female|Other mesenchymal|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39723250|Female|Other mesenchymal|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|39588700|Female|Other mesenchymal|2019|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|39588700|Female|Other mesenchymal|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|330|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|325|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|319|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.9|Malignant|342|40382360|Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|337|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|359|40670476|Female|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.1|1.0|Malignant|399|40633964|Female|Pilocytic astrocytoma|2010|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|358|40465313|Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|0.9|Malignant|382|40314778|Female|Pilocytic astrocytoma|2012|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|365|40221756|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.1|1.0|Malignant|410|40166969|Female|Pilocytic astrocytoma|2014|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|359|40165125|Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|0.1|0.1|0.1|Benign/Borderline|128|198751799|Female|Pilocytic astrocytoma|2015-2019|0.1|0.1|0.1
0-19|0.8|0.9|0.9|Malignant|1695|198751799|Female|Pilocytic astrocytoma|2015-2019|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.7|0.9|0.8|Malignant|329|40190633|Female|Pilocytic astrocytoma|2016|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Pilocytic astrocytoma|2017|~|~|~
0-19|0.9|1.1|1.0|Malignant|405|40166755|Female|Pilocytic astrocytoma|2017|0.9|1.1|1.0
0-19|0.2|0.2|0.2|Benign/Borderline|78|39723250|Female|Pilocytic astrocytoma|2018|0.2|0.2|0.2
0-19|0.7|0.9|0.8|Malignant|329|39723250|Female|Pilocytic astrocytoma|2018|0.7|0.9|0.8
0-19|0.1|0.2|0.1|Benign/Borderline|50|39588700|Female|Pilocytic astrocytoma|2019|0.1|0.2|0.1
0-19|0.6|0.8|0.7|Malignant|285|39588700|Female|Pilocytic astrocytoma|2019|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40633964|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40633964|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40465313|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40465313|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40314778|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|40314778|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40221756|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|40221756|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166969|Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40166969|Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165125|Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40165125|Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Benign/Borderline|+|198751799|Female|Pineal parenchymal|2015-2019|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|90|198751799|Female|Pineal parenchymal|2015-2019|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40190633|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Malignant|~|40190633|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40166755|Female|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|40166755|Female|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|39723250|Female|Pineal parenchymal|2018|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|39723250|Female|Pineal parenchymal|2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39588700|Female|Pineal parenchymal|2019|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|39588700|Female|Pineal parenchymal|2019|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Benign/Borderline|284|39865121|Female|Pituitary|2004|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|323|39998876|Female|Pituitary|2005|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|366|40165421|Female|Pituitary|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|353|40382360|Female|Pituitary|2007|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|414|40576293|Female|Pituitary|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|411|40670476|Female|Pituitary|2009|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|471|40633964|Female|Pituitary|2010|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40633964|Female|Pituitary|2010|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|480|40465313|Female|Pituitary|2011|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40465313|Female|Pituitary|2011|~|~|~
0-19|1.1|1.4|1.2|Benign/Borderline|512|40314778|Female|Pituitary|2012|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40314778|Female|Pituitary|2012|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|502|40221756|Female|Pituitary|2013|1.1|1.4|1.2
0-19|~|~|~|Malignant|~|40221756|Female|Pituitary|2013|~|~|~
0-19|1.2|1.5|1.3|Benign/Borderline|547|40166969|Female|Pituitary|2014|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40166969|Female|Pituitary|2014|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|537|40165125|Female|Pituitary|2015|1.2|1.5|1.3
0-19|~|~|~|Malignant|~|40165125|Female|Pituitary|2015|~|~|~
0-19|1.3|1.4|1.4|Benign/Borderline|2762|198751799|Female|Pituitary|2015-2019|1.3|1.4|1.4
0-19|~|~|~|Malignant|~|198751799|Female|Pituitary|2015-2019|~|~|~
0-19|1.3|1.6|1.4|Benign/Borderline|583|40190633|Female|Pituitary|2016|1.3|1.6|1.5
0-19|~|~|~|Malignant|~|40190633|Female|Pituitary|2016|~|~|~
0-19|1.3|1.6|1.5|Benign/Borderline|592|40166755|Female|Pituitary|2017|1.4|1.6|1.5
0-19|~|~|~|Malignant|~|40166755|Female|Pituitary|2017|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|572|39723250|Female|Pituitary|2018|1.3|1.6|1.4
0-19|~|~|~|Malignant|~|39723250|Female|Pituitary|2018|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|491|39588700|Female|Pituitary|2019|1.1|1.4|1.2
0-19|~|~|~|Malignant|~|39588700|Female|Pituitary|2019|~|~|~
0-19|1.9|2.2|2.0|Benign/Borderline|808|39865121|Female|Total|2004|1.9|2.2|2.0
0-19|3.1|3.5|3.3|Malignant|1309|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.2|2.5|2.4|Benign/Borderline|971|39998876|Female|Total|2005|2.3|2.6|2.4
0-19|2.9|3.3|3.1|Malignant|1243|39998876|Female|Total|2005|2.9|3.3|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|990|40165421|Female|Total|2006|2.3|2.6|2.5
0-19|2.9|3.3|3.1|Malignant|1232|40165421|Female|Total|2006|2.9|3.2|3.1
0-19|2.3|2.6|2.4|Benign/Borderline|1005|40382360|Female|Total|2007|2.3|2.6|2.5
0-19|3.1|3.4|3.2|Malignant|1307|40382360|Female|Total|2007|3.1|3.4|3.2
0-19|2.5|2.8|2.7|Benign/Borderline|1097|40576293|Female|Total|2008|2.5|2.9|2.7
0-19|3.0|3.4|3.2|Malignant|1287|40576293|Female|Total|2008|3.0|3.3|3.2
0-19|2.5|2.9|2.7|Benign/Borderline|1116|40670476|Female|Total|2009|2.6|2.9|2.7
0-19|3.0|3.4|3.2|Malignant|1303|40670476|Female|Total|2009|3.0|3.4|3.2
0-19|2.7|3.1|2.9|Benign/Borderline|1192|40633964|Female|Total|2010|2.8|3.1|2.9
0-19|3.1|3.4|3.2|Malignant|1309|40633964|Female|Total|2010|3.0|3.4|3.2
0-19|2.8|3.2|3.0|Benign/Borderline|1225|40465313|Female|Total|2011|2.9|3.2|3.0
0-19|3.2|3.5|3.4|Malignant|1358|40465313|Female|Total|2011|3.2|3.5|3.4
0-19|3.0|3.3|3.2|Benign/Borderline|1282|40314778|Female|Total|2012|3.0|3.4|3.2
0-19|2.9|3.3|3.1|Malignant|1242|40314778|Female|Total|2012|2.9|3.3|3.1
0-19|3.1|3.4|3.2|Benign/Borderline|1314|40221756|Female|Total|2013|3.1|3.4|3.3
0-19|3.2|3.6|3.4|Malignant|1364|40221756|Female|Total|2013|3.2|3.6|3.4
0-19|3.1|3.4|3.3|Benign/Borderline|1317|40166969|Female|Total|2014|3.1|3.5|3.3
0-19|3.3|3.6|3.5|Malignant|1388|40166969|Female|Total|2014|3.3|3.6|3.5
0-19|3.2|3.5|3.3|Benign/Borderline|1345|40165125|Female|Total|2015|3.2|3.5|3.3
0-19|3.0|3.4|3.2|Malignant|1291|40165125|Female|Total|2015|3.0|3.4|3.2
0-19|3.1|3.3|3.2|Benign/Borderline|6368|198751799|Female|Total|2015-2019|3.1|3.3|3.2
0-19|2.9|3.1|3.0|Malignant|5987|198751799|Female|Total|2015-2019|2.9|3.1|3.0
0-19|3.1|3.5|3.3|Benign/Borderline|1341|40190633|Female|Total|2016|3.2|3.5|3.3
0-19|3.0|3.4|3.2|Malignant|1280|40190633|Female|Total|2016|3.0|3.4|3.2
0-19|3.1|3.4|3.2|Benign/Borderline|1314|40166755|Female|Total|2017|3.1|3.5|3.3
0-19|3.1|3.5|3.3|Malignant|1332|40166755|Female|Total|2017|3.1|3.5|3.3
0-19|3.0|3.4|3.2|Benign/Borderline|1287|39723250|Female|Total|2018|3.1|3.4|3.2
0-19|2.7|3.0|2.9|Malignant|1140|39723250|Female|Total|2018|2.7|3.0|2.9
0-19|2.6|3.0|2.8|Benign/Borderline|1113|39588700|Female|Total|2019|2.6|3.0|2.8
0-19|2.3|2.6|2.5|Malignant|981|39588700|Female|Total|2019|2.3|2.6|2.5
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|161|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|157|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|40633964|Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40633964|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40465313|Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40465313|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40314778|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40314778|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40221756|Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40221756|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|107|40166969|Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40166969|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|159|40165125|Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165125|Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|562|198751799|Female|Tumors of Cranial and Spinal Nerves|2015-2019|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|198751799|Female|Tumors of Cranial and Spinal Nerves|2015-2019|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40190633|Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40190633|Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40166755|Female|Tumors of Cranial and Spinal Nerves|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40166755|Female|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39723250|Female|Tumors of Cranial and Spinal Nerves|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39723250|Female|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|39588700|Female|Tumors of Cranial and Spinal Nerves|2019|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39588700|Female|Tumors of Cranial and Spinal Nerves|2019|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|191|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|1211|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|198|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1152|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.1|2.9
0-19|0.4|0.6|0.5|Benign/Borderline|206|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1162|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.1|2.9
0-19|0.5|0.7|0.6|Benign/Borderline|232|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1244|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.3|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|231|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1232|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|216|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
0-19|2.9|3.2|3.0|Malignant|1223|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|235|40633964|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.7|0.6
0-19|2.9|3.2|3.0|Malignant|1228|40633964|Female|Tumors of Neuroepthelial Tissue|2010|2.9|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|249|40465313|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|3.0|3.3|3.2|Malignant|1280|40465313|Female|Tumors of Neuroepthelial Tissue|2011|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|255|40314778|Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.6
0-19|2.8|3.1|2.9|Malignant|1178|40314778|Female|Tumors of Neuroepthelial Tissue|2012|2.8|3.1|2.9
0-19|0.6|0.8|0.7|Benign/Borderline|268|40221756|Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.0|3.4|3.2|Malignant|1274|40221756|Female|Tumors of Neuroepthelial Tissue|2013|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|256|40166969|Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1313|40166969|Female|Tumors of Neuroepthelial Tissue|2014|3.1|3.5|3.3
0-19|0.6|0.7|0.6|Benign/Borderline|257|40165125|Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.7|0.6
0-19|2.8|3.2|3.0|Malignant|1208|40165125|Female|Tumors of Neuroepthelial Tissue|2015|2.8|3.2|3.0
0-19|0.7|0.7|0.7|Benign/Borderline|1378|198751799|Female|Tumors of Neuroepthelial Tissue|2015-2019|0.7|0.7|0.7
0-19|2.7|2.9|2.8|Malignant|5572|198751799|Female|Tumors of Neuroepthelial Tissue|2015-2019|2.7|2.9|2.8
0-19|0.6|0.8|0.7|Benign/Borderline|277|40190633|Female|Tumors of Neuroepthelial Tissue|2016|0.6|0.8|0.7
0-19|2.8|3.1|2.9|Malignant|1178|40190633|Female|Tumors of Neuroepthelial Tissue|2016|2.8|3.1|2.9
0-19|0.6|0.8|0.7|Benign/Borderline|275|40166755|Female|Tumors of Neuroepthelial Tissue|2017|0.6|0.8|0.7
0-19|3.0|3.3|3.1|Malignant|1255|40166755|Female|Tumors of Neuroepthelial Tissue|2017|3.0|3.3|3.1
0-19|0.7|0.9|0.8|Benign/Borderline|315|39723250|Female|Tumors of Neuroepthelial Tissue|2018|0.7|0.9|0.8
0-19|2.5|2.8|2.7|Malignant|1060|39723250|Female|Tumors of Neuroepthelial Tissue|2018|2.5|2.8|2.7
0-19|0.6|0.7|0.7|Benign/Borderline|263|39588700|Female|Tumors of Neuroepthelial Tissue|2019|0.6|0.7|0.7
0-19|2.1|2.4|2.3|Malignant|906|39588700|Female|Tumors of Neuroepthelial Tissue|2019|2.1|2.4|2.3
0-19|0.8|1.0|0.9|Benign/Borderline|368|39865121|Female|Tumors of Sellar Region|2004|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|401|39998876|Female|Tumors of Sellar Region|2005|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|443|40165421|Female|Tumors of Sellar Region|2006|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|449|40382360|Female|Tumors of Sellar Region|2007|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.3|1.1|Benign/Borderline|480|40576293|Female|Tumors of Sellar Region|2008|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|502|40670476|Female|Tumors of Sellar Region|2009|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.2|1.5|1.4|Benign/Borderline|563|40633964|Female|Tumors of Sellar Region|2010|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40633964|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|567|40465313|Female|Tumors of Sellar Region|2011|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40465313|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.3|1.6|1.4|Benign/Borderline|590|40314778|Female|Tumors of Sellar Region|2012|1.3|1.6|1.5
0-19|~|~|~|Malignant|~|40314778|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.3|1.6|1.5|Benign/Borderline|591|40221756|Female|Tumors of Sellar Region|2013|1.4|1.6|1.5
0-19|~|~|~|Malignant|~|40221756|Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|640|40166969|Female|Tumors of Sellar Region|2014|1.5|1.7|1.6
0-19|~|~|~|Malignant|~|40166969|Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.4|1.6|1.5|Benign/Borderline|618|40165125|Female|Tumors of Sellar Region|2015|1.4|1.7|1.5
0-19|~|~|~|Malignant|~|40165125|Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.5|1.6|1.5|Benign/Borderline|3113|198751799|Female|Tumors of Sellar Region|2015-2019|1.5|1.6|1.6
0-19|~|~|~|Malignant|~|198751799|Female|Tumors of Sellar Region|2015-2019|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|651|40190633|Female|Tumors of Sellar Region|2016|1.5|1.7|1.6
0-19|~|~|~|Malignant|~|40190633|Female|Tumors of Sellar Region|2016|~|~|~
0-19|1.5|1.8|1.7|Benign/Borderline|671|40166755|Female|Tumors of Sellar Region|2017|1.5|1.8|1.7
0-19|~|~|~|Malignant|~|40166755|Female|Tumors of Sellar Region|2017|~|~|~
0-19|1.4|1.7|1.6|Benign/Borderline|625|39723250|Female|Tumors of Sellar Region|2018|1.5|1.7|1.6
0-19|~|~|~|Malignant|~|39723250|Female|Tumors of Sellar Region|2018|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|565|39588700|Female|Tumors of Sellar Region|2019|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|39588700|Female|Tumors of Sellar Region|2019|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|102|40633964|Female|Tumors of the Meninges|2010|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40633964|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40465313|Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40465313|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|40314778|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40314778|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|139|40221756|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40221756|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40166969|Female|Tumors of the Meninges|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40166969|Female|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|40165125|Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40165125|Female|Tumors of the Meninges|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|652|198751799|Female|Tumors of the Meninges|2015-2019|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|44|198751799|Female|Tumors of the Meninges|2015-2019|0.0|0.0|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|146|40190633|Female|Tumors of the Meninges|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40190633|Female|Tumors of the Meninges|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|125|40166755|Female|Tumors of the Meninges|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40166755|Female|Tumors of the Meninges|2017|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|128|39723250|Female|Tumors of the Meninges|2018|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|39723250|Female|Tumors of the Meninges|2018|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|118|39588700|Female|Tumors of the Meninges|2019|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|39588700|Female|Tumors of the Meninges|2019|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|49|39865121|Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|81|39998876|Female|Unclassified Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|20|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|86|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|84|40382360|Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|129|40576293|Female|Unclassified Tumors|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|135|40633964|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40633964|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40465313|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|20|40465313|Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|142|40314778|Female|Unclassified Tumors|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|25|40314778|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|140|40221756|Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40221756|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|144|40166969|Female|Unclassified Tumors|2014|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|24|40166969|Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|157|40165125|Female|Unclassified Tumors|2015|0.3|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40165125|Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|567|198751799|Female|Unclassified Tumors|2015-2019|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|103|198751799|Female|Unclassified Tumors|2015-2019|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|110|40190633|Female|Unclassified Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|24|40190633|Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|105|40166755|Female|Unclassified Tumors|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|21|40166755|Female|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|117|39723250|Female|Unclassified Tumors|2018|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|27|39723250|Female|Unclassified Tumors|2018|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|82|39588700|Female|Unclassified Tumors|2019|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|17|39588700|Female|Unclassified Tumors|2019|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|+|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|+|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|32|40633964|Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40633964|Female|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40465313|Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|23|40465313|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|34|40314778|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40314778|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|39|40221756|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|40221756|Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|44|40166969|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40166969|Female|Unique astrocytoma variants|2014|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|21|40165125|Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165125|Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|110|198751799|Female|Unique astrocytoma variants|2015-2019|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|116|198751799|Female|Unique astrocytoma variants|2015-2019|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40190633|Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|21|40190633|Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40166755|Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|40166755|Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|39723250|Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|39723250|Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|39588700|Female|Unique astrocytoma variants|2019|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|21|39588700|Female|Unique astrocytoma variants|2019|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42373156|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42373156|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186700|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|42186700|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42049482|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|42049482|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955285|Male|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|41955285|Male|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|69|207542387|Male|All other|2015-2019|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Malignant|285|207542387|Male|All other|2015-2019|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41970804|Male|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|41970804|Male|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41947609|Male|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|41477470|Male|All other|2018|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Malignant|121|41477470|Male|All other|2018|0.2|0.3|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|34|41328224|Male|All other|2019|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Malignant|133|41328224|Male|All other|2019|0.3|0.4|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|56|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42550328|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42373156|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42186700|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|42049482|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.2|0.1|Malignant|58|41972229|Male|Anaplastic astrocytoma|2014|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|41955285|Male|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Anaplastic astrocytoma|2015-2019|~|~|~
0-19|0.1|0.1|0.1|Malignant|194|207542387|Male|Anaplastic astrocytoma|2015-2019|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|41970804|Male|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Anaplastic astrocytoma|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|41947609|Male|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Anaplastic astrocytoma|2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41477470|Male|Anaplastic astrocytoma|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Anaplastic astrocytoma|2019|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|41328224|Male|Anaplastic astrocytoma|2019|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42373156|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42186700|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42049482|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41955285|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Anaplastic oligodendroglioma|2015-2019|~|~|~
0-19|~|~|~|Malignant|~|207542387|Male|Anaplastic oligodendroglioma|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41970804|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Anaplastic oligodendroglioma|2019|~|~|~
0-19|~|~|~|Malignant|~|41328224|Male|Anaplastic oligodendroglioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|123|42550328|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|42373156|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|42186700|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|42049482|Male|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|113|41972229|Male|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|41955285|Male|Astrocytoma, NOS|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Astrocytoma, NOS|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|450|207542387|Male|Astrocytoma, NOS|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|41970804|Male|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|105|41947609|Male|Astrocytoma, NOS|2017|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|41477470|Male|Astrocytoma, NOS|2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Astrocytoma, NOS|2019|~|~|~
0-19|0.1|0.2|0.2|Malignant|73|41328224|Male|Astrocytoma, NOS|2019|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|42550328|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|+|42550328|Male|Choroid plexus|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|34|42373156|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42373156|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42186700|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42186700|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42049482|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42049482|Male|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|41972229|Male|Choroid plexus|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41972229|Male|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41955285|Male|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|+|41955285|Male|Choroid plexus|2015|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|173|207542387|Male|Choroid plexus|2015-2019|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|62|207542387|Male|Choroid plexus|2015-2019|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|41970804|Male|Choroid plexus|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41970804|Male|Choroid plexus|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41947609|Male|Choroid plexus|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41947609|Male|Choroid plexus|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|41477470|Male|Choroid plexus|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41477470|Male|Choroid plexus|2018|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41328224|Male|Choroid plexus|2019|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41328224|Male|Choroid plexus|2019|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|41889233|Male|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|42367071|Male|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42609915|Male|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42550328|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42550328|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|42373156|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42373156|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|78|42186700|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42186700|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42049482|Male|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42049482|Male|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|41972229|Male|Craniopharyngioma|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41972229|Male|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|41955285|Male|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41955285|Male|Craniopharyngioma|2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|445|207542387|Male|Craniopharyngioma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|207542387|Male|Craniopharyngioma|2015-2019|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|75|41970804|Male|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41970804|Male|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|103|41947609|Male|Craniopharyngioma|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41947609|Male|Craniopharyngioma|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|99|41477470|Male|Craniopharyngioma|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41477470|Male|Craniopharyngioma|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|41328224|Male|Craniopharyngioma|2019|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41328224|Male|Craniopharyngioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|+|42373156|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|42186700|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|42049482|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|41955285|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Diffuse astrocytoma|2015-2019|~|~|~
0-19|~|~|~|Malignant|~|207542387|Male|Diffuse astrocytoma|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|41970804|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Diffuse astrocytoma|2019|~|~|~
0-19|~|~|~|Malignant|~|41328224|Male|Diffuse astrocytoma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|294|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|296|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|299|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|323|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|310|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|314|42550328|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|301|42373156|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|286|42186700|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.7|Malignant|273|42049482|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.8|0.7|Malignant|282|41972229|Male|Embryonal/primitive/medulloblastoma|2014|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|41955285|Male|Embryonal/primitive/medulloblastoma|2015|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Embryonal/primitive/medulloblastoma|2015-2019|~|~|~
0-19|0.6|0.6|0.6|Malignant|1259|207542387|Male|Embryonal/primitive/medulloblastoma|2015-2019|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.6|0.8|0.7|Malignant|288|41970804|Male|Embryonal/primitive/medulloblastoma|2016|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.6|0.8|0.7|Malignant|301|41947609|Male|Embryonal/primitive/medulloblastoma|2017|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.4|0.6|0.5|Malignant|200|41477470|Male|Embryonal/primitive/medulloblastoma|2018|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Embryonal/primitive/medulloblastoma|2019|~|~|~
0-19|0.4|0.5|0.4|Malignant|180|41328224|Male|Embryonal/primitive/medulloblastoma|2019|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|+|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|+|42550328|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550328|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42373156|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42373156|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42186700|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42186700|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42049482|Male|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42049482|Male|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|Ependymoma variants|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|41955285|Male|Ependymoma variants|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41955285|Male|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|106|207542387|Male|Ependymoma variants|2015-2019|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|207542387|Male|Ependymoma variants|2015-2019|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|+|41970804|Male|Ependymoma variants|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41970804|Male|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|+|41947609|Male|Ependymoma variants|2017|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41947609|Male|Ependymoma variants|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|+|41477470|Male|Ependymoma variants|2018|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41477470|Male|Ependymoma variants|2018|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|+|41328224|Male|Ependymoma variants|2019|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41328224|Male|Ependymoma variants|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42550328|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42373156|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42186700|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42049482|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41972229|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|41955285|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Ependymoma/anaplastic ependymoma|2015-2019|~|~|~
0-19|0.2|0.3|0.3|Malignant|530|207542387|Male|Ependymoma/anaplastic ependymoma|2015-2019|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|41970804|Male|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.4|0.3|Malignant|125|41947609|Male|Ependymoma/anaplastic ependymoma|2017|0.2|0.4|0.3
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|41477470|Male|Ependymoma/anaplastic ependymoma|2018|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Ependymoma/anaplastic ependymoma|2019|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|41328224|Male|Ependymoma/anaplastic ependymoma|2019|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|+|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|+|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|+|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|100|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|29|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|22|42550328|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|112|42550328|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|101|42373156|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|25|42186700|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42186700|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|42049482|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|111|42049482|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|41972229|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|103|41972229|Male|Germ Cell Tumors|2014|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|19|41955285|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|106|41955285|Male|Germ Cell Tumors|2015|0.2|0.3|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|131|207542387|Male|Germ Cell Tumors|2015-2019|0.1|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|534|207542387|Male|Germ Cell Tumors|2015-2019|0.2|0.3|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|34|41970804|Male|Germ Cell Tumors|2016|0.1|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|41970804|Male|Germ Cell Tumors|2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|+|41947609|Male|Germ Cell Tumors|2017|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Malignant|131|41947609|Male|Germ Cell Tumors|2017|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|33|41477470|Male|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|86|41477470|Male|Germ Cell Tumors|2018|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|+|41328224|Male|Germ Cell Tumors|2019|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|105|41328224|Male|Germ Cell Tumors|2019|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42550328|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|84|42373156|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|79|42186700|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|42049482|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|78|41972229|Male|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41955285|Male|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Glioblastoma|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|381|207542387|Male|Glioblastoma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Glioblastoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|41970804|Male|Glioblastoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|72|41947609|Male|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Glioblastoma|2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|41477470|Male|Glioblastoma|2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Glioblastoma|2019|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|41328224|Male|Glioblastoma|2019|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|224|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|244|42158997|Male|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|245|42367071|Male|Glioma malignant, NOS|2007|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|271|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|274|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.8|0.7|Malignant|286|42550328|Male|Glioma malignant, NOS|2010|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|285|42373156|Male|Glioma malignant, NOS|2011|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|18|42186700|Male|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|284|42186700|Male|Glioma malignant, NOS|2012|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|+|42049482|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|276|42049482|Male|Glioma malignant, NOS|2013|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|24|41972229|Male|Glioma malignant, NOS|2014|0.0|0.1|0.1
0-19|0.6|0.7|0.6|Malignant|263|41972229|Male|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|+|41955285|Male|Glioma malignant, NOS|2015|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|308|41955285|Male|Glioma malignant, NOS|2015|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|120|207542387|Male|Glioma malignant, NOS|2015-2019|0.0|0.1|0.1
0-19|0.6|0.7|0.7|Malignant|1348|207542387|Male|Glioma malignant, NOS|2015-2019|0.6|0.7|0.6
0-19|0.0|0.1|0.1|Benign/Borderline|30|41970804|Male|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|297|41970804|Male|Glioma malignant, NOS|2016|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|23|41947609|Male|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.9|0.8|Malignant|327|41947609|Male|Glioma malignant, NOS|2017|0.7|0.9|0.8
0-19|0.1|0.1|0.1|Benign/Borderline|31|41477470|Male|Glioma malignant, NOS|2018|0.1|0.1|0.1
0-19|0.5|0.6|0.5|Malignant|219|41477470|Male|Glioma malignant, NOS|2018|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Glioma malignant, NOS|2019|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|41328224|Male|Glioma malignant, NOS|2019|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Benign/Borderline|+|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42609915|Male|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42373156|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42373156|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|42186700|Male|Hemangioblastoma|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42186700|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|42049482|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42049482|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|41972229|Male|Hemangioblastoma|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41972229|Male|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|41955285|Male|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41955285|Male|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|89|207542387|Male|Hemangioblastoma|2015-2019|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|207542387|Male|Hemangioblastoma|2015-2019|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41970804|Male|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41970804|Male|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|41947609|Male|Hemangioblastoma|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41947609|Male|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41477470|Male|Hemangioblastoma|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41477470|Male|Hemangioblastoma|2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|+|41328224|Male|Hemangioblastoma|2019|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41328224|Male|Hemangioblastoma|2019|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41889233|Male|Hemangioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42158997|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|48|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|42550328|Male|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42550328|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|42373156|Male|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42373156|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|42186700|Male|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42186700|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|42049482|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42049482|Male|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|41972229|Male|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41972229|Male|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|41955285|Male|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41955285|Male|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|301|207542387|Male|Hemangioma|2015-2019|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|207542387|Male|Hemangioma|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41970804|Male|Hemangioma|2016|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41970804|Male|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|41947609|Male|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41947609|Male|Hemangioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|41477470|Male|Hemangioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41477470|Male|Hemangioma|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|41328224|Male|Hemangioma|2019|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41328224|Male|Hemangioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42373156|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|42186700|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|42049482|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|41955285|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Local Extensions from Regional Tumors|2015-2019|~|~|~
0-19|~|~|~|Malignant|~|207542387|Male|Local Extensions from Regional Tumors|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|41970804|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Local Extensions from Regional Tumors|2019|~|~|~
0-19|~|~|~|Malignant|~|41328224|Male|Local Extensions from Regional Tumors|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42373156|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|42186700|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|42049482|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|41955285|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Lymphomas and Hematopoietic Neoplasms|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|40|207542387|Male|Lymphomas and Hematopoietic Neoplasms|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|41970804|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
0-19|~|~|~|Malignant|~|41328224|Male|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|42550328|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42550328|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|42373156|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42373156|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|42186700|Male|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42186700|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|42049482|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42049482|Male|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41972229|Male|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41972229|Male|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|41955285|Male|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41955285|Male|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|307|207542387|Male|Meningioma|2015-2019|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|207542387|Male|Meningioma|2015-2019|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41970804|Male|Meningioma|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41970804|Male|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41947609|Male|Meningioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41947609|Male|Meningioma|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|41477470|Male|Meningioma|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41477470|Male|Meningioma|2018|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|41328224|Male|Meningioma|2019|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41328224|Male|Meningioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|42550328|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42373156|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42186700|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42049482|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41955285|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Mixed glioma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|207542387|Male|Mixed glioma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41970804|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Mixed glioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Mixed glioma|2019|~|~|~
0-19|~|~|~|Malignant|~|41328224|Male|Mixed glioma|2019|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|54|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|65|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|50|42541971|Male|Neoplasm, unspecified|2008|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|+|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|91|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|+|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|80|42550328|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|+|42550328|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|71|42373156|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42373156|Male|Neoplasm, unspecified|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42186700|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|29|42186700|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|69|42049482|Male|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42049482|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|41972229|Male|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|41972229|Male|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|63|41955285|Male|Neoplasm, unspecified|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|+|41955285|Male|Neoplasm, unspecified|2015|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|313|207542387|Male|Neoplasm, unspecified|2015-2019|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|111|207542387|Male|Neoplasm, unspecified|2015-2019|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|68|41970804|Male|Neoplasm, unspecified|2016|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|41970804|Male|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|68|41947609|Male|Neoplasm, unspecified|2017|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|30|41947609|Male|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|62|41477470|Male|Neoplasm, unspecified|2018|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|17|41477470|Male|Neoplasm, unspecified|2018|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|53|41328224|Male|Neoplasm, unspecified|2019|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|25|41328224|Male|Neoplasm, unspecified|2019|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Nerve sheath, benign and malignant|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|175|42158997|Male|Nerve sheath, benign and malignant|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|163|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42550328|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42550328|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|42373156|Male|Nerve sheath, benign and malignant|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42373156|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42186700|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42186700|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|164|42049482|Male|Nerve sheath, benign and malignant|2013|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42049482|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|151|41972229|Male|Nerve sheath, benign and malignant|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41972229|Male|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|41955285|Male|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41955285|Male|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|629|207542387|Male|Nerve sheath, benign and malignant|2015-2019|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|207542387|Male|Nerve sheath, benign and malignant|2015-2019|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|181|41970804|Male|Nerve sheath, benign and malignant|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41970804|Male|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|41947609|Male|Nerve sheath, benign and malignant|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41947609|Male|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|41477470|Male|Nerve sheath, benign and malignant|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41477470|Male|Nerve sheath, benign and malignant|2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|41328224|Male|Nerve sheath, benign and malignant|2019|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41328224|Male|Nerve sheath, benign and malignant|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42373156|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|42186700|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|42049482|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|41972229|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|41955285|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Neuroepithelial|2015-2019|~|~|~
0-19|~|~|~|Malignant|~|207542387|Male|Neuroepithelial|2015-2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|41970804|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Neuroepithelial|2019|~|~|~
0-19|~|~|~|Malignant|~|41328224|Male|Neuroepithelial|2019|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|150|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|157|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|175|42367071|Male|Neuronal/glial, neuronal|2007|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|29|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|179|42541971|Male|Neuronal/glial, neuronal|2008|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|28|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|160|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|173|42550328|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42550328|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|192|42373156|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|+|42373156|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.6|0.5|Benign/Borderline|207|42186700|Male|Neuronal/glial, neuronal|2012|0.4|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|22|42186700|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|191|42049482|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|23|42049482|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|175|41972229|Male|Neuronal/glial, neuronal|2014|0.4|0.5|0.4
0-19|0.1|0.1|0.1|Malignant|31|41972229|Male|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.4|0.6|0.5|Benign/Borderline|217|41955285|Male|Neuronal/glial, neuronal|2015|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|26|41955285|Male|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|1091|207542387|Male|Neuronal/glial, neuronal|2015-2019|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|111|207542387|Male|Neuronal/glial, neuronal|2015-2019|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|227|41970804|Male|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|25|41970804|Male|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.5|0.6|0.6|Benign/Borderline|232|41947609|Male|Neuronal/glial, neuronal|2017|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Malignant|17|41947609|Male|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|0.4|0.6|0.5|Benign/Borderline|205|41477470|Male|Neuronal/glial, neuronal|2018|0.4|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|21|41477470|Male|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|215|41328224|Male|Neuronal/glial, neuronal|2019|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|23|41328224|Male|Neuronal/glial, neuronal|2019|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42541971|Male|Oligodendroglioma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42550328|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42373156|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|42186700|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42049482|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41972229|Male|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41955285|Male|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Oligodendroglioma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|70|207542387|Male|Oligodendroglioma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41970804|Male|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Oligodendroglioma|2019|~|~|~
0-19|~|~|~|Malignant|~|41328224|Male|Oligodendroglioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42550328|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42550328|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42373156|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42373156|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|42186700|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42186700|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42049482|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42049482|Male|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|41972229|Male|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41972229|Male|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41955285|Male|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41955285|Male|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|204|207542387|Male|Other mesenchymal|2015-2019|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|41|207542387|Male|Other mesenchymal|2015-2019|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|50|41970804|Male|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41970804|Male|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|47|41947609|Male|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41947609|Male|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41477470|Male|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41477470|Male|Other mesenchymal|2018|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|41328224|Male|Other mesenchymal|2019|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41328224|Male|Other mesenchymal|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|371|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|354|42006384|Male|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.9|Malignant|358|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|350|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|396|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|370|42609915|Male|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|380|42550328|Male|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.9|1.1|1.0|Malignant|405|42373156|Male|Pilocytic astrocytoma|2011|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|429|42186700|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|435|42049482|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|1.0|0.9|Malignant|382|41972229|Male|Pilocytic astrocytoma|2014|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|383|41955285|Male|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|0.1|0.1|0.1|Benign/Borderline|132|207542387|Male|Pilocytic astrocytoma|2015-2019|0.1|0.1|0.1
0-19|0.9|0.9|0.9|Malignant|1874|207542387|Male|Pilocytic astrocytoma|2015-2019|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|1.0|0.9|Malignant|383|41970804|Male|Pilocytic astrocytoma|2016|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Pilocytic astrocytoma|2017|~|~|~
0-19|1.0|1.2|1.1|Malignant|443|41947609|Male|Pilocytic astrocytoma|2017|1.0|1.2|1.1
0-19|0.1|0.2|0.2|Benign/Borderline|66|41477470|Male|Pilocytic astrocytoma|2018|0.1|0.2|0.2
0-19|0.7|0.9|0.8|Malignant|346|41477470|Male|Pilocytic astrocytoma|2018|0.7|0.9|0.8
0-19|0.1|0.2|0.2|Benign/Borderline|66|41328224|Male|Pilocytic astrocytoma|2019|0.1|0.2|0.2
0-19|0.7|0.9|0.8|Malignant|326|41328224|Male|Pilocytic astrocytoma|2019|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42550328|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42550328|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42373156|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|42373156|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42186700|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|42186700|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42049482|Male|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|+|42049482|Male|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41972229|Male|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41972229|Male|Pineal parenchymal|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41955285|Male|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41955285|Male|Pineal parenchymal|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|207542387|Male|Pineal parenchymal|2015-2019|~|~|~
0-19|0.0|0.1|0.0|Malignant|86|207542387|Male|Pineal parenchymal|2015-2019|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41970804|Male|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|+|41970804|Male|Pineal parenchymal|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41947609|Male|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Malignant|~|41947609|Male|Pineal parenchymal|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|41477470|Male|Pineal parenchymal|2018|~|~|~
0-19|~|~|~|Malignant|~|41477470|Male|Pineal parenchymal|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|41328224|Male|Pineal parenchymal|2019|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|41328224|Male|Pineal parenchymal|2019|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|85|41889233|Male|Pituitary|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|124|42006384|Male|Pituitary|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|116|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|42541971|Male|Pituitary|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|158|42609915|Male|Pituitary|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42550328|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42550328|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|150|42373156|Male|Pituitary|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42373156|Male|Pituitary|2011|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|178|42186700|Male|Pituitary|2012|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42186700|Male|Pituitary|2012|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|177|42049482|Male|Pituitary|2013|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42049482|Male|Pituitary|2013|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|198|41972229|Male|Pituitary|2014|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41972229|Male|Pituitary|2014|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|166|41955285|Male|Pituitary|2015|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41955285|Male|Pituitary|2015|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|950|207542387|Male|Pituitary|2015-2019|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|207542387|Male|Pituitary|2015-2019|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|201|41970804|Male|Pituitary|2016|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41970804|Male|Pituitary|2016|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|225|41947609|Male|Pituitary|2017|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|41947609|Male|Pituitary|2017|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|181|41477470|Male|Pituitary|2018|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41477470|Male|Pituitary|2018|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|181|41328224|Male|Pituitary|2019|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41328224|Male|Pituitary|2019|~|~|~
0-19|1.5|1.8|1.6|Benign/Borderline|688|41889233|Male|Total|2004|1.5|1.8|1.6
0-19|3.4|3.8|3.6|Malignant|1505|41889233|Male|Total|2004|3.4|3.8|3.6
0-19|1.7|2.0|1.9|Benign/Borderline|791|42006384|Male|Total|2005|1.8|2.0|1.9
0-19|3.3|3.6|3.4|Malignant|1434|42006384|Male|Total|2005|3.2|3.6|3.4
0-19|1.8|2.1|1.9|Benign/Borderline|818|42158997|Male|Total|2006|1.8|2.1|1.9
0-19|3.4|3.8|3.6|Malignant|1512|42158997|Male|Total|2006|3.4|3.8|3.6
0-19|1.9|2.2|2.0|Benign/Borderline|860|42367071|Male|Total|2007|1.9|2.2|2.0
0-19|3.4|3.8|3.6|Malignant|1526|42367071|Male|Total|2007|3.4|3.8|3.6
0-19|1.9|2.2|2.0|Benign/Borderline|872|42541971|Male|Total|2008|1.9|2.2|2.0
0-19|3.6|4.0|3.8|Malignant|1608|42541971|Male|Total|2008|3.6|4.0|3.8
0-19|2.1|2.4|2.2|Benign/Borderline|949|42609915|Male|Total|2009|2.1|2.4|2.2
0-19|3.5|3.9|3.7|Malignant|1562|42609915|Male|Total|2009|3.5|3.9|3.7
0-19|2.0|2.3|2.1|Benign/Borderline|910|42550328|Male|Total|2010|2.0|2.3|2.1
0-19|3.6|4.0|3.8|Malignant|1611|42550328|Male|Total|2010|3.6|4.0|3.8
0-19|2.1|2.4|2.3|Benign/Borderline|972|42373156|Male|Total|2011|2.2|2.4|2.3
0-19|3.6|4.0|3.8|Malignant|1605|42373156|Male|Total|2011|3.6|4.0|3.8
0-19|2.3|2.6|2.4|Benign/Borderline|1021|42186700|Male|Total|2012|2.3|2.6|2.4
0-19|3.7|4.1|3.9|Malignant|1627|42186700|Male|Total|2012|3.7|4.0|3.9
0-19|2.2|2.5|2.4|Benign/Borderline|1007|42049482|Male|Total|2013|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1604|42049482|Male|Total|2013|3.6|4.0|3.8
0-19|2.3|2.6|2.4|Benign/Borderline|1023|41972229|Male|Total|2014|2.3|2.6|2.4
0-19|3.6|3.9|3.7|Malignant|1569|41972229|Male|Total|2014|3.6|3.9|3.7
0-19|2.2|2.5|2.4|Benign/Borderline|1002|41955285|Male|Total|2015|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1606|41955285|Male|Total|2015|3.6|4.0|3.8
0-19|2.4|2.6|2.5|Benign/Borderline|5188|207542387|Male|Total|2015-2019|2.4|2.6|2.5
0-19|3.4|3.6|3.5|Malignant|7294|207542387|Male|Total|2015-2019|3.4|3.6|3.5
0-19|2.5|2.8|2.7|Benign/Borderline|1116|41970804|Male|Total|2016|2.5|2.8|2.7
0-19|3.5|3.9|3.7|Malignant|1564|41970804|Male|Total|2016|3.5|3.9|3.7
0-19|2.4|2.7|2.5|Benign/Borderline|1068|41947609|Male|Total|2017|2.4|2.7|2.5
0-19|3.8|4.2|4.0|Malignant|1672|41947609|Male|Total|2017|3.8|4.2|4.0
0-19|2.4|2.7|2.6|Benign/Borderline|1075|41477470|Male|Total|2018|2.4|2.8|2.6
0-19|2.9|3.3|3.1|Malignant|1283|41477470|Male|Total|2018|2.9|3.3|3.1
0-19|2.1|2.4|2.3|Benign/Borderline|943|41328224|Male|Total|2019|2.1|2.4|2.3
0-19|2.8|3.1|2.9|Malignant|1216|41328224|Male|Total|2019|2.8|3.1|2.9
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|175|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|163|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42550328|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42550328|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|42373156|Male|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42373156|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42186700|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42186700|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|165|42049482|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42049482|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|153|41972229|Male|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41972229|Male|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|41955285|Male|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41955285|Male|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|629|207542387|Male|Tumors of Cranial and Spinal Nerves|2015-2019|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|207542387|Male|Tumors of Cranial and Spinal Nerves|2015-2019|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|181|41970804|Male|Tumors of Cranial and Spinal Nerves|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41970804|Male|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|41947609|Male|Tumors of Cranial and Spinal Nerves|2017|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41947609|Male|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|41477470|Male|Tumors of Cranial and Spinal Nerves|2018|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41477470|Male|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|41328224|Male|Tumors of Cranial and Spinal Nerves|2019|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41328224|Male|Tumors of Cranial and Spinal Nerves|2019|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|234|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.6
0-19|3.1|3.5|3.3|Malignant|1363|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|262|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.6|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1300|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|259|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1364|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.1|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|272|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1378|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.1|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|283|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1445|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.6|3.4
0-19|0.6|0.7|0.6|Benign/Borderline|275|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.2|3.5|3.3|Malignant|1418|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.2|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|290|42550328|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.8|0.7
0-19|3.3|3.6|3.4|Malignant|1455|42550328|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.6|3.4
0-19|0.7|0.8|0.7|Benign/Borderline|313|42373156|Male|Tumors of Neuroepthelial Tissue|2011|0.7|0.8|0.7
0-19|3.3|3.7|3.5|Malignant|1468|42373156|Male|Tumors of Neuroepthelial Tissue|2011|3.3|3.6|3.5
0-19|0.7|0.9|0.8|Benign/Borderline|323|42186700|Male|Tumors of Neuroepthelial Tissue|2012|0.7|0.9|0.8
0-19|3.3|3.6|3.5|Malignant|1459|42186700|Male|Tumors of Neuroepthelial Tissue|2012|3.3|3.6|3.5
0-19|0.7|0.8|0.7|Benign/Borderline|307|42049482|Male|Tumors of Neuroepthelial Tissue|2013|0.7|0.8|0.7
0-19|3.3|3.6|3.4|Malignant|1446|42049482|Male|Tumors of Neuroepthelial Tissue|2013|3.3|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|296|41972229|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1418|41972229|Male|Tumors of Neuroepthelial Tissue|2014|3.2|3.6|3.4
0-19|0.7|0.9|0.8|Benign/Borderline|324|41955285|Male|Tumors of Neuroepthelial Tissue|2015|0.7|0.9|0.8
0-19|3.3|3.6|3.5|Malignant|1450|41955285|Male|Tumors of Neuroepthelial Tissue|2015|3.3|3.6|3.5
0-19|0.8|0.9|0.9|Benign/Borderline|1816|207542387|Male|Tumors of Neuroepthelial Tissue|2015-2019|0.8|0.9|0.9
0-19|3.1|3.2|3.2|Malignant|6533|207542387|Male|Tumors of Neuroepthelial Tissue|2015-2019|3.1|3.2|3.1
0-19|0.8|1.0|0.9|Benign/Borderline|361|41970804|Male|Tumors of Neuroepthelial Tissue|2016|0.8|1.0|0.9
0-19|3.2|3.5|3.3|Malignant|1404|41970804|Male|Tumors of Neuroepthelial Tissue|2016|3.2|3.5|3.3
0-19|0.7|0.9|0.8|Benign/Borderline|345|41947609|Male|Tumors of Neuroepthelial Tissue|2017|0.7|0.9|0.8
0-19|3.4|3.7|3.6|Malignant|1491|41947609|Male|Tumors of Neuroepthelial Tissue|2017|3.4|3.7|3.6
0-19|0.9|1.1|1.0|Benign/Borderline|411|41477470|Male|Tumors of Neuroepthelial Tissue|2018|0.9|1.1|1.0
0-19|2.6|3.0|2.8|Malignant|1160|41477470|Male|Tumors of Neuroepthelial Tissue|2018|2.6|3.0|2.8
0-19|0.8|1.0|0.9|Benign/Borderline|383|41328224|Male|Tumors of Neuroepthelial Tissue|2019|0.8|1.0|0.9
0-19|2.4|2.7|2.6|Malignant|1067|41328224|Male|Tumors of Neuroepthelial Tissue|2019|2.4|2.7|2.6
0-19|0.3|0.5|0.4|Benign/Borderline|170|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|218|42006384|Male|Tumors of Sellar Region|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|178|42158997|Male|Tumors of Sellar Region|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|203|42367071|Male|Tumors of Sellar Region|2007|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|232|42541971|Male|Tumors of Sellar Region|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|239|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|225|42550328|Male|Tumors of Sellar Region|2010|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42550328|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|221|42373156|Male|Tumors of Sellar Region|2011|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42373156|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|256|42186700|Male|Tumors of Sellar Region|2012|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42186700|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|270|42049482|Male|Tumors of Sellar Region|2013|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|42049482|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|304|41972229|Male|Tumors of Sellar Region|2014|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41972229|Male|Tumors of Sellar Region|2014|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|263|41955285|Male|Tumors of Sellar Region|2015|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|41955285|Male|Tumors of Sellar Region|2015|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|1395|207542387|Male|Tumors of Sellar Region|2015-2019|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|207542387|Male|Tumors of Sellar Region|2015-2019|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|276|41970804|Male|Tumors of Sellar Region|2016|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|41970804|Male|Tumors of Sellar Region|2016|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|328|41947609|Male|Tumors of Sellar Region|2017|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|41947609|Male|Tumors of Sellar Region|2017|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|280|41477470|Male|Tumors of Sellar Region|2018|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41477470|Male|Tumors of Sellar Region|2018|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|254|41328224|Male|Tumors of Sellar Region|2019|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|41328224|Male|Tumors of Sellar Region|2019|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|42006384|Male|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|86|42158997|Male|Tumors of the Meninges|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42367071|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42550328|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42550328|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|128|42373156|Male|Tumors of the Meninges|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42373156|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|42186700|Male|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42186700|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|111|42049482|Male|Tumors of the Meninges|2013|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42049482|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|114|41972229|Male|Tumors of the Meninges|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41972229|Male|Tumors of the Meninges|2014|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|124|41955285|Male|Tumors of the Meninges|2015|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|41955285|Male|Tumors of the Meninges|2015|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|600|207542387|Male|Tumors of the Meninges|2015-2019|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|48|207542387|Male|Tumors of the Meninges|2015-2019|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|113|41970804|Male|Tumors of the Meninges|2016|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41970804|Male|Tumors of the Meninges|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|128|41947609|Male|Tumors of the Meninges|2017|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41947609|Male|Tumors of the Meninges|2017|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|41477470|Male|Tumors of the Meninges|2018|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41477470|Male|Tumors of the Meninges|2018|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|41328224|Male|Tumors of the Meninges|2019|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41328224|Male|Tumors of the Meninges|2019|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|63|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|77|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|91|42158997|Male|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|118|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|26|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|98|42541971|Male|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Malignant|+|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|153|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|42550328|Male|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|+|42550328|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|143|42373156|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|16|42373156|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|128|42186700|Male|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|42186700|Male|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|128|42049482|Male|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|19|42049482|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|130|41972229|Male|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|41972229|Male|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|120|41955285|Male|Unclassified Tumors|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|41955285|Male|Unclassified Tumors|2015|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|616|207542387|Male|Unclassified Tumors|2015-2019|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|115|207542387|Male|Unclassified Tumors|2015-2019|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|151|41970804|Male|Unclassified Tumors|2016|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|22|41970804|Male|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|128|41947609|Male|Unclassified Tumors|2017|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|31|41947609|Male|Unclassified Tumors|2017|0.1|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|118|41477470|Male|Unclassified Tumors|2018|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|41477470|Male|Unclassified Tumors|2018|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|100|41328224|Male|Unclassified Tumors|2019|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|25|41328224|Male|Unclassified Tumors|2019|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|33|41889233|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|32|42367071|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|42|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|+|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|43|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|33|42550328|Male|Unique astrocytoma variants|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|+|42550328|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|47|42373156|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|28|42373156|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|41|42186700|Male|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42186700|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|38|42049482|Male|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42049482|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|48|41972229|Male|Unique astrocytoma variants|2014|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|41972229|Male|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|28|41955285|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41955285|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|172|207542387|Male|Unique astrocytoma variants|2015-2019|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|113|207542387|Male|Unique astrocytoma variants|2015-2019|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|37|41970804|Male|Unique astrocytoma variants|2016|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|41970804|Male|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|33|41947609|Male|Unique astrocytoma variants|2017|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|41947609|Male|Unique astrocytoma variants|2017|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|42|41477470|Male|Unique astrocytoma variants|2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|41477470|Male|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|32|41328224|Male|Unique astrocytoma variants|2019|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|41328224|Male|Unique astrocytoma variants|2019|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83184292|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82838469|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|82501478|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|82271238|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|82139198|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82120410|Male and Female|All other|2015|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|138|406294186|Male and Female|All other|2015-2019|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Malignant|582|406294186|Male and Female|All other|2015-2019|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|All other|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82161437|Male and Female|All other|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|All other|2017|~|~|~
0-19|~|~|~|Malignant|~|82114364|Male and Female|All other|2017|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|46|81200720|Male and Female|All other|2018|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Malignant|244|81200720|Male and Female|All other|2018|0.3|0.3|0.3
0-19|0.1|0.1|0.1|Benign/Borderline|67|80916924|Male and Female|All other|2019|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Malignant|287|80916924|Male and Female|All other|2019|0.3|0.4|0.4
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|71|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|87|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|76|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|83184292|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82838469|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|68|82501478|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|96|82271238|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|98|82139198|Male and Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|79|82120410|Male and Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Anaplastic astrocytoma|2015-2019|~|~|~
0-19|0.1|0.1|0.1|Malignant|340|406294186|Male and Female|Anaplastic astrocytoma|2015-2019|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82161437|Male and Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Anaplastic astrocytoma|2017|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82114364|Male and Female|Anaplastic astrocytoma|2017|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Anaplastic astrocytoma|2018|~|~|~
0-19|0.1|0.1|0.1|Malignant|63|81200720|Male and Female|Anaplastic astrocytoma|2018|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Anaplastic astrocytoma|2019|~|~|~
0-19|0.1|0.1|0.1|Malignant|66|80916924|Male and Female|Anaplastic astrocytoma|2019|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83184292|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82838469|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|82501478|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|82271238|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|82139198|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82120410|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Anaplastic oligodendroglioma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|406294186|Male and Female|Anaplastic oligodendroglioma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82161437|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82114364|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Malignant|~|81200720|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Anaplastic oligodendroglioma|2019|~|~|~
0-19|~|~|~|Malignant|~|80916924|Male and Female|Anaplastic oligodendroglioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|202|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|192|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|198|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|179|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|205|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|83184292|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82838469|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|164|82501478|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|193|82271238|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|216|82139198|Male and Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|171|82120410|Male and Female|Astrocytoma, NOS|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Astrocytoma, NOS|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|836|406294186|Male and Female|Astrocytoma, NOS|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|175|82161437|Male and Female|Astrocytoma, NOS|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Astrocytoma, NOS|2017|~|~|~
0-19|0.2|0.3|0.2|Malignant|183|82114364|Male and Female|Astrocytoma, NOS|2017|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Astrocytoma, NOS|2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|81200720|Male and Female|Astrocytoma, NOS|2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Astrocytoma, NOS|2019|~|~|~
0-19|0.1|0.2|0.2|Malignant|143|80916924|Male and Female|Astrocytoma, NOS|2019|0.1|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|57|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|55|82005260|Male and Female|Choroid plexus|2005|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|68|83184292|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|23|83184292|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82838469|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82838469|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|63|82501478|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|82501478|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82271238|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82271238|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82139198|Male and Female|Choroid plexus|2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|82139198|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82120410|Male and Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|82120410|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|309|406294186|Male and Female|Choroid plexus|2015-2019|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|97|406294186|Male and Female|Choroid plexus|2015-2019|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82161437|Male and Female|Choroid plexus|2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82161437|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82114364|Male and Female|Choroid plexus|2017|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82114364|Male and Female|Choroid plexus|2017|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|67|81200720|Male and Female|Choroid plexus|2018|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|81200720|Male and Female|Choroid plexus|2018|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|52|80916924|Male and Female|Choroid plexus|2019|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|80916924|Male and Female|Choroid plexus|2019|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|183|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|163|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|175|83184292|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83184292|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82838469|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82838469|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|82501478|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82501478|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82271238|Male and Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82271238|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|199|82139198|Male and Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82139198|Male and Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|178|82120410|Male and Female|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82120410|Male and Female|Craniopharyngioma|2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|796|406294186|Male and Female|Craniopharyngioma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|406294186|Male and Female|Craniopharyngioma|2015-2019|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|143|82161437|Male and Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82161437|Male and Female|Craniopharyngioma|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82114364|Male and Female|Craniopharyngioma|2017|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82114364|Male and Female|Craniopharyngioma|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|152|81200720|Male and Female|Craniopharyngioma|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81200720|Male and Female|Craniopharyngioma|2018|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|147|80916924|Male and Female|Craniopharyngioma|2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|80916924|Male and Female|Craniopharyngioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|42|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83184292|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82838469|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82501478|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82271238|Male and Female|Diffuse astrocytoma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|82139198|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|82120410|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Diffuse astrocytoma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|406294186|Male and Female|Diffuse astrocytoma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|82161437|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Malignant|~|82114364|Male and Female|Diffuse astrocytoma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Malignant|~|81200720|Male and Female|Diffuse astrocytoma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Diffuse astrocytoma|2019|~|~|~
0-19|~|~|~|Malignant|~|80916924|Male and Female|Diffuse astrocytoma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|509|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|500|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|518|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|552|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|514|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|489|83184292|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|497|82838469|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|467|82501478|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|460|82271238|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.7|0.6|Malignant|494|82139198|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.5|0.7|0.6|Malignant|489|82120410|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Embryonal/primitive/medulloblastoma|2015-2019|~|~|~
0-19|0.5|0.5|0.5|Malignant|2060|406294186|Male and Female|Embryonal/primitive/medulloblastoma|2015-2019|0.5|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.5|0.6|0.6|Malignant|466|82161437|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
0-19|0.5|0.6|0.6|Malignant|471|82114364|Male and Female|Embryonal/primitive/medulloblastoma|2017|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
0-19|0.4|0.5|0.4|Malignant|354|81200720|Male and Female|Embryonal/primitive/medulloblastoma|2018|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Embryonal/primitive/medulloblastoma|2019|~|~|~
0-19|0.3|0.4|0.4|Malignant|292|80916924|Male and Female|Embryonal/primitive/medulloblastoma|2019|0.3|0.4|0.4
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|41|83184292|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83184292|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82838469|Male and Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82838469|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82501478|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82501478|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82271238|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82271238|Male and Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|82139198|Male and Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|82120410|Male and Female|Ependymoma variants|2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82120410|Male and Female|Ependymoma variants|2015|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|167|406294186|Male and Female|Ependymoma variants|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|406294186|Male and Female|Ependymoma variants|2015-2019|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82161437|Male and Female|Ependymoma variants|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82161437|Male and Female|Ependymoma variants|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82114364|Male and Female|Ependymoma variants|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82114364|Male and Female|Ependymoma variants|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|81200720|Male and Female|Ependymoma variants|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81200720|Male and Female|Ependymoma variants|2018|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|80916924|Male and Female|Ependymoma variants|2019|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|80916924|Male and Female|Ependymoma variants|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|209|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|187|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|171|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|83184292|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|82838469|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|82501478|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|205|82271238|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|198|82139198|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|204|82120410|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Ependymoma/anaplastic ependymoma|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|931|406294186|Male and Female|Ependymoma/anaplastic ependymoma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82161437|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
0-19|0.2|0.3|0.3|Malignant|223|82114364|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
0-19|0.2|0.2|0.2|Malignant|169|81200720|Male and Female|Ependymoma/anaplastic ependymoma|2018|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Ependymoma/anaplastic ependymoma|2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|163|80916924|Male and Female|Ependymoma/anaplastic ependymoma|2019|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|32|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|47|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|146|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|49|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|43|83184292|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|165|83184292|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|38|82838469|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|137|82838469|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|42|82501478|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|131|82501478|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|47|82271238|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|159|82271238|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|50|82139198|Male and Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|137|82139198|Male and Female|Germ Cell Tumors|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82120410|Male and Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|152|82120410|Male and Female|Germ Cell Tumors|2015|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|227|406294186|Male and Female|Germ Cell Tumors|2015-2019|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|769|406294186|Male and Female|Germ Cell Tumors|2015-2019|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|61|82161437|Male and Female|Germ Cell Tumors|2016|0.1|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|168|82161437|Male and Female|Germ Cell Tumors|2016|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|39|82114364|Male and Female|Germ Cell Tumors|2017|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|175|82114364|Male and Female|Germ Cell Tumors|2017|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|57|81200720|Male and Female|Germ Cell Tumors|2018|0.1|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|126|81200720|Male and Female|Germ Cell Tumors|2018|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|33|80916924|Male and Female|Germ Cell Tumors|2019|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|152|80916924|Male and Female|Germ Cell Tumors|2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|111|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|122|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83184292|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|160|82838469|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|155|82501478|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|163|82271238|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|145|82139198|Male and Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|150|82120410|Male and Female|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Glioblastoma|2015-2019|~|~|~
0-19|0.2|0.2|0.2|Malignant|682|406294186|Male and Female|Glioblastoma|2015-2019|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.2|Malignant|135|82161437|Male and Female|Glioblastoma|2016|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Glioblastoma|2017|~|~|~
0-19|0.1|0.2|0.2|Malignant|142|82114364|Male and Female|Glioblastoma|2017|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Glioblastoma|2018|~|~|~
0-19|0.1|0.2|0.2|Malignant|139|81200720|Male and Female|Glioblastoma|2018|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Glioblastoma|2019|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|80916924|Male and Female|Glioblastoma|2019|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|463|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|490|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|515|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|551|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.8|0.7|Malignant|572|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|22|83184292|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|550|83184292|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|33|82838469|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|599|82838469|Male and Female|Glioma malignant, NOS|2011|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|35|82501478|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|512|82501478|Male and Female|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|33|82271238|Male and Female|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|581|82271238|Male and Female|Glioma malignant, NOS|2013|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|42|82139198|Male and Female|Glioma malignant, NOS|2014|0.0|0.1|0.1
0-19|0.6|0.7|0.7|Malignant|535|82139198|Male and Female|Glioma malignant, NOS|2014|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|38|82120410|Male and Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|587|82120410|Male and Female|Glioma malignant, NOS|2015|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|216|406294186|Male and Female|Glioma malignant, NOS|2015-2019|0.0|0.1|0.1
0-19|0.6|0.7|0.7|Malignant|2705|406294186|Male and Female|Glioma malignant, NOS|2015-2019|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|53|82161437|Male and Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|613|82161437|Male and Female|Glioma malignant, NOS|2016|0.7|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|45|82114364|Male and Female|Glioma malignant, NOS|2017|0.0|0.1|0.1
0-19|0.7|0.8|0.8|Malignant|643|82114364|Male and Female|Glioma malignant, NOS|2017|0.7|0.8|0.8
0-19|0.0|0.1|0.1|Benign/Borderline|52|81200720|Male and Female|Glioma malignant, NOS|2018|0.0|0.1|0.1
0-19|0.5|0.6|0.6|Malignant|464|81200720|Male and Female|Glioma malignant, NOS|2018|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|29|80916924|Male and Female|Glioma malignant, NOS|2019|0.0|0.1|0.0
0-19|0.5|0.6|0.5|Malignant|412|80916924|Male and Female|Glioma malignant, NOS|2019|0.5|0.6|0.5
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|83184292|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83184292|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|41|82838469|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82838469|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82501478|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82501478|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82271238|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82271238|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|52|82139198|Male and Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82139198|Male and Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|82120410|Male and Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82120410|Male and Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|169|406294186|Male and Female|Hemangioblastoma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|406294186|Male and Female|Hemangioblastoma|2015-2019|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|41|82161437|Male and Female|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82161437|Male and Female|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|82114364|Male and Female|Hemangioblastoma|2017|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82114364|Male and Female|Hemangioblastoma|2017|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|81200720|Male and Female|Hemangioblastoma|2018|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81200720|Male and Female|Hemangioblastoma|2018|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|80916924|Male and Female|Hemangioblastoma|2019|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|80916924|Male and Female|Hemangioblastoma|2019|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|49|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|44|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|71|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|85|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|98|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|103|83184292|Male and Female|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83184292|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|145|82838469|Male and Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82838469|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|134|82501478|Male and Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82501478|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|123|82271238|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82271238|Male and Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|124|82139198|Male and Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82139198|Male and Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|130|82120410|Male and Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82120410|Male and Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|572|406294186|Male and Female|Hemangioma|2015-2019|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|406294186|Male and Female|Hemangioma|2015-2019|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|138|82161437|Male and Female|Hemangioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82161437|Male and Female|Hemangioma|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|82114364|Male and Female|Hemangioma|2017|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82114364|Male and Female|Hemangioma|2017|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|108|81200720|Male and Female|Hemangioma|2018|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|81200720|Male and Female|Hemangioma|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|87|80916924|Male and Female|Hemangioma|2019|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|80916924|Male and Female|Hemangioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83184292|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82838469|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|82501478|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|82271238|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|82139198|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|82120410|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Local Extensions from Regional Tumors|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|406294186|Male and Female|Local Extensions from Regional Tumors|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|82161437|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Malignant|~|82114364|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Malignant|~|81200720|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Local Extensions from Regional Tumors|2019|~|~|~
0-19|~|~|~|Malignant|~|80916924|Male and Female|Local Extensions from Regional Tumors|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83184292|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82838469|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82501478|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|82271238|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|82139198|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82120410|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|61|406294186|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82161437|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Malignant|~|82114364|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Malignant|~|81200720|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
0-19|~|~|~|Malignant|~|80916924|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|91|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|100|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|120|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|83184292|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83184292|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|138|82838469|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82838469|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|129|82501478|Male and Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82501478|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|135|82271238|Male and Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82271238|Male and Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|132|82139198|Male and Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82139198|Male and Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|141|82120410|Male and Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82120410|Male and Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|652|406294186|Male and Female|Meningioma|2015-2019|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|21|406294186|Male and Female|Meningioma|2015-2019|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|116|82161437|Male and Female|Meningioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82161437|Male and Female|Meningioma|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82114364|Male and Female|Meningioma|2017|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82114364|Male and Female|Meningioma|2017|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|145|81200720|Male and Female|Meningioma|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81200720|Male and Female|Meningioma|2018|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|124|80916924|Male and Female|Meningioma|2019|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|80916924|Male and Female|Meningioma|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83184292|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82838469|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82501478|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82271238|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Mixed glioma|2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82139198|Male and Female|Mixed glioma|2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Mixed glioma|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82120410|Male and Female|Mixed glioma|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Mixed glioma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|36|406294186|Male and Female|Mixed glioma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82161437|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Malignant|~|82114364|Male and Female|Mixed glioma|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Malignant|~|81200720|Male and Female|Mixed glioma|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Mixed glioma|2019|~|~|~
0-19|~|~|~|Malignant|~|80916924|Male and Female|Mixed glioma|2019|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|114|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|106|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|117|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|129|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|153|83280391|Male and Female|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|37|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|83184292|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83184292|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|138|82838469|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|35|82838469|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|136|82501478|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|54|82501478|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|144|82271238|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|40|82271238|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|150|82139198|Male and Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|47|82139198|Male and Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|145|82120410|Male and Female|Neoplasm, unspecified|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|36|82120410|Male and Female|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|609|406294186|Male and Female|Neoplasm, unspecified|2015-2019|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|210|406294186|Male and Female|Neoplasm, unspecified|2015-2019|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|123|82161437|Male and Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|45|82161437|Male and Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|121|82114364|Male and Female|Neoplasm, unspecified|2017|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82114364|Male and Female|Neoplasm, unspecified|2017|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|127|81200720|Male and Female|Neoplasm, unspecified|2018|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|43|81200720|Male and Female|Neoplasm, unspecified|2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|95|80916924|Male and Female|Neoplasm, unspecified|2019|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|80916924|Male and Female|Neoplasm, unspecified|2019|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|242|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|290|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|336|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|294|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|295|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|313|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|278|83184292|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83184292|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|285|82838469|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82838469|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|303|82501478|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82501478|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|318|82271238|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82271238|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|258|82139198|Male and Female|Nerve sheath, benign and malignant|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82139198|Male and Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|311|82120410|Male and Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82120410|Male and Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1190|406294186|Male and Female|Nerve sheath, benign and malignant|2015-2019|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|406294186|Male and Female|Nerve sheath, benign and malignant|2015-2019|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|311|82161437|Male and Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82161437|Male and Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|237|82114364|Male and Female|Nerve sheath, benign and malignant|2017|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82114364|Male and Female|Nerve sheath, benign and malignant|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|169|81200720|Male and Female|Nerve sheath, benign and malignant|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81200720|Male and Female|Nerve sheath, benign and malignant|2018|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|163|80916924|Male and Female|Nerve sheath, benign and malignant|2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|80916924|Male and Female|Nerve sheath, benign and malignant|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83184292|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82838469|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|82501478|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|82271238|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|82139198|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|82120410|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Neuroepithelial|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|30|406294186|Male and Female|Neuroepithelial|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|82161437|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Malignant|~|82114364|Male and Female|Neuroepithelial|2017|~|~|~
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Malignant|~|81200720|Male and Female|Neuroepithelial|2018|~|~|~
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Neuroepithelial|2019|~|~|~
0-19|~|~|~|Malignant|~|80916924|Male and Female|Neuroepithelial|2019|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|265|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|296|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|57|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|283|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|315|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|63|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|314|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|297|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|317|83184292|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83184292|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|346|82838469|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|36|82838469|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|361|82501478|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|39|82501478|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|353|82271238|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|45|82271238|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|336|82139198|Male and Female|Neuronal/glial, neuronal|2014|0.4|0.5|0.4
0-19|0.1|0.1|0.1|Malignant|56|82139198|Male and Female|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|389|82120410|Male and Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|43|82120410|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|1906|406294186|Male and Female|Neuronal/glial, neuronal|2015-2019|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|229|406294186|Male and Female|Neuronal/glial, neuronal|2015-2019|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|413|82161437|Male and Female|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|54|82161437|Male and Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|406|82114364|Male and Female|Neuronal/glial, neuronal|2017|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|39|82114364|Male and Female|Neuronal/glial, neuronal|2017|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|355|81200720|Male and Female|Neuronal/glial, neuronal|2018|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|50|81200720|Male and Female|Neuronal/glial, neuronal|2018|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|351|80916924|Male and Female|Neuronal/glial, neuronal|2019|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|44|80916924|Male and Female|Neuronal/glial, neuronal|2019|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|54|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|49|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83184292|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|82838469|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|47|82501478|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82271238|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82139198|Male and Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82120410|Male and Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|406294186|Male and Female|Oligodendroglioma|2015-2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|142|406294186|Male and Female|Oligodendroglioma|2015-2019|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82161437|Male and Female|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Oligodendroglioma|2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82114364|Male and Female|Oligodendroglioma|2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Oligodendroglioma|2018|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|81200720|Male and Female|Oligodendroglioma|2018|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Oligodendroglioma|2019|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|80916924|Male and Female|Oligodendroglioma|2019|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|27|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|31|82749431|Male and Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|50|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|53|83184292|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83184292|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|62|82838469|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82838469|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|82501478|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82501478|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|77|82271238|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82271238|Male and Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|76|82139198|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82139198|Male and Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|85|82120410|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82120410|Male and Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|431|406294186|Male and Female|Other mesenchymal|2015-2019|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|69|406294186|Male and Female|Other mesenchymal|2015-2019|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|102|82161437|Male and Female|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82161437|Male and Female|Other mesenchymal|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|94|82114364|Male and Female|Other mesenchymal|2017|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82114364|Male and Female|Other mesenchymal|2017|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|90|81200720|Male and Female|Other mesenchymal|2018|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81200720|Male and Female|Other mesenchymal|2018|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|60|80916924|Male and Female|Other mesenchymal|2019|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|80916924|Male and Female|Other mesenchymal|2019|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|701|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|679|82005260|Male and Female|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|677|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|692|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|733|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|729|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.0|0.9|Malignant|779|83184292|Male and Female|Pilocytic astrocytoma|2010|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.9|1.0|0.9|Malignant|763|82838469|Male and Female|Pilocytic astrocytoma|2011|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|811|82501478|Male and Female|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|1.0|Malignant|800|82271238|Male and Female|Pilocytic astrocytoma|2013|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.0|1.0|Malignant|792|82139198|Male and Female|Pilocytic astrocytoma|2014|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|742|82120410|Male and Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|0.1|0.1|0.1|Benign/Borderline|260|406294186|Male and Female|Pilocytic astrocytoma|2015-2019|0.1|0.1|0.1
0-19|0.9|0.9|0.9|Malignant|3569|406294186|Male and Female|Pilocytic astrocytoma|2015-2019|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|0.9|0.9|Malignant|712|82161437|Male and Female|Pilocytic astrocytoma|2016|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Pilocytic astrocytoma|2017|~|~|~
0-19|1.0|1.1|1.0|Malignant|848|82114364|Male and Female|Pilocytic astrocytoma|2017|1.0|1.1|1.0
0-19|0.2|0.2|0.2|Benign/Borderline|144|81200720|Male and Female|Pilocytic astrocytoma|2018|0.1|0.2|0.2
0-19|0.8|0.9|0.8|Malignant|675|81200720|Male and Female|Pilocytic astrocytoma|2018|0.8|0.9|0.8
0-19|0.1|0.2|0.1|Benign/Borderline|116|80916924|Male and Female|Pilocytic astrocytoma|2019|0.1|0.2|0.1
0-19|0.7|0.8|0.8|Malignant|611|80916924|Male and Female|Pilocytic astrocytoma|2019|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83184292|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83184292|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82838469|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82838469|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82501478|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82501478|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82271238|Male and Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|82271238|Male and Female|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82139198|Male and Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82139198|Male and Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82120410|Male and Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82120410|Male and Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Benign/Borderline|35|406294186|Male and Female|Pineal parenchymal|2015-2019|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|176|406294186|Male and Female|Pineal parenchymal|2015-2019|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82161437|Male and Female|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82161437|Male and Female|Pineal parenchymal|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82114364|Male and Female|Pineal parenchymal|2017|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82114364|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81200720|Male and Female|Pineal parenchymal|2018|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81200720|Male and Female|Pineal parenchymal|2018|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|80916924|Male and Female|Pineal parenchymal|2019|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|80916924|Male and Female|Pineal parenchymal|2019|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|369|81754354|Male and Female|Pituitary|2004|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|447|82005260|Male and Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|463|82324418|Male and Female|Pituitary|2006|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|469|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|549|83118264|Male and Female|Pituitary|2008|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|569|83280391|Male and Female|Pituitary|2009|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|613|83184292|Male and Female|Pituitary|2010|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|83184292|Male and Female|Pituitary|2010|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|630|82838469|Male and Female|Pituitary|2011|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82838469|Male and Female|Pituitary|2011|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|690|82501478|Male and Female|Pituitary|2012|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82501478|Male and Female|Pituitary|2012|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|679|82271238|Male and Female|Pituitary|2013|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82271238|Male and Female|Pituitary|2013|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|745|82139198|Male and Female|Pituitary|2014|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|82139198|Male and Female|Pituitary|2014|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|703|82120410|Male and Female|Pituitary|2015|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|82120410|Male and Female|Pituitary|2015|~|~|~
0-19|0.9|0.9|0.9|Benign/Borderline|3712|406294186|Male and Female|Pituitary|2015-2019|0.9|0.9|0.9
0-19|~|~|~|Malignant|~|406294186|Male and Female|Pituitary|2015-2019|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|784|82161437|Male and Female|Pituitary|2016|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82161437|Male and Female|Pituitary|2016|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|817|82114364|Male and Female|Pituitary|2017|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|82114364|Male and Female|Pituitary|2017|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|753|81200720|Male and Female|Pituitary|2018|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|81200720|Male and Female|Pituitary|2018|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|672|80916924|Male and Female|Pituitary|2019|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|80916924|Male and Female|Pituitary|2019|~|~|~
0-19|1.7|1.9|1.8|Benign/Borderline|1496|81754354|Male and Female|Total|2004|1.7|1.9|1.8
0-19|3.3|3.6|3.5|Malignant|2814|81754354|Male and Female|Total|2004|3.3|3.6|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1762|82005260|Male and Female|Total|2005|2.0|2.3|2.1
0-19|3.2|3.4|3.3|Malignant|2677|82005260|Male and Female|Total|2005|3.1|3.4|3.3
0-19|2.1|2.3|2.2|Benign/Borderline|1808|82324418|Male and Female|Total|2006|2.1|2.3|2.2
0-19|3.2|3.5|3.3|Malignant|2744|82324418|Male and Female|Total|2006|3.2|3.5|3.3
0-19|2.1|2.3|2.2|Benign/Borderline|1865|82749431|Male and Female|Total|2007|2.2|2.4|2.3
0-19|3.3|3.6|3.4|Malignant|2833|82749431|Male and Female|Total|2007|3.3|3.6|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1969|83118264|Male and Female|Total|2008|2.3|2.5|2.4
0-19|3.4|3.6|3.5|Malignant|2895|83118264|Male and Female|Total|2008|3.4|3.6|3.5
0-19|2.3|2.6|2.5|Benign/Borderline|2065|83280391|Male and Female|Total|2009|2.4|2.6|2.5
0-19|3.3|3.6|3.5|Malignant|2865|83280391|Male and Female|Total|2009|3.3|3.6|3.4
0-19|2.4|2.6|2.5|Benign/Borderline|2102|83184292|Male and Female|Total|2010|2.4|2.6|2.5
0-19|3.4|3.7|3.5|Malignant|2920|83184292|Male and Female|Total|2010|3.4|3.6|3.5
0-19|2.5|2.7|2.6|Benign/Borderline|2197|82838469|Male and Female|Total|2011|2.5|2.8|2.7
0-19|3.5|3.7|3.6|Malignant|2963|82838469|Male and Female|Total|2011|3.4|3.7|3.6
0-19|2.7|2.9|2.8|Benign/Borderline|2303|82501478|Male and Female|Total|2012|2.7|2.9|2.8
0-19|3.4|3.6|3.5|Malignant|2869|82501478|Male and Female|Total|2012|3.4|3.6|3.5
0-19|2.7|2.9|2.8|Benign/Borderline|2321|82271238|Male and Female|Total|2013|2.7|2.9|2.8
0-19|3.5|3.7|3.6|Malignant|2968|82271238|Male and Female|Total|2013|3.5|3.7|3.6
0-19|2.7|3.0|2.8|Benign/Borderline|2340|82139198|Male and Female|Total|2014|2.7|3.0|2.8
0-19|3.5|3.7|3.6|Malignant|2957|82139198|Male and Female|Total|2014|3.5|3.7|3.6
0-19|2.7|3.0|2.8|Benign/Borderline|2347|82120410|Male and Female|Total|2015|2.7|3.0|2.9
0-19|3.4|3.7|3.5|Malignant|2897|82120410|Male and Female|Total|2015|3.4|3.7|3.5
0-19|2.8|2.9|2.8|Benign/Borderline|11556|406294186|Male and Female|Total|2015-2019|2.8|2.9|2.8
0-19|3.2|3.3|3.3|Malignant|13281|406294186|Male and Female|Total|2015-2019|3.2|3.3|3.3
0-19|2.9|3.1|3.0|Benign/Borderline|2457|82161437|Male and Female|Total|2016|2.9|3.1|3.0
0-19|3.3|3.6|3.5|Malignant|2844|82161437|Male and Female|Total|2016|3.3|3.6|3.5
0-19|2.8|3.0|2.9|Benign/Borderline|2382|82114364|Male and Female|Total|2017|2.8|3.0|2.9
0-19|3.5|3.8|3.7|Malignant|3004|82114364|Male and Female|Total|2017|3.5|3.8|3.7
0-19|2.8|3.0|2.9|Benign/Borderline|2362|81200720|Male and Female|Total|2018|2.8|3.0|2.9
0-19|2.9|3.1|3.0|Malignant|2423|81200720|Male and Female|Total|2018|2.9|3.1|3.0
0-19|2.4|2.6|2.5|Benign/Borderline|2056|80916924|Male and Female|Total|2019|2.4|2.7|2.5
0-19|2.6|2.8|2.7|Malignant|2197|80916924|Male and Female|Total|2019|2.6|2.8|2.7
0-19|0.3|0.3|0.3|Benign/Borderline|242|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|290|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|336|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|294|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|295|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|313|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|278|83184292|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83184292|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|285|82838469|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82838469|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|303|82501478|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82501478|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|319|82271238|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82271238|Male and Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|260|82139198|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82139198|Male and Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|311|82120410|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82120410|Male and Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1191|406294186|Male and Female|Tumors of Cranial and Spinal Nerves|2015-2019|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|406294186|Male and Female|Tumors of Cranial and Spinal Nerves|2015-2019|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|311|82161437|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82161437|Male and Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|238|82114364|Male and Female|Tumors of Cranial and Spinal Nerves|2017|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82114364|Male and Female|Tumors of Cranial and Spinal Nerves|2017|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|169|81200720|Male and Female|Tumors of Cranial and Spinal Nerves|2018|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81200720|Male and Female|Tumors of Cranial and Spinal Nerves|2018|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|163|80916924|Male and Female|Tumors of Cranial and Spinal Nerves|2019|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|80916924|Male and Female|Tumors of Cranial and Spinal Nerves|2019|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|425|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.2|Malignant|2574|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|460|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|2452|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|465|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2526|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|504|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2622|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|514|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|2677|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.1|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|491|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.1|3.3|3.2|Malignant|2641|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.1|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|525|83184292|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|2683|83184292|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.1|3.3|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|562|82838469|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.7
0-19|3.2|3.4|3.3|Malignant|2748|82838469|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.2|3.4|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|578|82501478|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.8|0.7
0-19|3.1|3.3|3.2|Malignant|2637|82501478|Male and Female|Tumors of Neuroepthelial Tissue|2012|3.1|3.3|3.2
0-19|0.6|0.8|0.7|Benign/Borderline|575|82271238|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.2|3.4|3.3|Malignant|2720|82271238|Male and Female|Tumors of Neuroepthelial Tissue|2013|3.2|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|552|82139198|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.7
0-19|3.2|3.5|3.3|Malignant|2731|82139198|Male and Female|Tumors of Neuroepthelial Tissue|2014|3.2|3.5|3.3
0-19|0.7|0.8|0.7|Benign/Borderline|581|82120410|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.7|0.8|0.7
0-19|3.1|3.4|3.2|Malignant|2658|82120410|Male and Female|Tumors of Neuroepthelial Tissue|2015|3.1|3.4|3.2
0-19|0.8|0.8|0.8|Benign/Borderline|3194|406294186|Male and Female|Tumors of Neuroepthelial Tissue|2015-2019|0.8|0.8|0.8
0-19|2.9|3.0|3.0|Malignant|12105|406294186|Male and Female|Tumors of Neuroepthelial Tissue|2015-2019|2.9|3.0|3.0
0-19|0.7|0.8|0.8|Benign/Borderline|638|82161437|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.7|0.8|0.8
0-19|3.0|3.3|3.1|Malignant|2582|82161437|Male and Female|Tumors of Neuroepthelial Tissue|2016|3.0|3.3|3.1
0-19|0.7|0.8|0.8|Benign/Borderline|620|82114364|Male and Female|Tumors of Neuroepthelial Tissue|2017|0.7|0.8|0.8
0-19|3.2|3.5|3.3|Malignant|2746|82114364|Male and Female|Tumors of Neuroepthelial Tissue|2017|3.2|3.5|3.3
0-19|0.8|1.0|0.9|Benign/Borderline|726|81200720|Male and Female|Tumors of Neuroepthelial Tissue|2018|0.8|1.0|0.9
0-19|2.6|2.9|2.7|Malignant|2220|81200720|Male and Female|Tumors of Neuroepthelial Tissue|2018|2.6|2.9|2.7
0-19|0.7|0.9|0.8|Benign/Borderline|646|80916924|Male and Female|Tumors of Neuroepthelial Tissue|2019|0.7|0.9|0.8
0-19|2.3|2.6|2.4|Malignant|1973|80916924|Male and Female|Tumors of Neuroepthelial Tissue|2019|2.3|2.5|2.4
0-19|0.6|0.7|0.7|Benign/Borderline|538|81754354|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|619|82005260|Male and Female|Tumors of Sellar Region|2005|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|621|82324418|Male and Female|Tumors of Sellar Region|2006|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|652|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|712|83118264|Male and Female|Tumors of Sellar Region|2008|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|741|83280391|Male and Female|Tumors of Sellar Region|2009|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|788|83184292|Male and Female|Tumors of Sellar Region|2010|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|83184292|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|788|82838469|Male and Female|Tumors of Sellar Region|2011|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82838469|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|846|82501478|Male and Female|Tumors of Sellar Region|2012|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|82501478|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.0|1.1|1.0|Benign/Borderline|861|82271238|Male and Female|Tumors of Sellar Region|2013|1.0|1.1|1.0
0-19|~|~|~|Malignant|~|82271238|Male and Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.1|1.2|1.1|Benign/Borderline|944|82139198|Male and Female|Tumors of Sellar Region|2014|1.1|1.2|1.1
0-19|~|~|~|Malignant|~|82139198|Male and Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.0|1.1|1.1|Benign/Borderline|881|82120410|Male and Female|Tumors of Sellar Region|2015|1.0|1.1|1.1
0-19|~|~|~|Malignant|~|82120410|Male and Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.1|1.1|1.1|Benign/Borderline|4508|406294186|Male and Female|Tumors of Sellar Region|2015-2019|1.1|1.1|1.1
0-19|~|~|~|Malignant|~|406294186|Male and Female|Tumors of Sellar Region|2015-2019|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|927|82161437|Male and Female|Tumors of Sellar Region|2016|1.1|1.2|1.1
0-19|~|~|~|Malignant|~|82161437|Male and Female|Tumors of Sellar Region|2016|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|999|82114364|Male and Female|Tumors of Sellar Region|2017|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|82114364|Male and Female|Tumors of Sellar Region|2017|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|905|81200720|Male and Female|Tumors of Sellar Region|2018|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|81200720|Male and Female|Tumors of Sellar Region|2018|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|819|80916924|Male and Female|Tumors of Sellar Region|2019|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|80916924|Male and Female|Tumors of Sellar Region|2019|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|147|81754354|Male and Female|Tumors of the Meninges|2004|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|198|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|162|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|178|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|181|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|203|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|22|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|195|83184292|Male and Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|83184292|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|241|82838469|Male and Female|Tumors of the Meninges|2011|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|16|82838469|Male and Female|Tumors of the Meninges|2011|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|264|82501478|Male and Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|20|82501478|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|250|82271238|Male and Female|Tumors of the Meninges|2013|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|22|82271238|Male and Female|Tumors of the Meninges|2013|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|260|82139198|Male and Female|Tumors of the Meninges|2014|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|18|82139198|Male and Female|Tumors of the Meninges|2014|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|260|82120410|Male and Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|23|82120410|Male and Female|Tumors of the Meninges|2015|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1252|406294186|Male and Female|Tumors of the Meninges|2015-2019|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|92|406294186|Male and Female|Tumors of the Meninges|2015-2019|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|259|82161437|Male and Female|Tumors of the Meninges|2016|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|22|82161437|Male and Female|Tumors of the Meninges|2016|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|253|82114364|Male and Female|Tumors of the Meninges|2017|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|16|82114364|Male and Female|Tumors of the Meninges|2017|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|270|81200720|Male and Female|Tumors of the Meninges|2018|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|17|81200720|Male and Female|Tumors of the Meninges|2018|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|212|80916924|Male and Female|Tumors of the Meninges|2019|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|80916924|Male and Female|Tumors of the Meninges|2019|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|158|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|177|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|202|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|42|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|227|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|268|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|273|83184292|Male and Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|28|83184292|Male and Female|Unclassified Tumors|2010|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|283|82838469|Male and Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|36|82838469|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|270|82501478|Male and Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|57|82501478|Male and Female|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|268|82271238|Male and Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|43|82271238|Male and Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|274|82139198|Male and Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|82139198|Male and Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|277|82120410|Male and Female|Unclassified Tumors|2015|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|38|82120410|Male and Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1183|406294186|Male and Female|Unclassified Tumors|2015-2019|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|218|406294186|Male and Female|Unclassified Tumors|2015-2019|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|261|82161437|Male and Female|Unclassified Tumors|2016|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|46|82161437|Male and Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|233|82114364|Male and Female|Unclassified Tumors|2017|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|52|82114364|Male and Female|Unclassified Tumors|2017|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|235|81200720|Male and Female|Unclassified Tumors|2018|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|46|81200720|Male and Female|Unclassified Tumors|2018|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|182|80916924|Male and Female|Unclassified Tumors|2019|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|42|80916924|Male and Female|Unclassified Tumors|2019|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|54|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|62|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|50|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|37|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|58|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|69|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|31|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|65|83184292|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|26|83184292|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82838469|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|51|82838469|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|75|82501478|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|45|82501478|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|77|82271238|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|82271238|Male and Female|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|92|82139198|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82139198|Male and Female|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|49|82120410|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|52|82120410|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|282|406294186|Male and Female|Unique astrocytoma variants|2015-2019|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|229|406294186|Male and Female|Unique astrocytoma variants|2015-2019|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|58|82161437|Male and Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|48|82161437|Male and Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|57|82114364|Male and Female|Unique astrocytoma variants|2017|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|82114364|Male and Female|Unique astrocytoma variants|2017|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|65|81200720|Male and Female|Unique astrocytoma variants|2018|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|48|81200720|Male and Female|Unique astrocytoma variants|2018|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|56|80916924|Male and Female|Unique astrocytoma variants|2019|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|40|80916924|Male and Female|Unique astrocytoma variants|2019|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|+|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|+|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|+|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|+|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|+|116615701|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|+|116615701|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117905188|Female|All other|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|117905188|Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|+|119165857|Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119165857|Female|All other|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|120324137|Female|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|22|120324137|Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|+|121523550|Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|121523550|Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|122667026|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|122667026|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|173|618176604|Female|All other|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|453|618176604|Female|All other|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|31|123795429|Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|123795429|Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|124841928|Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|30|124841928|Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|47|124643976|Female|All other|2018|0.0|0.1|0.0
20+|0.1|0.2|0.1|Malignant|169|124643976|Female|All other|2018|0.1|0.2|0.1
20+|0.0|0.0|0.0|Benign/Borderline|43|125507651|Female|All other|2019|0.0|0.0|0.0
20+|0.1|0.2|0.2|Malignant|202|125507651|Female|All other|2019|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|512|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|530|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|503|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|501|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116615701|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|574|116615701|Female|Anaplastic astrocytoma|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|117905188|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|570|117905188|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|119165857|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|590|119165857|Female|Anaplastic astrocytoma|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|120324137|Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|641|120324137|Female|Anaplastic astrocytoma|2013|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|121523550|Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.5|0.5|0.5|Malignant|618|121523550|Female|Anaplastic astrocytoma|2014|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|122667026|Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|703|122667026|Female|Anaplastic astrocytoma|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|618176604|Female|Anaplastic astrocytoma|2015-2019|~|~|~
20+|0.5|0.5|0.5|Malignant|3186|618176604|Female|Anaplastic astrocytoma|2015-2019|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|123795429|Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.5|0.5|0.5|Malignant|642|123795429|Female|Anaplastic astrocytoma|2016|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|124841928|Female|Anaplastic astrocytoma|2017|~|~|~
20+|0.5|0.6|0.5|Malignant|670|124841928|Female|Anaplastic astrocytoma|2017|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|124643976|Female|Anaplastic astrocytoma|2018|~|~|~
20+|0.4|0.5|0.5|Malignant|620|124643976|Female|Anaplastic astrocytoma|2018|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|125507651|Female|Anaplastic astrocytoma|2019|~|~|~
20+|0.4|0.5|0.4|Malignant|564|125507651|Female|Anaplastic astrocytoma|2019|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|184|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.2|Malignant|167|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|137|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|160|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|171|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|148|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116615701|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|136|116615701|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117905188|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|154|117905188|Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119165857|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|169|119165857|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|120324137|Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|154|120324137|Female|Anaplastic oligodendroglioma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121523550|Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|153|121523550|Female|Anaplastic oligodendroglioma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122667026|Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|164|122667026|Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|618176604|Female|Anaplastic oligodendroglioma|2015-2019|~|~|~
20+|0.1|0.1|0.1|Malignant|826|618176604|Female|Anaplastic oligodendroglioma|2015-2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123795429|Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|168|123795429|Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|124841928|Female|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.1|0.2|0.2|Malignant|188|124841928|Female|Anaplastic oligodendroglioma|2017|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|124643976|Female|Anaplastic oligodendroglioma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|152|124643976|Female|Anaplastic oligodendroglioma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|125507651|Female|Anaplastic oligodendroglioma|2019|~|~|~
20+|0.1|0.2|0.1|Malignant|156|125507651|Female|Anaplastic oligodendroglioma|2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|572|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|564|110320645|Female|Astrocytoma, NOS|2005|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|541|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|535|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|496|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|482|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116615701|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|480|116615701|Female|Astrocytoma, NOS|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|117905188|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|463|117905188|Female|Astrocytoma, NOS|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119165857|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.4|0.4|Malignant|491|119165857|Female|Astrocytoma, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|120324137|Female|Astrocytoma, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|453|120324137|Female|Astrocytoma, NOS|2013|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|121523550|Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.4|0.4|Malignant|496|121523550|Female|Astrocytoma, NOS|2014|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|122667026|Female|Astrocytoma, NOS|2015|~|~|~
20+|0.4|0.5|0.4|Malignant|519|122667026|Female|Astrocytoma, NOS|2015|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|618176604|Female|Astrocytoma, NOS|2015-2019|~|~|~
20+|0.4|0.5|0.4|Malignant|2703|618176604|Female|Astrocytoma, NOS|2015-2019|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|123795429|Female|Astrocytoma, NOS|2016|~|~|~
20+|0.4|0.5|0.5|Malignant|569|123795429|Female|Astrocytoma, NOS|2016|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|124841928|Female|Astrocytoma, NOS|2017|~|~|~
20+|0.4|0.5|0.4|Malignant|515|124841928|Female|Astrocytoma, NOS|2017|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|124643976|Female|Astrocytoma, NOS|2018|~|~|~
20+|0.4|0.5|0.5|Malignant|587|124643976|Female|Astrocytoma, NOS|2018|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|125507651|Female|Astrocytoma, NOS|2019|~|~|~
20+|0.4|0.4|0.4|Malignant|517|125507651|Female|Astrocytoma, NOS|2019|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|39|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|42|111567226|Female|Choroid plexus|2006|0.0|0.1|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.1|Benign/Borderline|56|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|116615701|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116615701|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|53|117905188|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|117905188|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|42|119165857|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119165857|Female|Choroid plexus|2012|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|120324137|Female|Choroid plexus|2013|0.0|0.1|0.0
20+|~|~|~|Malignant|~|120324137|Female|Choroid plexus|2013|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|121523550|Female|Choroid plexus|2014|0.0|0.1|0.0
20+|~|~|~|Malignant|~|121523550|Female|Choroid plexus|2014|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|122667026|Female|Choroid plexus|2015|0.0|0.1|0.0
20+|~|~|~|Malignant|~|122667026|Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|234|618176604|Female|Choroid plexus|2015-2019|0.0|0.0|0.0
20+|~|~|~|Malignant|~|618176604|Female|Choroid plexus|2015-2019|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|42|123795429|Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123795429|Female|Choroid plexus|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|43|124841928|Female|Choroid plexus|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124841928|Female|Choroid plexus|2017|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|58|124643976|Female|Choroid plexus|2018|0.0|0.1|0.0
20+|~|~|~|Malignant|~|124643976|Female|Choroid plexus|2018|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|44|125507651|Female|Choroid plexus|2019|0.0|0.0|0.0
20+|~|~|~|Malignant|~|125507651|Female|Choroid plexus|2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|206|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|203|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|221|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|231|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|116615701|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116615701|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|117905188|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117905188|Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|228|119165857|Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119165857|Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|244|120324137|Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120324137|Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|224|121523550|Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121523550|Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|122667026|Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122667026|Female|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1160|618176604|Female|Craniopharyngioma|2015-2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|618176604|Female|Craniopharyngioma|2015-2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|123795429|Female|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|123795429|Female|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|247|124841928|Female|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124841928|Female|Craniopharyngioma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|124643976|Female|Craniopharyngioma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124643976|Female|Craniopharyngioma|2018|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|219|125507651|Female|Craniopharyngioma|2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|125507651|Female|Craniopharyngioma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|114|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|94|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|133|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|130|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116615701|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|164|116615701|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117905188|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|115|117905188|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119165857|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|94|119165857|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120324137|Female|Diffuse astrocytoma|2013|~|~|~
20+|0.0|0.1|0.1|Malignant|71|120324137|Female|Diffuse astrocytoma|2013|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121523550|Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.0|Malignant|63|121523550|Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122667026|Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|35|122667026|Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|618176604|Female|Diffuse astrocytoma|2015-2019|~|~|~
20+|0.0|0.0|0.0|Malignant|71|618176604|Female|Diffuse astrocytoma|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123795429|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Malignant|~|123795429|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|124841928|Female|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Malignant|~|124841928|Female|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|124643976|Female|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Malignant|~|124643976|Female|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|125507651|Female|Diffuse astrocytoma|2019|~|~|~
20+|~|~|~|Malignant|~|125507651|Female|Diffuse astrocytoma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|85|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|93|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|89|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|104|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116615701|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|73|116615701|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117905188|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|69|117905188|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119165857|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|80|119165857|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120324137|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|90|120324137|Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121523550|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|74|121523550|Female|Embryonal/primitive/medulloblastoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122667026|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.0|0.1|0.1|Malignant|68|122667026|Female|Embryonal/primitive/medulloblastoma|2015|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|618176604|Female|Embryonal/primitive/medulloblastoma|2015-2019|~|~|~
20+|0.0|0.1|0.1|Malignant|308|618176604|Female|Embryonal/primitive/medulloblastoma|2015-2019|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|123795429|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|63|123795429|Female|Embryonal/primitive/medulloblastoma|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124841928|Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.0|0.1|0.1|Malignant|63|124841928|Female|Embryonal/primitive/medulloblastoma|2017|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124643976|Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
20+|0.0|0.1|0.0|Malignant|57|124643976|Female|Embryonal/primitive/medulloblastoma|2018|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|125507651|Female|Embryonal/primitive/medulloblastoma|2019|~|~|~
20+|0.0|0.1|0.1|Malignant|60|125507651|Female|Embryonal/primitive/medulloblastoma|2019|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|119|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|149|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|114|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|110|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|113|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|116615701|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116615701|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|120|117905188|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|117905188|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|130|119165857|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|119165857|Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|117|120324137|Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|120324137|Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|131|121523550|Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|121523550|Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|135|122667026|Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|122667026|Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|583|618176604|Female|Ependymoma variants|2015-2019|0.1|0.1|0.1
20+|~|~|~|Malignant|~|618176604|Female|Ependymoma variants|2015-2019|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|124|123795429|Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|123795429|Female|Ependymoma variants|2016|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|124841928|Female|Ependymoma variants|2017|0.1|0.1|0.1
20+|~|~|~|Malignant|~|124841928|Female|Ependymoma variants|2017|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|112|124643976|Female|Ependymoma variants|2018|0.1|0.1|0.1
20+|~|~|~|Malignant|~|124643976|Female|Ependymoma variants|2018|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|100|125507651|Female|Ependymoma variants|2019|0.1|0.1|0.1
20+|~|~|~|Malignant|~|125507651|Female|Ependymoma variants|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|294|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|303|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|295|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|298|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|313|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|346|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116615701|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|296|116615701|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117905188|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|297|117905188|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119165857|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|303|119165857|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120324137|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|278|120324137|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|121523550|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|244|121523550|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122667026|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.2|Malignant|278|122667026|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|56|618176604|Female|Ependymoma/anaplastic ependymoma|2015-2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|1307|618176604|Female|Ependymoma/anaplastic ependymoma|2015-2019|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|123795429|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.3|0.2|Malignant|276|123795429|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|124841928|Female|Ependymoma/anaplastic ependymoma|2017|~|~|~
20+|0.2|0.3|0.2|Malignant|290|124841928|Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|124643976|Female|Ependymoma/anaplastic ependymoma|2018|~|~|~
20+|0.2|0.2|0.2|Malignant|229|124643976|Female|Ependymoma/anaplastic ependymoma|2018|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|125507651|Female|Ependymoma/anaplastic ependymoma|2019|~|~|~
20+|0.2|0.2|0.2|Malignant|236|125507651|Female|Ependymoma/anaplastic ependymoma|2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|43|115293599|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116615701|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116615701|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|39|117905188|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117905188|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|119165857|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119165857|Female|Germ Cell Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|120324137|Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|120324137|Female|Germ Cell Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|121523550|Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|121523550|Female|Germ Cell Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|122667026|Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|122667026|Female|Germ Cell Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|141|618176604|Female|Germ Cell Tumors|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|34|618176604|Female|Germ Cell Tumors|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|123795429|Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123795429|Female|Germ Cell Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|24|124841928|Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124841928|Female|Germ Cell Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|20|124643976|Female|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|~|~|~|Malignant|~|124643976|Female|Germ Cell Tumors|2018|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|125507651|Female|Germ Cell Tumors|2019|0.0|0.0|0.0
20+|~|~|~|Malignant|~|125507651|Female|Germ Cell Tumors|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4096|109112165|Female|Glioblastoma|2004|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4162|110320645|Female|Glioblastoma|2005|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.5|3.7|3.6|Malignant|4288|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4373|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4403|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4483|115293599|Female|Glioblastoma|2009|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116615701|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4621|116615701|Female|Glioblastoma|2010|3.8|4.1|4.0
20+|~|~|~|Benign/Borderline|~|117905188|Female|Glioblastoma|2011|~|~|~
20+|3.4|3.6|3.5|Malignant|4589|117905188|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|119165857|Female|Glioblastoma|2012|~|~|~
20+|3.5|3.7|3.6|Malignant|4868|119165857|Female|Glioblastoma|2012|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|120324137|Female|Glioblastoma|2013|~|~|~
20+|3.4|3.6|3.5|Malignant|4918|120324137|Female|Glioblastoma|2013|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|121523550|Female|Glioblastoma|2014|~|~|~
20+|3.3|3.5|3.4|Malignant|4797|121523550|Female|Glioblastoma|2014|3.8|4.1|3.9
20+|~|~|~|Benign/Borderline|~|122667026|Female|Glioblastoma|2015|~|~|~
20+|3.5|3.7|3.6|Malignant|5137|122667026|Female|Glioblastoma|2015|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|618176604|Female|Glioblastoma|2015-2019|~|~|~
20+|3.4|3.5|3.5|Malignant|25753|618176604|Female|Glioblastoma|2015-2019|4.1|4.2|4.2
20+|~|~|~|Benign/Borderline|~|123795429|Female|Glioblastoma|2016|~|~|~
20+|3.5|3.7|3.6|Malignant|5220|123795429|Female|Glioblastoma|2016|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|124841928|Female|Glioblastoma|2017|~|~|~
20+|3.4|3.6|3.5|Malignant|5232|124841928|Female|Glioblastoma|2017|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|124643976|Female|Glioblastoma|2018|~|~|~
20+|3.3|3.5|3.4|Malignant|5204|124643976|Female|Glioblastoma|2018|4.1|4.3|4.2
20+|~|~|~|Benign/Borderline|~|125507651|Female|Glioblastoma|2019|~|~|~
20+|3.3|3.4|3.3|Malignant|5130|125507651|Female|Glioblastoma|2019|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|427|109112165|Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|393|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|401|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|413|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|445|114027722|Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|516|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116615701|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|411|116615701|Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117905188|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|452|117905188|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|+|119165857|Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|444|119165857|Female|Glioma malignant, NOS|2012|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|+|120324137|Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|469|120324137|Female|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|+|121523550|Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|450|121523550|Female|Glioma malignant, NOS|2014|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|122667026|Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|524|122667026|Female|Glioma malignant, NOS|2015|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|117|618176604|Female|Glioma malignant, NOS|2015-2019|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2541|618176604|Female|Glioma malignant, NOS|2015-2019|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|22|123795429|Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|529|123795429|Female|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|28|124841928|Female|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|556|124841928|Female|Glioma malignant, NOS|2017|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|124643976|Female|Glioma malignant, NOS|2018|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|484|124643976|Female|Glioma malignant, NOS|2018|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|125507651|Female|Glioma malignant, NOS|2019|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|458|125507651|Female|Glioma malignant, NOS|2019|0.3|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|208|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|232|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|218|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|241|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|231|116615701|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116615701|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|249|117905188|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117905188|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|261|119165857|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119165857|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|235|120324137|Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120324137|Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|121523550|Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121523550|Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|247|122667026|Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122667026|Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1219|618176604|Female|Hemangioblastoma|2015-2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|618176604|Female|Hemangioblastoma|2015-2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|271|123795429|Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|123795429|Female|Hemangioblastoma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|124841928|Female|Hemangioblastoma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124841928|Female|Hemangioblastoma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|215|124643976|Female|Hemangioblastoma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|124643976|Female|Hemangioblastoma|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|267|125507651|Female|Hemangioblastoma|2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|125507651|Female|Hemangioblastoma|2019|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|245|109112165|Female|Hemangioma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|287|110320645|Female|Hemangioma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|321|111567226|Female|Hemangioma|2006|0.3|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|373|112783993|Female|Hemangioma|2007|0.3|0.4|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|478|114027722|Female|Hemangioma|2008|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|530|115293599|Female|Hemangioma|2009|0.4|0.5|0.5
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|664|116615701|Female|Hemangioma|2010|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116615701|Female|Hemangioma|2010|~|~|~
20+|0.6|0.6|0.6|Benign/Borderline|718|117905188|Female|Hemangioma|2011|0.6|0.7|0.6
20+|~|~|~|Malignant|~|117905188|Female|Hemangioma|2011|~|~|~
20+|0.6|0.7|0.6|Benign/Borderline|730|119165857|Female|Hemangioma|2012|0.6|0.7|0.6
20+|~|~|~|Malignant|~|119165857|Female|Hemangioma|2012|~|~|~
20+|0.6|0.7|0.6|Benign/Borderline|740|120324137|Female|Hemangioma|2013|0.6|0.7|0.6
20+|~|~|~|Malignant|~|120324137|Female|Hemangioma|2013|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|683|121523550|Female|Hemangioma|2014|0.5|0.6|0.6
20+|~|~|~|Malignant|~|121523550|Female|Hemangioma|2014|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|590|122667026|Female|Hemangioma|2015|0.4|0.5|0.5
20+|~|~|~|Malignant|~|122667026|Female|Hemangioma|2015|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2669|618176604|Female|Hemangioma|2015-2019|0.4|0.4|0.4
20+|~|~|~|Malignant|~|618176604|Female|Hemangioma|2015-2019|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|568|123795429|Female|Hemangioma|2016|0.4|0.5|0.5
20+|~|~|~|Malignant|~|123795429|Female|Hemangioma|2016|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|523|124841928|Female|Hemangioma|2017|0.4|0.5|0.4
20+|~|~|~|Malignant|~|124841928|Female|Hemangioma|2017|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|522|124643976|Female|Hemangioma|2018|0.4|0.5|0.4
20+|~|~|~|Malignant|~|124643976|Female|Hemangioma|2018|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|475|125507651|Female|Hemangioma|2019|0.3|0.4|0.4
20+|~|~|~|Malignant|~|125507651|Female|Hemangioma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116615701|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|24|116615701|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117905188|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|117905188|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119165857|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|20|119165857|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120324137|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|16|120324137|Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121523550|Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|27|121523550|Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122667026|Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|18|122667026|Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|618176604|Female|Local Extensions from Regional Tumors|2015-2019|~|~|~
20+|0.0|0.0|0.0|Malignant|69|618176604|Female|Local Extensions from Regional Tumors|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123795429|Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|~|~|~|Malignant|~|123795429|Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|124841928|Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|~|~|~|Malignant|~|124841928|Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|124643976|Female|Local Extensions from Regional Tumors|2018|~|~|~
20+|~|~|~|Malignant|~|124643976|Female|Local Extensions from Regional Tumors|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|125507651|Female|Local Extensions from Regional Tumors|2019|~|~|~
20+|~|~|~|Malignant|~|125507651|Female|Local Extensions from Regional Tumors|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|592|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|664|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|674|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|641|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|703|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|667|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116615701|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|747|116615701|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|117905188|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|717|117905188|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|119165857|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|705|119165857|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|120324137|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|739|120324137|Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|121523550|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|813|121523550|Female|Lymphomas and Hematopoietic Neoplasms|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|122667026|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.5|0.6|0.5|Malignant|760|122667026|Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|618176604|Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|~|~|~
20+|0.5|0.6|0.5|Malignant|4005|618176604|Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|123795429|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|836|123795429|Female|Lymphomas and Hematopoietic Neoplasms|2016|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|124841928|Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.5|0.6|0.6|Malignant|828|124841928|Female|Lymphomas and Hematopoietic Neoplasms|2017|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|124643976|Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
20+|0.5|0.6|0.6|Malignant|822|124643976|Female|Lymphomas and Hematopoietic Neoplasms|2018|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|125507651|Female|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
20+|0.5|0.5|0.5|Malignant|772|125507651|Female|Lymphomas and Hematopoietic Neoplasms|2019|0.6|0.7|0.6
20+|12.1|12.5|12.3|Benign/Borderline|14294|109112165|Female|Meningioma|2004|12.9|13.3|13.1
20+|0.2|0.3|0.2|Malignant|275|109112165|Female|Meningioma|2004|0.2|0.3|0.3
20+|13.6|14.1|13.8|Benign/Borderline|16365|110320645|Female|Meningioma|2005|14.6|15.1|14.8
20+|0.2|0.3|0.2|Malignant|281|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|14.3|14.7|14.5|Benign/Borderline|17414|111567226|Female|Meningioma|2006|15.4|15.8|15.6
20+|0.2|0.2|0.2|Malignant|252|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.8|15.3|15.1|Benign/Borderline|18395|112783993|Female|Meningioma|2007|16.1|16.5|16.3
20+|0.2|0.2|0.2|Malignant|270|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|15.6|16.1|15.8|Benign/Borderline|19696|114027722|Female|Meningioma|2008|17.0|17.5|17.3
20+|0.2|0.2|0.2|Malignant|218|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|16.7|17.2|16.9|Benign/Borderline|21402|115293599|Female|Meningioma|2009|18.3|18.8|18.6
20+|0.1|0.2|0.2|Malignant|203|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|16.2|16.6|16.4|Benign/Borderline|21048|116615701|Female|Meningioma|2010|17.8|18.3|18.0
20+|0.1|0.2|0.2|Malignant|207|116615701|Female|Meningioma|2010|0.2|0.2|0.2
20+|16.3|16.7|16.5|Benign/Borderline|21495|117905188|Female|Meningioma|2011|18.0|18.5|18.2
20+|0.1|0.2|0.1|Malignant|186|117905188|Female|Meningioma|2011|0.1|0.2|0.2
20+|16.6|17.0|16.8|Benign/Borderline|22311|119165857|Female|Meningioma|2012|18.5|19.0|18.7
20+|0.1|0.2|0.2|Malignant|204|119165857|Female|Meningioma|2012|0.1|0.2|0.2
20+|16.8|17.2|17.0|Benign/Borderline|22822|120324137|Female|Meningioma|2013|18.7|19.2|19.0
20+|0.1|0.2|0.2|Malignant|225|120324137|Female|Meningioma|2013|0.2|0.2|0.2
20+|17.1|17.6|17.3|Benign/Borderline|23784|121523550|Female|Meningioma|2014|19.3|19.8|19.6
20+|0.1|0.2|0.2|Malignant|217|121523550|Female|Meningioma|2014|0.2|0.2|0.2
20+|17.6|18.1|17.9|Benign/Borderline|24928|122667026|Female|Meningioma|2015|20.1|20.6|20.3
20+|0.1|0.2|0.1|Malignant|200|122667026|Female|Meningioma|2015|0.1|0.2|0.2
20+|18.0|18.2|18.1|Benign/Borderline|129213|618176604|Female|Meningioma|2015-2019|20.8|21.0|20.9
20+|0.1|0.1|0.1|Malignant|873|618176604|Female|Meningioma|2015-2019|0.1|0.2|0.1
20+|17.9|18.4|18.2|Benign/Borderline|25641|123795429|Female|Meningioma|2016|20.5|21.0|20.7
20+|0.1|0.1|0.1|Malignant|173|123795429|Female|Meningioma|2016|0.1|0.2|0.1
20+|18.2|18.6|18.4|Benign/Borderline|26539|124841928|Female|Meningioma|2017|21.0|21.5|21.3
20+|0.1|0.1|0.1|Malignant|179|124841928|Female|Meningioma|2017|0.1|0.2|0.1
20+|17.8|18.3|18.1|Benign/Borderline|26243|124643976|Female|Meningioma|2018|20.8|21.3|21.1
20+|0.1|0.1|0.1|Malignant|175|124643976|Female|Meningioma|2018|0.1|0.2|0.1
20+|17.8|18.2|18.0|Benign/Borderline|26503|125507651|Female|Meningioma|2019|20.9|21.4|21.1
20+|0.1|0.1|0.1|Malignant|152|125507651|Female|Meningioma|2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|197|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|236|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|273|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|239|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|263|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.3|Malignant|287|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116615701|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|271|116615701|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|117905188|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|271|117905188|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|119165857|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|244|119165857|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|120324137|Female|Mixed glioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|247|120324137|Female|Mixed glioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|121523550|Female|Mixed glioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|199|121523550|Female|Mixed glioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122667026|Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|132|122667026|Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|618176604|Female|Mixed glioma|2015-2019|~|~|~
20+|0.0|0.0|0.0|Malignant|225|618176604|Female|Mixed glioma|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123795429|Female|Mixed glioma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|42|123795429|Female|Mixed glioma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124841928|Female|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|31|124841928|Female|Mixed glioma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124643976|Female|Mixed glioma|2018|~|~|~
20+|~|~|~|Malignant|~|124643976|Female|Mixed glioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|125507651|Female|Mixed glioma|2019|~|~|~
20+|~|~|~|Malignant|~|125507651|Female|Mixed glioma|2019|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|691|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|703|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|870|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|720|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|806|111567226|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|722|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|843|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|652|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|837|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|753|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|924|115293599|Female|Neoplasm, unspecified|2009|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|783|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|829|116615701|Female|Neoplasm, unspecified|2010|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|646|116615701|Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|848|117905188|Female|Neoplasm, unspecified|2011|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|644|117905188|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|880|119165857|Female|Neoplasm, unspecified|2012|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|656|119165857|Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|797|120324137|Female|Neoplasm, unspecified|2013|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|665|120324137|Female|Neoplasm, unspecified|2013|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|890|121523550|Female|Neoplasm, unspecified|2014|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|743|121523550|Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|867|122667026|Female|Neoplasm, unspecified|2015|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|736|122667026|Female|Neoplasm, unspecified|2015|0.6|0.6|0.6
20+|0.5|0.5|0.5|Benign/Borderline|3666|618176604|Female|Neoplasm, unspecified|2015-2019|0.6|0.6|0.6
20+|0.4|0.4|0.4|Malignant|3324|618176604|Female|Neoplasm, unspecified|2015-2019|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|783|123795429|Female|Neoplasm, unspecified|2016|0.6|0.7|0.6
20+|0.4|0.4|0.4|Malignant|615|123795429|Female|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|0.5|0.6|0.5|Benign/Borderline|765|124841928|Female|Neoplasm, unspecified|2017|0.6|0.7|0.6
20+|0.4|0.5|0.4|Malignant|683|124841928|Female|Neoplasm, unspecified|2017|0.5|0.6|0.5
20+|0.5|0.5|0.5|Benign/Borderline|697|124643976|Female|Neoplasm, unspecified|2018|0.5|0.6|0.6
20+|0.4|0.5|0.4|Malignant|655|124643976|Female|Neoplasm, unspecified|2018|0.5|0.6|0.5
20+|0.4|0.4|0.4|Benign/Borderline|564|125507651|Female|Neoplasm, unspecified|2019|0.4|0.5|0.4
20+|0.4|0.4|0.4|Malignant|654|125507651|Female|Neoplasm, unspecified|2019|0.5|0.6|0.5
20+|2.2|2.4|2.3|Benign/Borderline|2581|109112165|Female|Nerve sheath, benign and malignant|2004|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2854|110320645|Female|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2978|111567226|Female|Nerve sheath, benign and malignant|2006|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2996|112783993|Female|Nerve sheath, benign and malignant|2007|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3119|114027722|Female|Nerve sheath, benign and malignant|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3274|115293599|Female|Nerve sheath, benign and malignant|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3091|116615701|Female|Nerve sheath, benign and malignant|2010|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|22|116615701|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3333|117905188|Female|Nerve sheath, benign and malignant|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|117905188|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3557|119165857|Female|Nerve sheath, benign and malignant|2012|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|27|119165857|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3731|120324137|Female|Nerve sheath, benign and malignant|2013|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|120324137|Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3861|121523550|Female|Nerve sheath, benign and malignant|2014|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|17|121523550|Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3970|122667026|Female|Nerve sheath, benign and malignant|2015|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|23|122667026|Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|18801|618176604|Female|Nerve sheath, benign and malignant|2015-2019|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|101|618176604|Female|Nerve sheath, benign and malignant|2015-2019|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3909|123795429|Female|Nerve sheath, benign and malignant|2016|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|27|123795429|Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3835|124841928|Female|Nerve sheath, benign and malignant|2017|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|18|124841928|Female|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3703|124643976|Female|Nerve sheath, benign and malignant|2018|2.9|3.1|3.0
20+|~|~|~|Malignant|~|124643976|Female|Nerve sheath, benign and malignant|2018|~|~|~
20+|2.4|2.6|2.5|Benign/Borderline|3454|125507651|Female|Nerve sheath, benign and malignant|2019|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|18|125507651|Female|Nerve sheath, benign and malignant|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116615701|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116615701|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117905188|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|24|117905188|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119165857|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|119165857|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120324137|Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|21|120324137|Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121523550|Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121523550|Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122667026|Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|38|122667026|Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|21|618176604|Female|Neuroepithelial|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|99|618176604|Female|Neuroepithelial|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123795429|Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|22|123795429|Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|124841928|Female|Neuroepithelial|2017|~|~|~
20+|~|~|~|Malignant|~|124841928|Female|Neuroepithelial|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|124643976|Female|Neuroepithelial|2018|~|~|~
20+|~|~|~|Malignant|~|124643976|Female|Neuroepithelial|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|125507651|Female|Neuroepithelial|2019|~|~|~
20+|~|~|~|Malignant|~|125507651|Female|Neuroepithelial|2019|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|154|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|186|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|206|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|205|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|224|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|248|116615701|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|+|116615701|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|244|117905188|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|117905188|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|214|119165857|Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|119165857|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|120324137|Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.2
20+|~|~|~|Malignant|~|120324137|Female|Neuronal/glial, neuronal|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|121523550|Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121523550|Female|Neuronal/glial, neuronal|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|231|122667026|Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122667026|Female|Neuronal/glial, neuronal|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1151|618176604|Female|Neuronal/glial, neuronal|2015-2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|95|618176604|Female|Neuronal/glial, neuronal|2015-2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|242|123795429|Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|123795429|Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|267|124841928|Female|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|+|124841928|Female|Neuronal/glial, neuronal|2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|207|124643976|Female|Neuronal/glial, neuronal|2018|0.1|0.2|0.2
20+|~|~|~|Malignant|~|124643976|Female|Neuronal/glial, neuronal|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|213|125507651|Female|Neuronal/glial, neuronal|2019|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|125507651|Female|Neuronal/glial, neuronal|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|355|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|363|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|381|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|375|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|366|114027722|Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|366|115293599|Female|Oligodendroglioma|2009|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|116615701|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|331|116615701|Female|Oligodendroglioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117905188|Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|321|117905188|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119165857|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|302|119165857|Female|Oligodendroglioma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120324137|Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|353|120324137|Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|121523550|Female|Oligodendroglioma|2014|~|~|~
20+|0.2|0.3|0.3|Malignant|308|121523550|Female|Oligodendroglioma|2014|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|122667026|Female|Oligodendroglioma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|313|122667026|Female|Oligodendroglioma|2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|618176604|Female|Oligodendroglioma|2015-2019|~|~|~
20+|0.3|0.3|0.3|Malignant|1572|618176604|Female|Oligodendroglioma|2015-2019|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|123795429|Female|Oligodendroglioma|2016|~|~|~
20+|0.3|0.3|0.3|Malignant|337|123795429|Female|Oligodendroglioma|2016|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|124841928|Female|Oligodendroglioma|2017|~|~|~
20+|0.2|0.3|0.3|Malignant|322|124841928|Female|Oligodendroglioma|2017|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|124643976|Female|Oligodendroglioma|2018|~|~|~
20+|0.2|0.3|0.3|Malignant|309|124643976|Female|Oligodendroglioma|2018|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|125507651|Female|Oligodendroglioma|2019|~|~|~
20+|0.2|0.3|0.3|Malignant|295|125507651|Female|Oligodendroglioma|2019|0.2|0.3|0.2
20+|0.0|0.1|0.1|Benign/Borderline|69|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|89|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|52|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|99|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|97|116615701|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|116615701|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|117905188|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|117905188|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|108|119165857|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|119165857|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|105|120324137|Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|41|120324137|Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|121523550|Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|121523550|Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|94|122667026|Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|41|122667026|Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|447|618176604|Female|Other mesenchymal|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|233|618176604|Female|Other mesenchymal|2015-2019|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|79|123795429|Female|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|123795429|Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|111|124841928|Female|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|61|124841928|Female|Other mesenchymal|2017|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|91|124643976|Female|Other mesenchymal|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|43|124643976|Female|Other mesenchymal|2018|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|74|125507651|Female|Other mesenchymal|2019|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|50|125507651|Female|Other mesenchymal|2019|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|128|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|151|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|148|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|166|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116615701|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|167|116615701|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117905188|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|162|117905188|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119165857|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|124|119165857|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120324137|Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|159|120324137|Female|Pilocytic astrocytoma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|121523550|Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|148|121523550|Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122667026|Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|148|122667026|Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|+|618176604|Female|Pilocytic astrocytoma|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|659|618176604|Female|Pilocytic astrocytoma|2015-2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123795429|Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|138|123795429|Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124841928|Female|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|128|124841928|Female|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|124643976|Female|Pilocytic astrocytoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|125|124643976|Female|Pilocytic astrocytoma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|125507651|Female|Pilocytic astrocytoma|2019|~|~|~
20+|0.1|0.1|0.1|Malignant|124|125507651|Female|Pilocytic astrocytoma|2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|+|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|+|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|+|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|114027722|Female|Pineal parenchymal|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|+|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|+|116615701|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|116615701|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|47|117905188|Female|Pineal parenchymal|2011|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|26|117905188|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|37|119165857|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|119165857|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|+|120324137|Female|Pineal parenchymal|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|34|120324137|Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|121523550|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|121523550|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|+|122667026|Female|Pineal parenchymal|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|31|122667026|Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|188|618176604|Female|Pineal parenchymal|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|137|618176604|Female|Pineal parenchymal|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|123795429|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|123795429|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|38|124841928|Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|124841928|Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|35|124643976|Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|124643976|Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|+|125507651|Female|Pineal parenchymal|2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|+|125507651|Female|Pineal parenchymal|2019|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|4204|109112165|Female|Pituitary|2004|3.7|4.0|3.9
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|4.3|4.6|4.5|Benign/Borderline|4903|110320645|Female|Pituitary|2005|4.3|4.6|4.4
20+|0.0|0.0|0.0|Malignant|+|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.7|5.0|4.9|Benign/Borderline|5391|111567226|Female|Pituitary|2006|4.7|5.0|4.8
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|5605|112783993|Female|Pituitary|2007|4.8|5.1|5.0
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|5.3|5.5|5.4|Benign/Borderline|6075|114027722|Female|Pituitary|2008|5.2|5.5|5.3
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|5.7|6.0|5.9|Benign/Borderline|6668|115293599|Female|Pituitary|2009|5.6|5.9|5.8
20+|0.0|0.0|0.0|Malignant|+|115293599|Female|Pituitary|2009|0.0|0.0|0.0
20+|5.7|6.0|5.9|Benign/Borderline|6712|116615701|Female|Pituitary|2010|5.6|5.9|5.8
20+|0.0|0.0|0.0|Malignant|16|116615701|Female|Pituitary|2010|0.0|0.0|0.0
20+|5.8|6.1|6.0|Benign/Borderline|6905|117905188|Female|Pituitary|2011|5.7|6.0|5.9
20+|~|~|~|Malignant|~|117905188|Female|Pituitary|2011|~|~|~
20+|6.2|6.5|6.4|Benign/Borderline|7426|119165857|Female|Pituitary|2012|6.1|6.4|6.2
20+|0.0|0.0|0.0|Malignant|16|119165857|Female|Pituitary|2012|0.0|0.0|0.0
20+|6.1|6.4|6.2|Benign/Borderline|7365|120324137|Female|Pituitary|2013|6.0|6.3|6.1
20+|~|~|~|Malignant|~|120324137|Female|Pituitary|2013|~|~|~
20+|6.2|6.5|6.4|Benign/Borderline|7532|121523550|Female|Pituitary|2014|6.1|6.3|6.2
20+|~|~|~|Malignant|~|121523550|Female|Pituitary|2014|~|~|~
20+|6.5|6.8|6.6|Benign/Borderline|7927|122667026|Female|Pituitary|2015|6.3|6.6|6.5
20+|~|~|~|Malignant|~|122667026|Female|Pituitary|2015|~|~|~
20+|6.5|6.7|6.6|Benign/Borderline|39894|618176604|Female|Pituitary|2015-2019|6.4|6.5|6.5
20+|0.0|0.0|0.0|Malignant|41|618176604|Female|Pituitary|2015-2019|0.0|0.0|0.0
20+|6.5|6.8|6.6|Benign/Borderline|8047|123795429|Female|Pituitary|2016|6.4|6.6|6.5
20+|~|~|~|Malignant|~|123795429|Female|Pituitary|2016|~|~|~
20+|6.7|7.0|6.9|Benign/Borderline|8393|124841928|Female|Pituitary|2017|6.6|6.9|6.7
20+|~|~|~|Malignant|~|124841928|Female|Pituitary|2017|~|~|~
20+|6.5|6.8|6.6|Benign/Borderline|8074|124643976|Female|Pituitary|2018|6.3|6.6|6.5
20+|~|~|~|Malignant|~|124643976|Female|Pituitary|2018|~|~|~
20+|6.0|6.3|6.2|Benign/Borderline|7629|125507651|Female|Pituitary|2019|5.9|6.2|6.1
20+|~|~|~|Malignant|~|125507651|Female|Pituitary|2019|~|~|~
20+|19.9|20.4|20.1|Benign/Borderline|22901|109112165|Female|Total|2004|20.7|21.3|21.0
20+|7.5|7.8|7.6|Malignant|8757|109112165|Female|Total|2004|7.9|8.2|8.0
20+|22.4|23.0|22.7|Benign/Borderline|26269|110320645|Female|Total|2005|23.5|24.1|23.8
20+|7.5|7.8|7.7|Malignant|8931|110320645|Female|Total|2005|7.9|8.3|8.1
20+|23.6|24.1|23.8|Benign/Borderline|27954|111567226|Female|Total|2006|24.8|25.4|25.1
20+|7.5|7.8|7.6|Malignant|8988|111567226|Female|Total|2006|7.9|8.2|8.1
20+|24.3|24.9|24.6|Benign/Borderline|29264|112783993|Female|Total|2007|25.7|26.2|25.9
20+|7.4|7.8|7.6|Malignant|9091|112783993|Female|Total|2007|7.9|8.2|8.1
20+|25.6|26.2|25.9|Benign/Borderline|31311|114027722|Female|Total|2008|27.2|27.8|27.5
20+|7.4|7.7|7.6|Malignant|9236|114027722|Female|Total|2008|7.9|8.3|8.1
20+|27.4|28.0|27.7|Benign/Borderline|33933|115293599|Female|Total|2009|29.1|29.7|29.4
20+|7.4|7.7|7.6|Malignant|9393|115293599|Female|Total|2009|8.0|8.3|8.1
20+|26.6|27.2|26.9|Benign/Borderline|33498|116615701|Female|Total|2010|28.4|29.0|28.7
20+|7.2|7.5|7.4|Malignant|9330|116615701|Female|Total|2010|7.8|8.2|8.0
20+|27.2|27.7|27.4|Benign/Borderline|34481|117905188|Female|Total|2011|28.9|29.6|29.2
20+|7.0|7.3|7.2|Malignant|9212|117905188|Female|Total|2011|7.7|8.0|7.8
20+|28.0|28.6|28.3|Benign/Borderline|36088|119165857|Female|Total|2012|30.0|30.6|30.3
20+|7.2|7.5|7.3|Malignant|9498|119165857|Female|Total|2012|7.8|8.1|8.0
20+|28.0|28.6|28.3|Benign/Borderline|36598|120324137|Female|Total|2013|30.1|30.7|30.4
20+|7.2|7.4|7.3|Malignant|9671|120324137|Female|Total|2013|7.9|8.2|8.0
20+|28.6|29.2|28.9|Benign/Borderline|37923|121523550|Female|Total|2014|30.9|31.5|31.2
20+|6.9|7.2|7.1|Malignant|9534|121523550|Female|Total|2014|7.7|8.0|7.8
20+|29.3|29.9|29.6|Benign/Borderline|39521|122667026|Female|Total|2015|31.9|32.5|32.2
20+|7.1|7.4|7.3|Malignant|9941|122667026|Female|Total|2015|7.9|8.3|8.1
20+|29.3|29.5|29.4|Benign/Borderline|200162|618176604|Female|Total|2015-2019|32.2|32.5|32.4
20+|6.8|7.0|6.9|Malignant|48384|618176604|Female|Total|2015-2019|7.8|7.9|7.8
20+|29.4|30.0|29.7|Benign/Borderline|40156|123795429|Female|Total|2016|32.1|32.8|32.4
20+|6.9|7.2|7.1|Malignant|9849|123795429|Female|Total|2016|7.8|8.1|8.0
20+|29.8|30.4|30.1|Benign/Borderline|41278|124841928|Female|Total|2017|32.7|33.4|33.1
20+|6.9|7.1|7.0|Malignant|9908|124841928|Female|Total|2017|7.8|8.1|7.9
20+|28.9|29.5|29.2|Benign/Borderline|40369|124643976|Female|Total|2018|32.1|32.7|32.4
20+|6.6|6.9|6.7|Malignant|9608|124643976|Female|Total|2018|7.6|7.9|7.7
20+|28.0|28.6|28.3|Benign/Borderline|39773|125507651|Female|Total|2019|31.4|32.0|31.7
20+|6.3|6.6|6.5|Malignant|9331|125507651|Female|Total|2019|7.3|7.6|7.4
20+|2.2|2.4|2.3|Benign/Borderline|2581|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.3|2.5|2.4
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2857|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2979|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2997|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3121|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3277|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3094|116615701|Female|Tumors of Cranial and Spinal Nerves|2010|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|22|116615701|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3335|117905188|Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|117905188|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3557|119165857|Female|Tumors of Cranial and Spinal Nerves|2012|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|27|119165857|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3732|120324137|Female|Tumors of Cranial and Spinal Nerves|2013|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|120324137|Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3867|121523550|Female|Tumors of Cranial and Spinal Nerves|2014|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|17|121523550|Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3973|122667026|Female|Tumors of Cranial and Spinal Nerves|2015|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|23|122667026|Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|18812|618176604|Female|Tumors of Cranial and Spinal Nerves|2015-2019|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|101|618176604|Female|Tumors of Cranial and Spinal Nerves|2015-2019|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3915|123795429|Female|Tumors of Cranial and Spinal Nerves|2016|3.1|3.3|3.2
20+|0.0|0.0|0.0|Malignant|27|123795429|Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3836|124841928|Female|Tumors of Cranial and Spinal Nerves|2017|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|18|124841928|Female|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3704|124643976|Female|Tumors of Cranial and Spinal Nerves|2018|2.9|3.1|3.0
20+|~|~|~|Malignant|~|124643976|Female|Tumors of Cranial and Spinal Nerves|2018|~|~|~
20+|2.4|2.6|2.5|Benign/Borderline|3454|125507651|Female|Tumors of Cranial and Spinal Nerves|2019|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|18|125507651|Female|Tumors of Cranial and Spinal Nerves|2019|0.0|0.0|0.0
20+|0.3|0.4|0.4|Benign/Borderline|381|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.1|6.4|6.2|Malignant|7072|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.5
20+|0.4|0.4|0.4|Benign/Borderline|446|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.1|6.3|6.2|Malignant|7154|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|485|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7234|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|488|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7407|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.6
20+|0.4|0.5|0.4|Benign/Borderline|493|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7426|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|517|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7637|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.5|6.8|6.6
20+|0.4|0.5|0.5|Benign/Borderline|548|116615701|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.2|6.1|Malignant|7616|116615701|Female|Tumors of Neuroepthelial Tissue|2010|6.4|6.7|6.5
20+|0.5|0.5|0.5|Benign/Borderline|571|117905188|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.8|6.1|6.0|Malignant|7565|117905188|Female|Tumors of Neuroepthelial Tissue|2011|6.3|6.6|6.4
20+|0.4|0.5|0.5|Benign/Borderline|549|119165857|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.5
20+|5.9|6.2|6.1|Malignant|7816|119165857|Female|Tumors of Neuroepthelial Tissue|2012|6.4|6.7|6.6
20+|0.4|0.5|0.4|Benign/Borderline|528|120324137|Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.4
20+|5.9|6.2|6.0|Malignant|7933|120324137|Female|Tumors of Neuroepthelial Tissue|2013|6.4|6.7|6.6
20+|0.5|0.5|0.5|Benign/Borderline|599|121523550|Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.5|0.5
20+|5.6|5.9|5.7|Malignant|7648|121523550|Female|Tumors of Neuroepthelial Tissue|2014|6.2|6.4|6.3
20+|0.5|0.6|0.5|Benign/Borderline|620|122667026|Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.5|0.5
20+|5.9|6.2|6.0|Malignant|8131|122667026|Female|Tumors of Neuroepthelial Tissue|2015|6.5|6.8|6.6
20+|0.5|0.5|0.5|Benign/Borderline|2922|618176604|Female|Tumors of Neuroepthelial Tissue|2015-2019|0.5|0.5|0.5
20+|5.7|5.8|5.7|Malignant|39651|618176604|Female|Tumors of Neuroepthelial Tissue|2015-2019|6.4|6.5|6.4
20+|0.5|0.5|0.5|Benign/Borderline|592|123795429|Female|Tumors of Neuroepthelial Tissue|2016|0.4|0.5|0.5
20+|5.7|6.0|5.9|Malignant|8115|123795429|Female|Tumors of Neuroepthelial Tissue|2016|6.4|6.7|6.6
20+|0.5|0.5|0.5|Benign/Borderline|613|124841928|Female|Tumors of Neuroepthelial Tissue|2017|0.5|0.5|0.5
20+|5.7|5.9|5.8|Malignant|8105|124841928|Female|Tumors of Neuroepthelial Tissue|2017|6.4|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|562|124643976|Female|Tumors of Neuroepthelial Tissue|2018|0.4|0.5|0.5
20+|5.4|5.7|5.5|Malignant|7864|124643976|Female|Tumors of Neuroepthelial Tissue|2018|6.2|6.5|6.3
20+|0.4|0.5|0.4|Benign/Borderline|552|125507651|Female|Tumors of Neuroepthelial Tissue|2019|0.4|0.5|0.4
20+|5.2|5.5|5.3|Malignant|7650|125507651|Female|Tumors of Neuroepthelial Tissue|2019|6.0|6.2|6.1
20+|3.9|4.2|4.1|Benign/Borderline|4410|109112165|Female|Tumors of Sellar Region|2004|3.9|4.2|4.0
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.5|4.8|4.6|Benign/Borderline|5089|110320645|Female|Tumors of Sellar Region|2005|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|+|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.9|5.2|5.1|Benign/Borderline|5594|111567226|Female|Tumors of Sellar Region|2006|4.9|5.1|5.0
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|5.1|5.4|5.2|Benign/Borderline|5826|112783993|Female|Tumors of Sellar Region|2007|5.0|5.3|5.2
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|5.5|5.7|5.6|Benign/Borderline|6301|114027722|Female|Tumors of Sellar Region|2008|5.4|5.7|5.5
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.9|6.2|6.1|Benign/Borderline|6899|115293599|Female|Tumors of Sellar Region|2009|5.8|6.1|6.0
20+|0.0|0.0|0.0|Malignant|+|115293599|Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.9|6.2|6.1|Benign/Borderline|6951|116615701|Female|Tumors of Sellar Region|2010|5.8|6.1|6.0
20+|0.0|0.0|0.0|Malignant|16|116615701|Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|6.0|6.3|6.2|Benign/Borderline|7127|117905188|Female|Tumors of Sellar Region|2011|5.9|6.2|6.0
20+|~|~|~|Malignant|~|117905188|Female|Tumors of Sellar Region|2011|~|~|~
20+|6.4|6.7|6.6|Benign/Borderline|7654|119165857|Female|Tumors of Sellar Region|2012|6.3|6.6|6.4
20+|0.0|0.0|0.0|Malignant|16|119165857|Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|6.3|6.6|6.4|Benign/Borderline|7609|120324137|Female|Tumors of Sellar Region|2013|6.2|6.5|6.3
20+|0.0|0.0|0.0|Malignant|16|120324137|Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|6.4|6.7|6.5|Benign/Borderline|7756|121523550|Female|Tumors of Sellar Region|2014|6.2|6.5|6.4
20+|~|~|~|Malignant|~|121523550|Female|Tumors of Sellar Region|2014|~|~|~
20+|6.7|7.0|6.8|Benign/Borderline|8166|122667026|Female|Tumors of Sellar Region|2015|6.5|6.8|6.7
20+|~|~|~|Malignant|~|122667026|Female|Tumors of Sellar Region|2015|~|~|~
20+|6.7|6.8|6.8|Benign/Borderline|41054|618176604|Female|Tumors of Sellar Region|2015-2019|6.6|6.7|6.6
20+|0.0|0.0|0.0|Malignant|43|618176604|Female|Tumors of Sellar Region|2015-2019|0.0|0.0|0.0
20+|6.7|7.0|6.8|Benign/Borderline|8272|123795429|Female|Tumors of Sellar Region|2016|6.5|6.8|6.7
20+|~|~|~|Malignant|~|123795429|Female|Tumors of Sellar Region|2016|~|~|~
20+|6.9|7.2|7.1|Benign/Borderline|8640|124841928|Female|Tumors of Sellar Region|2017|6.8|7.1|6.9
20+|~|~|~|Malignant|~|124841928|Female|Tumors of Sellar Region|2017|~|~|~
20+|6.7|7.0|6.8|Benign/Borderline|8309|124643976|Female|Tumors of Sellar Region|2018|6.5|6.8|6.7
20+|~|~|~|Malignant|~|124643976|Female|Tumors of Sellar Region|2018|~|~|~
20+|6.2|6.5|6.3|Benign/Borderline|7848|125507651|Female|Tumors of Sellar Region|2019|6.1|6.4|6.3
20+|~|~|~|Malignant|~|125507651|Female|Tumors of Sellar Region|2019|~|~|~
20+|12.4|12.8|12.6|Benign/Borderline|14571|109112165|Female|Tumors of the Meninges|2004|13.1|13.6|13.4
20+|0.2|0.3|0.3|Malignant|302|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.9|14.3|14.1|Benign/Borderline|16678|110320645|Female|Tumors of the Meninges|2005|14.9|15.3|15.1
20+|0.2|0.3|0.3|Malignant|309|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|14.5|15.0|14.8|Benign/Borderline|17725|111567226|Female|Tumors of the Meninges|2006|15.7|16.1|15.9
20+|0.2|0.3|0.2|Malignant|283|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|15.1|15.6|15.3|Benign/Borderline|18696|112783993|Female|Tumors of the Meninges|2007|16.3|16.8|16.6
20+|0.2|0.3|0.3|Malignant|310|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|15.9|16.4|16.1|Benign/Borderline|20042|114027722|Female|Tumors of the Meninges|2008|17.3|17.8|17.6
20+|0.2|0.2|0.2|Malignant|271|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|17.0|17.5|17.2|Benign/Borderline|21740|115293599|Female|Tumors of the Meninges|2009|18.6|19.1|18.9
20+|0.2|0.2|0.2|Malignant|231|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|16.4|16.9|16.7|Benign/Borderline|21376|116615701|Female|Tumors of the Meninges|2010|18.1|18.6|18.3
20+|0.2|0.2|0.2|Malignant|243|116615701|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|16.6|17.0|16.8|Benign/Borderline|21839|117905188|Female|Tumors of the Meninges|2011|18.3|18.8|18.5
20+|0.1|0.2|0.2|Malignant|217|117905188|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|16.9|17.4|17.1|Benign/Borderline|22680|119165857|Female|Tumors of the Meninges|2012|18.8|19.3|19.0
20+|0.2|0.2|0.2|Malignant|243|119165857|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|17.0|17.5|17.3|Benign/Borderline|23162|120324137|Female|Tumors of the Meninges|2013|19.0|19.5|19.2
20+|0.2|0.2|0.2|Malignant|270|120324137|Female|Tumors of the Meninges|2013|0.2|0.3|0.2
20+|17.4|17.8|17.6|Benign/Borderline|24095|121523550|Female|Tumors of the Meninges|2014|19.6|20.1|19.8
20+|0.2|0.2|0.2|Malignant|257|121523550|Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|17.9|18.4|18.1|Benign/Borderline|25269|122667026|Female|Tumors of the Meninges|2015|20.3|20.9|20.6
20+|0.2|0.2|0.2|Malignant|245|122667026|Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|18.3|18.5|18.4|Benign/Borderline|130879|618176604|Female|Tumors of the Meninges|2015-2019|21.1|21.3|21.2
20+|0.2|0.2|0.2|Malignant|1119|618176604|Female|Tumors of the Meninges|2015-2019|0.2|0.2|0.2
20+|18.2|18.7|18.4|Benign/Borderline|25991|123795429|Female|Tumors of the Meninges|2016|20.7|21.3|21.0
20+|0.1|0.2|0.2|Malignant|215|123795429|Female|Tumors of the Meninges|2016|0.2|0.2|0.2
20+|18.4|18.9|18.7|Benign/Borderline|26873|124841928|Female|Tumors of the Meninges|2017|21.3|21.8|21.5
20+|0.1|0.2|0.2|Malignant|242|124841928|Female|Tumors of the Meninges|2017|0.2|0.2|0.2
20+|18.1|18.5|18.3|Benign/Borderline|26549|124643976|Female|Tumors of the Meninges|2018|21.0|21.6|21.3
20+|0.1|0.2|0.2|Malignant|221|124643976|Female|Tumors of the Meninges|2018|0.2|0.2|0.2
20+|18.0|18.5|18.3|Benign/Borderline|26844|125507651|Female|Tumors of the Meninges|2019|21.1|21.6|21.4
20+|0.1|0.2|0.1|Malignant|203|125507651|Female|Tumors of the Meninges|2019|0.1|0.2|0.2
20+|0.8|0.9|0.8|Benign/Borderline|940|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.9
20+|0.5|0.6|0.6|Malignant|709|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1161|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.1
20+|0.5|0.6|0.6|Malignant|724|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1135|111567226|Female|Unclassified Tumors|2006|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|727|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|1.0|1.1|1.0|Benign/Borderline|1220|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|655|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.2|1.1|Benign/Borderline|1320|114027722|Female|Unclassified Tumors|2008|1.1|1.2|1.2
20+|0.5|0.6|0.6|Malignant|767|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.3|1.2|Benign/Borderline|1455|115293599|Female|Unclassified Tumors|2009|1.2|1.3|1.3
20+|0.5|0.6|0.6|Malignant|790|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.2|1.3|1.2|Benign/Borderline|1496|116615701|Female|Unclassified Tumors|2010|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|654|116615701|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.2|1.3|1.3|Benign/Borderline|1570|117905188|Female|Unclassified Tumors|2011|1.3|1.4|1.3
20+|0.4|0.5|0.5|Malignant|650|117905188|Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.2|1.3|1.3|Benign/Borderline|1611|119165857|Female|Unclassified Tumors|2012|1.3|1.4|1.4
20+|0.4|0.5|0.5|Malignant|661|119165857|Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.3|1.2|Benign/Borderline|1541|120324137|Female|Unclassified Tumors|2013|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|669|120324137|Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.2|1.3|1.2|Benign/Borderline|1574|121523550|Female|Unclassified Tumors|2014|1.2|1.4|1.3
20+|0.5|0.5|0.5|Malignant|751|121523550|Female|Unclassified Tumors|2014|0.6|0.7|0.6
20+|1.0|1.2|1.1|Benign/Borderline|1460|122667026|Female|Unclassified Tumors|2015|1.1|1.3|1.2
20+|0.5|0.5|0.5|Malignant|744|122667026|Female|Unclassified Tumors|2015|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|6348|618176604|Female|Unclassified Tumors|2015-2019|1.0|1.1|1.0
20+|0.4|0.5|0.4|Malignant|3362|618176604|Female|Unclassified Tumors|2015-2019|0.5|0.6|0.5
20+|1.0|1.1|1.0|Benign/Borderline|1353|123795429|Female|Unclassified Tumors|2016|1.0|1.2|1.1
20+|0.4|0.4|0.4|Malignant|621|123795429|Female|Unclassified Tumors|2016|0.5|0.5|0.5
20+|0.9|1.0|1.0|Benign/Borderline|1290|124841928|Female|Unclassified Tumors|2017|1.0|1.1|1.0
20+|0.4|0.5|0.4|Malignant|691|124841928|Female|Unclassified Tumors|2017|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1223|124643976|Female|Unclassified Tumors|2018|0.9|1.0|1.0
20+|0.4|0.5|0.4|Malignant|666|124643976|Female|Unclassified Tumors|2018|0.5|0.6|0.5
20+|0.7|0.8|0.8|Benign/Borderline|1041|125507651|Female|Unclassified Tumors|2019|0.8|0.9|0.8
20+|0.4|0.4|0.4|Malignant|659|125507651|Female|Unclassified Tumors|2019|0.5|0.6|0.5
20+|0.0|0.1|0.0|Benign/Borderline|54|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|50|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|63|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|60|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|77|115293599|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|72|116615701|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|116615701|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|117905188|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|117905188|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|119165857|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|119165857|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|97|120324137|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|120324137|Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|101|121523550|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|121523550|Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|107|122667026|Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|23|122667026|Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|539|618176604|Female|Unique astrocytoma variants|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|150|618176604|Female|Unique astrocytoma variants|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|113|123795429|Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|123795429|Female|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|100|124841928|Female|Unique astrocytoma variants|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|124841928|Female|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|106|124643976|Female|Unique astrocytoma variants|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|124643976|Female|Unique astrocytoma variants|2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|114|125507651|Female|Unique astrocytoma variants|2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|125507651|Female|Unique astrocytoma variants|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Benign/Borderline|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|+|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109527150|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109527150|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|+|110839824|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|110839824|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112210327|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|+|112210327|Male|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|+|113464572|Male|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|113464572|Male|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114723581|Male|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114723581|Male|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|115951558|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|115951558|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|195|584748560|Male|All other|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|570|584748560|Male|All other|2015-2019|0.1|0.1|0.1
20+|0.0|0.1|0.0|Benign/Borderline|46|117114889|Male|All other|2016|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|27|117114889|Male|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|118165836|Male|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|118165836|Male|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|117962778|Male|All other|2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|221|117962778|Male|All other|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|40|118814607|Male|All other|2019|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|271|118814607|Male|All other|2019|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|672|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|701|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|699|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|674|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|710|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|716|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109527150|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|712|109527150|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|110839824|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|708|110839824|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112210327|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|751|112210327|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113464572|Male|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.7|0.7|Malignant|798|113464572|Male|Anaplastic astrocytoma|2013|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|114723581|Male|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|795|114723581|Male|Anaplastic astrocytoma|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|115951558|Male|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|780|115951558|Male|Anaplastic astrocytoma|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|584748560|Male|Anaplastic astrocytoma|2015-2019|~|~|~
20+|0.6|0.7|0.6|Malignant|3862|584748560|Male|Anaplastic astrocytoma|2015-2019|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|117114889|Male|Anaplastic astrocytoma|2016|~|~|~
20+|0.6|0.7|0.7|Malignant|832|117114889|Male|Anaplastic astrocytoma|2016|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|118165836|Male|Anaplastic astrocytoma|2017|~|~|~
20+|0.6|0.7|0.7|Malignant|786|118165836|Male|Anaplastic astrocytoma|2017|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|117962778|Male|Anaplastic astrocytoma|2018|~|~|~
20+|0.6|0.7|0.7|Malignant|796|117962778|Male|Anaplastic astrocytoma|2018|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|118814607|Male|Anaplastic astrocytoma|2019|~|~|~
20+|0.5|0.6|0.6|Malignant|688|118814607|Male|Anaplastic astrocytoma|2019|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|212|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|211|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|216|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|186|105697783|Male|Anaplastic oligodendroglioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|190|106947980|Male|Anaplastic oligodendroglioma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|190|108197539|Male|Anaplastic oligodendroglioma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109527150|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.2|0.2|0.2|Malignant|195|109527150|Male|Anaplastic oligodendroglioma|2010|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110839824|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|187|110839824|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112210327|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|187|112210327|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113464572|Male|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|225|113464572|Male|Anaplastic oligodendroglioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114723581|Male|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|206|114723581|Male|Anaplastic oligodendroglioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|115951558|Male|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.2|Malignant|192|115951558|Male|Anaplastic oligodendroglioma|2015|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|584748560|Male|Anaplastic oligodendroglioma|2015-2019|~|~|~
20+|0.2|0.2|0.2|Malignant|1021|584748560|Male|Anaplastic oligodendroglioma|2015-2019|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|117114889|Male|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.2|0.2|0.2|Malignant|201|117114889|Male|Anaplastic oligodendroglioma|2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|118165836|Male|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.2|0.2|0.2|Malignant|236|118165836|Male|Anaplastic oligodendroglioma|2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|117962778|Male|Anaplastic oligodendroglioma|2018|~|~|~
20+|0.1|0.2|0.2|Malignant|186|117962778|Male|Anaplastic oligodendroglioma|2018|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|118814607|Male|Anaplastic oligodendroglioma|2019|~|~|~
20+|0.2|0.2|0.2|Malignant|213|118814607|Male|Anaplastic oligodendroglioma|2019|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|637|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|634|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|650|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|629|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|629|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|574|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109527150|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|620|109527150|Male|Astrocytoma, NOS|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|110839824|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|586|110839824|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|112210327|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.5|0.5|0.5|Malignant|561|112210327|Male|Astrocytoma, NOS|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113464572|Male|Astrocytoma, NOS|2013|~|~|~
20+|0.5|0.5|0.5|Malignant|570|113464572|Male|Astrocytoma, NOS|2013|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114723581|Male|Astrocytoma, NOS|2014|~|~|~
20+|0.5|0.6|0.5|Malignant|601|114723581|Male|Astrocytoma, NOS|2014|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|115951558|Male|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|689|115951558|Male|Astrocytoma, NOS|2015|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|584748560|Male|Astrocytoma, NOS|2015-2019|~|~|~
20+|0.6|0.6|0.6|Malignant|3440|584748560|Male|Astrocytoma, NOS|2015-2019|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|117114889|Male|Astrocytoma, NOS|2016|~|~|~
20+|0.6|0.6|0.6|Malignant|703|117114889|Male|Astrocytoma, NOS|2016|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|118165836|Male|Astrocytoma, NOS|2017|~|~|~
20+|0.5|0.6|0.6|Malignant|698|118165836|Male|Astrocytoma, NOS|2017|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|117962778|Male|Astrocytoma, NOS|2018|~|~|~
20+|0.5|0.6|0.6|Malignant|690|117962778|Male|Astrocytoma, NOS|2018|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|118814607|Male|Astrocytoma, NOS|2019|~|~|~
20+|0.5|0.6|0.6|Malignant|676|118814607|Male|Astrocytoma, NOS|2019|0.5|0.6|0.6
20+|0.0|0.0|0.0|Benign/Borderline|25|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|109527150|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109527150|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|110839824|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110839824|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|112210327|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112210327|Male|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|113464572|Male|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113464572|Male|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|114723581|Male|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114723581|Male|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|115951558|Male|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115951558|Male|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|171|584748560|Male|Choroid plexus|2015-2019|0.0|0.0|0.0
20+|~|~|~|Malignant|~|584748560|Male|Choroid plexus|2015-2019|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|117114889|Male|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117114889|Male|Choroid plexus|2016|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|118165836|Male|Choroid plexus|2017|0.0|0.1|0.0
20+|~|~|~|Malignant|~|118165836|Male|Choroid plexus|2017|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|25|117962778|Male|Choroid plexus|2018|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117962778|Male|Choroid plexus|2018|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|118814607|Male|Choroid plexus|2019|0.0|0.0|0.0
20+|~|~|~|Malignant|~|118814607|Male|Choroid plexus|2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|188|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|234|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|192|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|200|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|201|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|203|109527150|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109527150|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|196|110839824|Male|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110839824|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|218|112210327|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112210327|Male|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|113464572|Male|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113464572|Male|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|211|114723581|Male|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114723581|Male|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|115951558|Male|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115951558|Male|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1158|584748560|Male|Craniopharyngioma|2015-2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|584748560|Male|Craniopharyngioma|2015-2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|246|117114889|Male|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117114889|Male|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|242|118165836|Male|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118165836|Male|Craniopharyngioma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|117962778|Male|Craniopharyngioma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117962778|Male|Craniopharyngioma|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|227|118814607|Male|Craniopharyngioma|2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118814607|Male|Craniopharyngioma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|145|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|210|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109527150|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|187|109527150|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110839824|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|136|110839824|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112210327|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|114|112210327|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113464572|Male|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|103|113464572|Male|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114723581|Male|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|68|114723581|Male|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115951558|Male|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.1|0.0|Malignant|49|115951558|Male|Diffuse astrocytoma|2015|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|584748560|Male|Diffuse astrocytoma|2015-2019|~|~|~
20+|0.0|0.0|0.0|Malignant|105|584748560|Male|Diffuse astrocytoma|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117114889|Male|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|+|117114889|Male|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118165836|Male|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Malignant|~|118165836|Male|Diffuse astrocytoma|2017|~|~|~
20+|~|~|~|Benign/Borderline|~|117962778|Male|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Malignant|~|117962778|Male|Diffuse astrocytoma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|118814607|Male|Diffuse astrocytoma|2019|~|~|~
20+|~|~|~|Malignant|~|118814607|Male|Diffuse astrocytoma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|97|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|105|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|124|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|133|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109527150|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|126|109527150|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110839824|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|110839824|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112210327|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|93|112210327|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113464572|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|97|113464572|Male|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114723581|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|107|114723581|Male|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115951558|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|101|115951558|Male|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|584748560|Male|Embryonal/primitive/medulloblastoma|2015-2019|~|~|~
20+|0.1|0.1|0.1|Malignant|476|584748560|Male|Embryonal/primitive/medulloblastoma|2015-2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117114889|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|118|117114889|Male|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118165836|Male|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|98|118165836|Male|Embryonal/primitive/medulloblastoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117962778|Male|Embryonal/primitive/medulloblastoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|86|117962778|Male|Embryonal/primitive/medulloblastoma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118814607|Male|Embryonal/primitive/medulloblastoma|2019|~|~|~
20+|0.1|0.1|0.1|Malignant|78|118814607|Male|Embryonal/primitive/medulloblastoma|2019|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|162|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|137|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|148|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|109527150|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109527150|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|110839824|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|110839824|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|164|112210327|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|112210327|Male|Ependymoma variants|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|161|113464572|Male|Ependymoma variants|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|113464572|Male|Ependymoma variants|2013|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|169|114723581|Male|Ependymoma variants|2014|0.1|0.2|0.1
20+|~|~|~|Malignant|~|114723581|Male|Ependymoma variants|2014|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|160|115951558|Male|Ependymoma variants|2015|0.1|0.2|0.1
20+|~|~|~|Malignant|~|115951558|Male|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|750|584748560|Male|Ependymoma variants|2015-2019|0.1|0.1|0.1
20+|~|~|~|Malignant|~|584748560|Male|Ependymoma variants|2015-2019|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|171|117114889|Male|Ependymoma variants|2016|0.1|0.2|0.1
20+|~|~|~|Malignant|~|117114889|Male|Ependymoma variants|2016|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|162|118165836|Male|Ependymoma variants|2017|0.1|0.2|0.1
20+|~|~|~|Malignant|~|118165836|Male|Ependymoma variants|2017|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|137|117962778|Male|Ependymoma variants|2018|0.1|0.1|0.1
20+|~|~|~|Malignant|~|117962778|Male|Ependymoma variants|2018|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|124|118814607|Male|Ependymoma variants|2019|0.1|0.1|0.1
20+|~|~|~|Malignant|~|118814607|Male|Ependymoma variants|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|303|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|301|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|292|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|289|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|322|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|341|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|109527150|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|333|109527150|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110839824|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|298|110839824|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112210327|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|328|112210327|Male|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113464572|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|302|113464572|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|+|114723581|Male|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|323|114723581|Male|Ependymoma/anaplastic ependymoma|2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115951558|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|308|115951558|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|56|584748560|Male|Ependymoma/anaplastic ependymoma|2015-2019|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|1498|584748560|Male|Ependymoma/anaplastic ependymoma|2015-2019|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117114889|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.3|0.3|Malignant|331|117114889|Male|Ependymoma/anaplastic ependymoma|2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118165836|Male|Ependymoma/anaplastic ependymoma|2017|~|~|~
20+|0.2|0.3|0.2|Malignant|301|118165836|Male|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117962778|Male|Ependymoma/anaplastic ependymoma|2018|~|~|~
20+|0.2|0.3|0.3|Malignant|299|117962778|Male|Ependymoma/anaplastic ependymoma|2018|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118814607|Male|Ependymoma/anaplastic ependymoma|2019|~|~|~
20+|0.2|0.2|0.2|Malignant|265|118814607|Male|Ependymoma/anaplastic ependymoma|2019|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|22|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|+|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|+|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|+|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|+|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|34|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|+|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|+|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|28|109527150|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|+|109527150|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|24|110839824|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|+|110839824|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|32|112210327|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|+|112210327|Male|Germ Cell Tumors|2012|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|113464572|Male|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|+|113464572|Male|Germ Cell Tumors|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|28|114723581|Male|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|+|114723581|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|115951558|Male|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|+|115951558|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|139|584748560|Male|Germ Cell Tumors|2015-2019|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|306|584748560|Male|Germ Cell Tumors|2015-2019|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|31|117114889|Male|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|+|117114889|Male|Germ Cell Tumors|2016|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|30|118165836|Male|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|+|118165836|Male|Germ Cell Tumors|2017|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|21|117962778|Male|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|+|117962778|Male|Germ Cell Tumors|2018|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|28|118814607|Male|Germ Cell Tumors|2019|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|+|118814607|Male|Germ Cell Tumors|2019|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5462|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.5|5.8|5.6|Malignant|5545|103190694|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5511|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.5|5.7|5.6|Malignant|5824|105697783|Male|Glioblastoma|2007|5.4|5.7|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.7|Malignant|6013|106947980|Male|Glioblastoma|2008|5.5|5.8|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.6|Malignant|6015|108197539|Male|Glioblastoma|2009|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|109527150|Male|Glioblastoma|2010|~|~|~
20+|5.4|5.6|5.5|Malignant|6124|109527150|Male|Glioblastoma|2010|5.5|5.7|5.6
20+|~|~|~|Benign/Borderline|~|110839824|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.7|5.5|Malignant|6307|110839824|Male|Glioblastoma|2011|5.6|5.8|5.7
20+|~|~|~|Benign/Borderline|~|112210327|Male|Glioblastoma|2012|~|~|~
20+|5.5|5.7|5.6|Malignant|6528|112210327|Male|Glioblastoma|2012|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|113464572|Male|Glioblastoma|2013|~|~|~
20+|5.4|5.7|5.6|Malignant|6645|113464572|Male|Glioblastoma|2013|5.7|6.0|5.9
20+|~|~|~|Benign/Borderline|~|114723581|Male|Glioblastoma|2014|~|~|~
20+|5.5|5.7|5.6|Malignant|6811|114723581|Male|Glioblastoma|2014|5.8|6.1|5.9
20+|~|~|~|Benign/Borderline|~|115951558|Male|Glioblastoma|2015|~|~|~
20+|5.4|5.7|5.6|Malignant|6913|115951558|Male|Glioblastoma|2015|5.8|6.1|6.0
20+|~|~|~|Benign/Borderline|~|584748560|Male|Glioblastoma|2015-2019|~|~|~
20+|5.5|5.7|5.6|Malignant|35957|584748560|Male|Glioblastoma|2015-2019|6.1|6.2|6.1
20+|~|~|~|Benign/Borderline|~|117114889|Male|Glioblastoma|2016|~|~|~
20+|5.5|5.8|5.7|Malignant|7223|117114889|Male|Glioblastoma|2016|6.0|6.3|6.2
20+|~|~|~|Benign/Borderline|~|118165836|Male|Glioblastoma|2017|~|~|~
20+|5.5|5.8|5.7|Malignant|7365|118165836|Male|Glioblastoma|2017|6.1|6.4|6.2
20+|~|~|~|Benign/Borderline|~|117962778|Male|Glioblastoma|2018|~|~|~
20+|5.5|5.7|5.6|Malignant|7341|117962778|Male|Glioblastoma|2018|6.1|6.4|6.2
20+|~|~|~|Benign/Borderline|~|118814607|Male|Glioblastoma|2019|~|~|~
20+|5.4|5.6|5.5|Malignant|7313|118814607|Male|Glioblastoma|2019|6.0|6.3|6.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|422|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|443|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|444|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|465|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioma malignant, NOS|2008|~|~|~
20+|0.4|0.5|0.5|Malignant|482|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|458|108197539|Male|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109527150|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|408|109527150|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|+|110839824|Male|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|496|110839824|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112210327|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|489|112210327|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113464572|Male|Glioma malignant, NOS|2013|~|~|~
20+|0.4|0.5|0.4|Malignant|461|113464572|Male|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114723581|Male|Glioma malignant, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|505|114723581|Male|Glioma malignant, NOS|2014|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|115951558|Male|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|486|115951558|Male|Glioma malignant, NOS|2015|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|107|584748560|Male|Glioma malignant, NOS|2015-2019|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|2685|584748560|Male|Glioma malignant, NOS|2015-2019|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|30|117114889|Male|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|541|117114889|Male|Glioma malignant, NOS|2016|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|18|118165836|Male|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.5|0.6|0.5|Malignant|597|118165836|Male|Glioma malignant, NOS|2017|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|18|117962778|Male|Glioma malignant, NOS|2018|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|567|117962778|Male|Glioma malignant, NOS|2018|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|18|118814607|Male|Glioma malignant, NOS|2019|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|513|118814607|Male|Glioma malignant, NOS|2019|0.4|0.5|0.4
20+|0.2|0.3|0.2|Benign/Borderline|254|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|288|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|277|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|257|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|293|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|274|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.3
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|304|109527150|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109527150|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|278|110839824|Male|Hemangioblastoma|2011|0.2|0.3|0.3
20+|~|~|~|Malignant|~|110839824|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|286|112210327|Male|Hemangioblastoma|2012|0.2|0.3|0.3
20+|~|~|~|Malignant|~|112210327|Male|Hemangioblastoma|2012|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|275|113464572|Male|Hemangioblastoma|2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|113464572|Male|Hemangioblastoma|2013|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|280|114723581|Male|Hemangioblastoma|2014|0.2|0.3|0.2
20+|~|~|~|Malignant|~|114723581|Male|Hemangioblastoma|2014|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|297|115951558|Male|Hemangioblastoma|2015|0.2|0.3|0.3
20+|~|~|~|Malignant|~|115951558|Male|Hemangioblastoma|2015|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|1465|584748560|Male|Hemangioblastoma|2015-2019|0.2|0.3|0.3
20+|0.0|0.0|0.0|Malignant|+|584748560|Male|Hemangioblastoma|2015-2019|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|282|117114889|Male|Hemangioblastoma|2016|0.2|0.3|0.2
20+|~|~|~|Malignant|~|117114889|Male|Hemangioblastoma|2016|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|334|118165836|Male|Hemangioblastoma|2017|0.3|0.3|0.3
20+|~|~|~|Malignant|~|118165836|Male|Hemangioblastoma|2017|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|300|117962778|Male|Hemangioblastoma|2018|0.2|0.3|0.3
20+|~|~|~|Malignant|~|117962778|Male|Hemangioblastoma|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|265|118814607|Male|Hemangioblastoma|2019|0.2|0.3|0.2
20+|~|~|~|Malignant|~|118814607|Male|Hemangioblastoma|2019|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|201|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|238|104488268|Male|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|270|105697783|Male|Hemangioma|2007|0.2|0.3|0.3
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|327|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|438|108197539|Male|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|452|109527150|Male|Hemangioma|2010|0.4|0.5|0.4
20+|~|~|~|Malignant|~|109527150|Male|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|513|110839824|Male|Hemangioma|2011|0.4|0.5|0.5
20+|~|~|~|Malignant|~|110839824|Male|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|513|112210327|Male|Hemangioma|2012|0.4|0.5|0.5
20+|~|~|~|Malignant|~|112210327|Male|Hemangioma|2012|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|512|113464572|Male|Hemangioma|2013|0.4|0.5|0.5
20+|~|~|~|Malignant|~|113464572|Male|Hemangioma|2013|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|506|114723581|Male|Hemangioma|2014|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114723581|Male|Hemangioma|2014|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|461|115951558|Male|Hemangioma|2015|0.4|0.4|0.4
20+|~|~|~|Malignant|~|115951558|Male|Hemangioma|2015|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|2160|584748560|Male|Hemangioma|2015-2019|0.4|0.4|0.4
20+|~|~|~|Malignant|~|584748560|Male|Hemangioma|2015-2019|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|415|117114889|Male|Hemangioma|2016|0.3|0.4|0.4
20+|~|~|~|Malignant|~|117114889|Male|Hemangioma|2016|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|432|118165836|Male|Hemangioma|2017|0.3|0.4|0.4
20+|~|~|~|Malignant|~|118165836|Male|Hemangioma|2017|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|433|117962778|Male|Hemangioma|2018|0.3|0.4|0.4
20+|~|~|~|Malignant|~|117962778|Male|Hemangioma|2018|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|423|118814607|Male|Hemangioma|2019|0.3|0.4|0.4
20+|~|~|~|Malignant|~|118814607|Male|Hemangioma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|35|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|30|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109527150|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|29|109527150|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110839824|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110839824|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112210327|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|112210327|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113464572|Male|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|30|113464572|Male|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114723581|Male|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|25|114723581|Male|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115951558|Male|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|23|115951558|Male|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|584748560|Male|Local Extensions from Regional Tumors|2015-2019|~|~|~
20+|0.0|0.0|0.0|Malignant|106|584748560|Male|Local Extensions from Regional Tumors|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117114889|Male|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|+|117114889|Male|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118165836|Male|Local Extensions from Regional Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|+|118165836|Male|Local Extensions from Regional Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117962778|Male|Local Extensions from Regional Tumors|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|+|117962778|Male|Local Extensions from Regional Tumors|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118814607|Male|Local Extensions from Regional Tumors|2019|~|~|~
20+|0.0|0.0|0.0|Malignant|+|118814607|Male|Local Extensions from Regional Tumors|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|748|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|775|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.8
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|762|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|737|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.8|Malignant|774|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|762|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|109527150|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.7|Malignant|755|109527150|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|110839824|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|805|110839824|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|112210327|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|756|112210327|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113464572|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.7|0.6|Malignant|729|113464572|Male|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|114723581|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|820|114723581|Male|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|115951558|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|820|115951558|Male|Lymphomas and Hematopoietic Neoplasms|2015|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|584748560|Male|Lymphomas and Hematopoietic Neoplasms|2015-2019|~|~|~
20+|0.6|0.7|0.7|Malignant|4154|584748560|Male|Lymphomas and Hematopoietic Neoplasms|2015-2019|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|117114889|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.7|0.7|Malignant|821|117114889|Male|Lymphomas and Hematopoietic Neoplasms|2016|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|118165836|Male|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.7|0.8|0.7|Malignant|885|118165836|Male|Lymphomas and Hematopoietic Neoplasms|2017|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|117962778|Male|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
20+|0.6|0.7|0.7|Malignant|833|117962778|Male|Lymphomas and Hematopoietic Neoplasms|2018|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|118814607|Male|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
20+|0.6|0.7|0.6|Malignant|818|118814607|Male|Lymphomas and Hematopoietic Neoplasms|2019|0.6|0.7|0.7
20+|5.1|5.4|5.2|Benign/Borderline|4927|101938779|Male|Meningioma|2004|4.7|5.0|4.8
20+|0.2|0.2|0.2|Malignant|170|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.6|5.9|5.8|Benign/Borderline|5495|103190694|Male|Meningioma|2005|5.2|5.5|5.3
20+|0.1|0.2|0.2|Malignant|155|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.9|6.2|6.1|Benign/Borderline|5907|104488268|Male|Meningioma|2006|5.5|5.8|5.7
20+|0.1|0.2|0.2|Malignant|153|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|6.0|6.4|6.2|Benign/Borderline|6149|105697783|Male|Meningioma|2007|5.7|6.0|5.8
20+|0.1|0.2|0.2|Malignant|174|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.5|6.8|6.6|Benign/Borderline|6751|106947980|Male|Meningioma|2008|6.2|6.5|6.3
20+|0.1|0.2|0.1|Malignant|148|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.9|7.3|7.1|Benign/Borderline|7306|108197539|Male|Meningioma|2009|6.6|6.9|6.8
20+|0.1|0.2|0.1|Malignant|150|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.8|7.1|7.0|Benign/Borderline|7333|109527150|Male|Meningioma|2010|6.5|6.9|6.7
20+|0.1|0.1|0.1|Malignant|124|109527150|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.8|7.2|7.0|Benign/Borderline|7552|110839824|Male|Meningioma|2011|6.7|7.0|6.8
20+|0.1|0.2|0.1|Malignant|143|110839824|Male|Meningioma|2011|0.1|0.2|0.1
20+|6.9|7.2|7.1|Benign/Borderline|7789|112210327|Male|Meningioma|2012|6.8|7.1|6.9
20+|0.1|0.2|0.1|Malignant|152|112210327|Male|Meningioma|2012|0.1|0.2|0.1
20+|7.2|7.5|7.3|Benign/Borderline|8278|113464572|Male|Meningioma|2013|7.1|7.5|7.3
20+|0.1|0.2|0.1|Malignant|157|113464572|Male|Meningioma|2013|0.1|0.2|0.1
20+|7.2|7.5|7.3|Benign/Borderline|8448|114723581|Male|Meningioma|2014|7.2|7.5|7.4
20+|0.1|0.2|0.1|Malignant|168|114723581|Male|Meningioma|2014|0.1|0.2|0.1
20+|7.5|7.8|7.6|Benign/Borderline|9007|115951558|Male|Meningioma|2015|7.6|7.9|7.8
20+|0.1|0.1|0.1|Malignant|150|115951558|Male|Meningioma|2015|0.1|0.2|0.1
20+|7.7|7.9|7.8|Benign/Borderline|47345|584748560|Male|Meningioma|2015-2019|8.0|8.2|8.1
20+|0.1|0.1|0.1|Malignant|724|584748560|Male|Meningioma|2015-2019|0.1|0.1|0.1
20+|7.5|7.9|7.7|Benign/Borderline|9238|117114889|Male|Meningioma|2016|7.7|8.1|7.9
20+|0.1|0.1|0.1|Malignant|159|117114889|Male|Meningioma|2016|0.1|0.2|0.1
20+|7.8|8.1|7.9|Benign/Borderline|9769|118165836|Male|Meningioma|2017|8.1|8.4|8.3
20+|0.1|0.1|0.1|Malignant|149|118165836|Male|Meningioma|2017|0.1|0.1|0.1
20+|7.6|7.9|7.7|Benign/Borderline|9634|117962778|Male|Meningioma|2018|8.0|8.3|8.2
20+|0.1|0.1|0.1|Malignant|135|117962778|Male|Meningioma|2018|0.1|0.1|0.1
20+|7.7|8.0|7.8|Benign/Borderline|9922|118814607|Male|Meningioma|2019|8.2|8.5|8.4
20+|0.1|0.1|0.1|Malignant|135|118814607|Male|Meningioma|2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|295|101938779|Male|Mixed glioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|330|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|366|104488268|Male|Mixed glioma|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|351|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|338|106947980|Male|Mixed glioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|393|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109527150|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|343|109527150|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110839824|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|365|110839824|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112210327|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|331|112210327|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113464572|Male|Mixed glioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|371|113464572|Male|Mixed glioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114723581|Male|Mixed glioma|2014|~|~|~
20+|0.2|0.3|0.2|Malignant|268|114723581|Male|Mixed glioma|2014|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115951558|Male|Mixed glioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|145|115951558|Male|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|584748560|Male|Mixed glioma|2015-2019|~|~|~
20+|0.0|0.1|0.0|Malignant|257|584748560|Male|Mixed glioma|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117114889|Male|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|65|117114889|Male|Mixed glioma|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118165836|Male|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|28|118165836|Male|Mixed glioma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117962778|Male|Mixed glioma|2018|~|~|~
20+|~|~|~|Malignant|~|117962778|Male|Mixed glioma|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|118814607|Male|Mixed glioma|2019|~|~|~
20+|~|~|~|Malignant|~|118814607|Male|Mixed glioma|2019|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|510|101938779|Male|Neoplasm, unspecified|2004|0.5|0.5|0.5
20+|0.6|0.7|0.7|Malignant|612|101938779|Male|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|629|103190694|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|604|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|618|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|566|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|587|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|566|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|615|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|616|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|614|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|639|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|671|109527150|Male|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.6|0.7|0.6|Malignant|601|109527150|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|631|110839824|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|610|110839824|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|712|112210327|Male|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|619|112210327|Male|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|694|113464572|Male|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|614|113464572|Male|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|643|114723581|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|664|114723581|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|637|115951558|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|632|115951558|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.5|0.5|Benign/Borderline|2759|584748560|Male|Neoplasm, unspecified|2015-2019|0.5|0.5|0.5
20+|0.5|0.6|0.5|Malignant|3131|584748560|Male|Neoplasm, unspecified|2015-2019|0.5|0.6|0.5
20+|0.5|0.6|0.5|Benign/Borderline|595|117114889|Male|Neoplasm, unspecified|2016|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|634|117114889|Male|Neoplasm, unspecified|2016|0.5|0.6|0.5
20+|0.4|0.5|0.5|Benign/Borderline|562|118165836|Male|Neoplasm, unspecified|2017|0.4|0.5|0.5
20+|0.4|0.5|0.5|Malignant|567|118165836|Male|Neoplasm, unspecified|2017|0.4|0.5|0.5
20+|0.4|0.5|0.4|Benign/Borderline|520|117962778|Male|Neoplasm, unspecified|2018|0.4|0.5|0.4
20+|0.5|0.6|0.5|Malignant|649|117962778|Male|Neoplasm, unspecified|2018|0.5|0.6|0.6
20+|0.3|0.4|0.4|Benign/Borderline|454|118814607|Male|Neoplasm, unspecified|2019|0.3|0.4|0.4
20+|0.5|0.6|0.6|Malignant|675|118814607|Male|Neoplasm, unspecified|2019|0.5|0.6|0.6
20+|2.2|2.4|2.3|Benign/Borderline|2338|101938779|Male|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2690|103190694|Male|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|31|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2670|104488268|Male|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2762|105697783|Male|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2734|106947980|Male|Nerve sheath, benign and malignant|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2929|108197539|Male|Nerve sheath, benign and malignant|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2949|109527150|Male|Nerve sheath, benign and malignant|2010|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|23|109527150|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3060|110839824|Male|Nerve sheath, benign and malignant|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|17|110839824|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3239|112210327|Male|Nerve sheath, benign and malignant|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|24|112210327|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3329|113464572|Male|Nerve sheath, benign and malignant|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|113464572|Male|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3599|114723581|Male|Nerve sheath, benign and malignant|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|114723581|Male|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3585|115951558|Male|Nerve sheath, benign and malignant|2015|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|16|115951558|Male|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|17224|584748560|Male|Nerve sheath, benign and malignant|2015-2019|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|99|584748560|Male|Nerve sheath, benign and malignant|2015-2019|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3521|117114889|Male|Nerve sheath, benign and malignant|2016|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|23|117114889|Male|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3561|118165836|Male|Nerve sheath, benign and malignant|2017|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|25|118165836|Male|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3438|117962778|Male|Nerve sheath, benign and malignant|2018|2.8|3.0|2.9
20+|~|~|~|Malignant|~|117962778|Male|Nerve sheath, benign and malignant|2018|~|~|~
20+|2.4|2.6|2.5|Benign/Borderline|3202|118814607|Male|Nerve sheath, benign and malignant|2019|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|118814607|Male|Nerve sheath, benign and malignant|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109527150|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109527150|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110839824|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|27|110839824|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112210327|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|112210327|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113464572|Male|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|27|113464572|Male|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114723581|Male|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|35|114723581|Male|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115951558|Male|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|32|115951558|Male|Neuroepithelial|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|584748560|Male|Neuroepithelial|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|95|584748560|Male|Neuroepithelial|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117114889|Male|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|25|117114889|Male|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118165836|Male|Neuroepithelial|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|+|118165836|Male|Neuroepithelial|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117962778|Male|Neuroepithelial|2018|~|~|~
20+|~|~|~|Malignant|~|117962778|Male|Neuroepithelial|2018|~|~|~
20+|~|~|~|Benign/Borderline|~|118814607|Male|Neuroepithelial|2019|~|~|~
20+|~|~|~|Malignant|~|118814607|Male|Neuroepithelial|2019|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|163|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|+|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|191|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|202|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|186|105697783|Male|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|217|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|218|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|234|109527150|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109527150|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|189|110839824|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|110839824|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|209|112210327|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112210327|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|113464572|Male|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|+|113464572|Male|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|225|114723581|Male|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|+|114723581|Male|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|268|115951558|Male|Neuronal/glial, neuronal|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Malignant|+|115951558|Male|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1235|584748560|Male|Neuronal/glial, neuronal|2015-2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|75|584748560|Male|Neuronal/glial, neuronal|2015-2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|241|117114889|Male|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|117114889|Male|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|247|118165836|Male|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|118165836|Male|Neuronal/glial, neuronal|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|245|117962778|Male|Neuronal/glial, neuronal|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117962778|Male|Neuronal/glial, neuronal|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|238|118814607|Male|Neuronal/glial, neuronal|2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|118814607|Male|Neuronal/glial, neuronal|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|475|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|440|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|473|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|441|105697783|Male|Oligodendroglioma|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.4|0.4|0.4|Malignant|413|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|475|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109527150|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|473|109527150|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|110839824|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|446|110839824|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112210327|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|377|112210327|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|113464572|Male|Oligodendroglioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|367|113464572|Male|Oligodendroglioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114723581|Male|Oligodendroglioma|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|415|114723581|Male|Oligodendroglioma|2014|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115951558|Male|Oligodendroglioma|2015|~|~|~
20+|0.3|0.4|0.4|Malignant|407|115951558|Male|Oligodendroglioma|2015|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|584748560|Male|Oligodendroglioma|2015-2019|~|~|~
20+|0.3|0.4|0.3|Malignant|1953|584748560|Male|Oligodendroglioma|2015-2019|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117114889|Male|Oligodendroglioma|2016|~|~|~
20+|0.3|0.4|0.4|Malignant|404|117114889|Male|Oligodendroglioma|2016|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|118165836|Male|Oligodendroglioma|2017|~|~|~
20+|0.3|0.4|0.4|Malignant|405|118165836|Male|Oligodendroglioma|2017|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|117962778|Male|Oligodendroglioma|2018|~|~|~
20+|0.3|0.4|0.3|Malignant|354|117962778|Male|Oligodendroglioma|2018|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|118814607|Male|Oligodendroglioma|2019|~|~|~
20+|0.3|0.4|0.4|Malignant|398|118814607|Male|Oligodendroglioma|2019|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|83|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|73|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|36|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|40|105697783|Male|Other mesenchymal|2007|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|50|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|79|109527150|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|109527150|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|69|110839824|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|110839824|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|112210327|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|112210327|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|74|113464572|Male|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|45|113464572|Male|Other mesenchymal|2013|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|88|114723581|Male|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|48|114723581|Male|Other mesenchymal|2014|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|108|115951558|Male|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|115951558|Male|Other mesenchymal|2015|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|421|584748560|Male|Other mesenchymal|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|240|584748560|Male|Other mesenchymal|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|117114889|Male|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|42|117114889|Male|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|118165836|Male|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|50|118165836|Male|Other mesenchymal|2017|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|81|117962778|Male|Other mesenchymal|2018|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|60|117962778|Male|Other mesenchymal|2018|0.0|0.1|0.1
20+|0.0|0.1|0.1|Benign/Borderline|71|118814607|Male|Other mesenchymal|2019|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|118814607|Male|Other mesenchymal|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|151|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|157|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|138|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109527150|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|164|109527150|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|110839824|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|175|110839824|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112210327|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|148|112210327|Male|Pilocytic astrocytoma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113464572|Male|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|146|113464572|Male|Pilocytic astrocytoma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114723581|Male|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|151|114723581|Male|Pilocytic astrocytoma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115951558|Male|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|149|115951558|Male|Pilocytic astrocytoma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|584748560|Male|Pilocytic astrocytoma|2015-2019|~|~|~
20+|0.1|0.1|0.1|Malignant|753|584748560|Male|Pilocytic astrocytoma|2015-2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117114889|Male|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|161|117114889|Male|Pilocytic astrocytoma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|118165836|Male|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|142|118165836|Male|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117962778|Male|Pilocytic astrocytoma|2018|~|~|~
20+|0.1|0.2|0.1|Malignant|149|117962778|Male|Pilocytic astrocytoma|2018|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|118814607|Male|Pilocytic astrocytoma|2019|~|~|~
20+|0.1|0.2|0.1|Malignant|155|118814607|Male|Pilocytic astrocytoma|2019|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|+|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|23|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109527150|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109527150|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|110839824|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|110839824|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|112210327|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|112210327|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113464572|Male|Pineal parenchymal|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|36|113464572|Male|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|114723581|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|114723581|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115951558|Male|Pineal parenchymal|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|28|115951558|Male|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|87|584748560|Male|Pineal parenchymal|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|123|584748560|Male|Pineal parenchymal|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|117114889|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|34|117114889|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|118165836|Male|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|28|118165836|Male|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|117962778|Male|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|19|117962778|Male|Pineal parenchymal|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|118814607|Male|Pineal parenchymal|2019|~|~|~
20+|~|~|~|Malignant|~|118814607|Male|Pineal parenchymal|2019|~|~|~
20+|3.4|3.6|3.5|Benign/Borderline|3471|101938779|Male|Pituitary|2004|3.3|3.5|3.4
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|3827|103190694|Male|Pituitary|2005|3.6|3.8|3.7
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.9|4.1|4.0|Benign/Borderline|4106|104488268|Male|Pituitary|2006|3.8|4.1|3.9
20+|0.0|0.0|0.0|Malignant|+|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4514|105697783|Male|Pituitary|2007|4.1|4.4|4.3
20+|0.0|0.0|0.0|Malignant|+|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.5|4.8|4.6|Benign/Borderline|4920|106947980|Male|Pituitary|2008|4.5|4.7|4.6
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.7|5.0|4.9|Benign/Borderline|5275|108197539|Male|Pituitary|2009|4.7|5.0|4.9
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.8|5.1|5.0|Benign/Borderline|5469|109527150|Male|Pituitary|2010|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|16|109527150|Male|Pituitary|2010|0.0|0.0|0.0
20+|4.9|5.2|5.0|Benign/Borderline|5611|110839824|Male|Pituitary|2011|4.9|5.2|5.1
20+|0.0|0.0|0.0|Malignant|+|110839824|Male|Pituitary|2011|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6109|112210327|Male|Pituitary|2012|5.3|5.6|5.4
20+|0.0|0.0|0.0|Malignant|19|112210327|Male|Pituitary|2012|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6185|113464572|Male|Pituitary|2013|5.3|5.6|5.5
20+|0.0|0.0|0.0|Malignant|+|113464572|Male|Pituitary|2013|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6298|114723581|Male|Pituitary|2014|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|+|114723581|Male|Pituitary|2014|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|6552|115951558|Male|Pituitary|2015|5.5|5.8|5.7
20+|0.0|0.0|0.0|Malignant|+|115951558|Male|Pituitary|2015|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|32797|584748560|Male|Pituitary|2015-2019|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|68|584748560|Male|Pituitary|2015-2019|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|6641|117114889|Male|Pituitary|2016|5.5|5.8|5.7
20+|~|~|~|Malignant|~|117114889|Male|Pituitary|2016|~|~|~
20+|5.5|5.7|5.6|Benign/Borderline|6847|118165836|Male|Pituitary|2017|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|+|118165836|Male|Pituitary|2017|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6619|117962778|Male|Pituitary|2018|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|+|117962778|Male|Pituitary|2018|0.0|0.0|0.0
20+|4.9|5.2|5.0|Benign/Borderline|6311|118814607|Male|Pituitary|2019|5.2|5.4|5.3
20+|~|~|~|Malignant|~|118814607|Male|Pituitary|2019|~|~|~
20+|12.5|12.9|12.7|Benign/Borderline|12391|101938779|Male|Total|2004|11.9|12.4|12.2
20+|10.7|11.1|10.9|Malignant|10645|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.9|14.4|14.1|Benign/Borderline|13999|103190694|Male|Total|2005|13.3|13.8|13.6
20+|10.7|11.1|10.9|Malignant|10813|103190694|Male|Total|2005|10.3|10.7|10.5
20+|14.3|14.8|14.5|Benign/Borderline|14673|104488268|Male|Total|2006|13.8|14.3|14.0
20+|10.5|10.9|10.7|Malignant|10847|104488268|Male|Total|2006|10.2|10.6|10.4
20+|14.7|15.2|15.0|Benign/Borderline|15388|105697783|Male|Total|2007|14.3|14.8|14.6
20+|10.5|10.9|10.7|Malignant|11088|105697783|Male|Total|2007|10.3|10.7|10.5
20+|15.6|16.1|15.9|Benign/Borderline|16570|106947980|Male|Total|2008|15.3|15.7|15.5
20+|10.6|11.0|10.8|Malignant|11390|106947980|Male|Total|2008|10.5|10.8|10.7
20+|16.5|17.0|16.8|Benign/Borderline|17777|108197539|Male|Total|2009|16.2|16.7|16.4
20+|10.5|10.9|10.7|Malignant|11451|108197539|Male|Total|2009|10.4|10.8|10.6
20+|16.5|17.0|16.7|Benign/Borderline|18141|109527150|Male|Total|2010|16.3|16.8|16.6
20+|10.2|10.6|10.4|Malignant|11430|109527150|Male|Total|2010|10.2|10.6|10.4
20+|16.6|17.0|16.8|Benign/Borderline|18550|110839824|Male|Total|2011|16.5|17.0|16.7
20+|10.3|10.6|10.4|Malignant|11670|110839824|Male|Total|2011|10.3|10.7|10.5
20+|17.2|17.7|17.4|Benign/Borderline|19629|112210327|Male|Total|2012|17.2|17.7|17.5
20+|10.1|10.4|10.3|Malignant|11694|112210327|Male|Total|2012|10.2|10.6|10.4
20+|17.4|17.9|17.7|Benign/Borderline|20228|113464572|Male|Total|2013|17.6|18.1|17.8
20+|10.0|10.4|10.2|Malignant|11892|113464572|Male|Total|2013|10.3|10.7|10.5
20+|17.6|18.1|17.8|Benign/Borderline|20790|114723581|Male|Total|2014|17.9|18.4|18.1
20+|10.1|10.5|10.3|Malignant|12214|114723581|Male|Total|2014|10.5|10.8|10.6
20+|17.9|18.4|18.2|Benign/Borderline|21613|115951558|Male|Total|2015|18.4|18.9|18.6
20+|9.8|10.2|10.0|Malignant|12098|115951558|Male|Total|2015|10.2|10.6|10.4
20+|17.8|18.0|17.9|Benign/Borderline|108965|584748560|Male|Total|2015-2019|18.5|18.7|18.6
20+|9.8|10.0|9.9|Malignant|61382|584748560|Male|Total|2015-2019|10.4|10.6|10.5
20+|17.8|18.3|18.1|Benign/Borderline|21777|117114889|Male|Total|2016|18.3|18.8|18.6
20+|10.0|10.3|10.1|Malignant|12518|117114889|Male|Total|2016|10.5|10.9|10.7
20+|18.1|18.6|18.4|Benign/Borderline|22574|118165836|Male|Total|2017|18.9|19.4|19.1
20+|9.9|10.2|10.0|Malignant|12560|118165836|Male|Total|2017|10.4|10.8|10.6
20+|17.5|18.0|17.7|Benign/Borderline|21954|117962778|Male|Total|2018|18.4|18.9|18.6
20+|9.6|10.0|9.8|Malignant|12378|117962778|Male|Total|2018|10.3|10.7|10.5
20+|16.9|17.4|17.2|Benign/Borderline|21576|118814607|Male|Total|2019|17.9|18.4|18.2
20+|9.3|9.7|9.5|Malignant|12174|118814607|Male|Total|2019|10.1|10.4|10.2
20+|2.2|2.4|2.3|Benign/Borderline|2338|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2690|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|31|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2671|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2763|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2736|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|2933|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2950|109527150|Male|Tumors of Cranial and Spinal Nerves|2010|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|23|109527150|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3063|110839824|Male|Tumors of Cranial and Spinal Nerves|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|17|110839824|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3241|112210327|Male|Tumors of Cranial and Spinal Nerves|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|24|112210327|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3333|113464572|Male|Tumors of Cranial and Spinal Nerves|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|113464572|Male|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|3602|114723581|Male|Tumors of Cranial and Spinal Nerves|2014|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|22|114723581|Male|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3592|115951558|Male|Tumors of Cranial and Spinal Nerves|2015|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|16|115951558|Male|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|17245|584748560|Male|Tumors of Cranial and Spinal Nerves|2015-2019|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|99|584748560|Male|Tumors of Cranial and Spinal Nerves|2015-2019|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3525|117114889|Male|Tumors of Cranial and Spinal Nerves|2016|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|23|117114889|Male|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3565|118165836|Male|Tumors of Cranial and Spinal Nerves|2017|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|25|118165836|Male|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3440|117962778|Male|Tumors of Cranial and Spinal Nerves|2018|2.8|3.0|2.9
20+|~|~|~|Malignant|~|117962778|Male|Tumors of Cranial and Spinal Nerves|2018|~|~|~
20+|2.4|2.6|2.5|Benign/Borderline|3206|118814607|Male|Tumors of Cranial and Spinal Nerves|2019|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|118814607|Male|Tumors of Cranial and Spinal Nerves|2019|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|453|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8964|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|528|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9109|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|563|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9204|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|527|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.5|0.5|0.5
20+|8.8|9.2|9.0|Malignant|9414|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|587|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9677|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.9|9.2|9.0
20+|0.5|0.6|0.5|Benign/Borderline|594|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.9|9.2|9.0|Malignant|9744|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.8|9.2|9.0
20+|0.6|0.6|0.6|Benign/Borderline|649|109527150|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.7|9.0|8.9|Malignant|9776|109527150|Male|Tumors of Neuroepthelial Tissue|2010|8.7|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|611|110839824|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.6
20+|8.6|9.0|8.8|Malignant|9928|110839824|Male|Tumors of Neuroepthelial Tissue|2011|8.8|9.1|9.0
20+|0.5|0.6|0.6|Benign/Borderline|636|112210327|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.6
20+|8.5|8.9|8.7|Malignant|10011|112210327|Male|Tumors of Neuroepthelial Tissue|2012|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|616|113464572|Male|Tumors of Neuroepthelial Tissue|2013|0.5|0.6|0.5
20+|8.6|8.9|8.7|Malignant|10214|113464572|Male|Tumors of Neuroepthelial Tissue|2013|8.8|9.2|9.0
20+|0.5|0.6|0.6|Benign/Borderline|683|114723581|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.6|0.6
20+|8.6|8.9|8.7|Malignant|10368|114723581|Male|Tumors of Neuroepthelial Tissue|2014|8.9|9.2|9.0
20+|0.6|0.7|0.6|Benign/Borderline|701|115951558|Male|Tumors of Neuroepthelial Tissue|2015|0.6|0.7|0.6
20+|8.3|8.7|8.5|Malignant|10330|115951558|Male|Tumors of Neuroepthelial Tissue|2015|8.7|9.1|8.9
20+|0.6|0.6|0.6|Benign/Borderline|3456|584748560|Male|Tumors of Neuroepthelial Tissue|2015-2019|0.6|0.6|0.6
20+|8.4|8.5|8.4|Malignant|52483|584748560|Male|Tumors of Neuroepthelial Tissue|2015-2019|8.9|9.1|9.0
20+|0.6|0.7|0.6|Benign/Borderline|720|117114889|Male|Tumors of Neuroepthelial Tissue|2016|0.6|0.7|0.6
20+|8.5|8.8|8.6|Malignant|10715|117114889|Male|Tumors of Neuroepthelial Tissue|2016|9.0|9.3|9.1
20+|0.6|0.6|0.6|Benign/Borderline|704|118165836|Male|Tumors of Neuroepthelial Tissue|2017|0.6|0.6|0.6
20+|8.4|8.7|8.6|Malignant|10773|118165836|Male|Tumors of Neuroepthelial Tissue|2017|8.9|9.3|9.1
20+|0.5|0.6|0.6|Benign/Borderline|678|117962778|Male|Tumors of Neuroepthelial Tissue|2018|0.5|0.6|0.6
20+|8.2|8.5|8.3|Malignant|10568|117962778|Male|Tumors of Neuroepthelial Tissue|2018|8.8|9.1|9.0
20+|0.5|0.6|0.6|Benign/Borderline|668|118814607|Male|Tumors of Neuroepthelial Tissue|2019|0.5|0.6|0.6
20+|7.9|8.2|8.1|Malignant|10388|118814607|Male|Tumors of Neuroepthelial Tissue|2019|8.6|8.9|8.7
20+|3.6|3.8|3.7|Benign/Borderline|3659|101938779|Male|Tumors of Sellar Region|2004|3.5|3.7|3.6
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|4061|103190694|Male|Tumors of Sellar Region|2005|3.8|4.1|3.9
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|4.1|4.3|4.2|Benign/Borderline|4298|104488268|Male|Tumors of Sellar Region|2006|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|+|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|4714|105697783|Male|Tumors of Sellar Region|2007|4.3|4.6|4.5
20+|0.0|0.0|0.0|Malignant|+|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.7|5.0|4.8|Benign/Borderline|5118|106947980|Male|Tumors of Sellar Region|2008|4.7|4.9|4.8
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|5476|108197539|Male|Tumors of Sellar Region|2009|4.9|5.2|5.1
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|5.0|5.3|5.1|Benign/Borderline|5672|109527150|Male|Tumors of Sellar Region|2010|5.0|5.3|5.2
20+|0.0|0.0|0.0|Malignant|16|109527150|Male|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|5807|110839824|Male|Tumors of Sellar Region|2011|5.1|5.4|5.2
20+|0.0|0.0|0.0|Malignant|+|110839824|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.4|5.7|5.6|Benign/Borderline|6327|112210327|Male|Tumors of Sellar Region|2012|5.5|5.8|5.6
20+|0.0|0.0|0.0|Malignant|19|112210327|Male|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.4|5.7|5.6|Benign/Borderline|6415|113464572|Male|Tumors of Sellar Region|2013|5.5|5.8|5.7
20+|0.0|0.0|0.0|Malignant|26|113464572|Male|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.4|5.7|5.5|Benign/Borderline|6509|114723581|Male|Tumors of Sellar Region|2014|5.5|5.8|5.7
20+|0.0|0.0|0.0|Malignant|+|114723581|Male|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|6779|115951558|Male|Tumors of Sellar Region|2015|5.7|6.0|5.8
20+|0.0|0.0|0.0|Malignant|+|115951558|Male|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.5|5.6|5.6|Benign/Borderline|33955|584748560|Male|Tumors of Sellar Region|2015-2019|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|69|584748560|Male|Tumors of Sellar Region|2015-2019|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|6887|117114889|Male|Tumors of Sellar Region|2016|5.7|6.0|5.9
20+|~|~|~|Malignant|~|117114889|Male|Tumors of Sellar Region|2016|~|~|~
20+|5.6|5.9|5.8|Benign/Borderline|7089|118165836|Male|Tumors of Sellar Region|2017|5.9|6.1|6.0
20+|0.0|0.0|0.0|Malignant|+|118165836|Male|Tumors of Sellar Region|2017|0.0|0.0|0.0
20+|5.4|5.7|5.5|Benign/Borderline|6839|117962778|Male|Tumors of Sellar Region|2018|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|+|117962778|Male|Tumors of Sellar Region|2018|0.0|0.0|0.0
20+|5.1|5.4|5.2|Benign/Borderline|6538|118814607|Male|Tumors of Sellar Region|2019|5.4|5.6|5.5
20+|~|~|~|Malignant|~|118814607|Male|Tumors of Sellar Region|2019|~|~|~
20+|5.4|5.7|5.6|Benign/Borderline|5264|101938779|Male|Tumors of the Meninges|2004|5.0|5.3|5.2
20+|0.2|0.2|0.2|Malignant|202|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|6.0|6.3|6.1|Benign/Borderline|5856|103190694|Male|Tumors of the Meninges|2005|5.5|5.8|5.7
20+|0.2|0.2|0.2|Malignant|194|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.2|6.6|6.4|Benign/Borderline|6252|104488268|Male|Tumors of the Meninges|2006|5.8|6.1|6.0
20+|0.2|0.2|0.2|Malignant|186|104488268|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|6.4|6.7|6.5|Benign/Borderline|6488|105697783|Male|Tumors of the Meninges|2007|6.0|6.3|6.1
20+|0.2|0.2|0.2|Malignant|219|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.8|7.2|7.0|Benign/Borderline|7148|106947980|Male|Tumors of the Meninges|2008|6.5|6.8|6.7
20+|0.2|0.2|0.2|Malignant|200|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|7.3|7.6|7.5|Benign/Borderline|7683|108197539|Male|Tumors of the Meninges|2009|6.9|7.3|7.1
20+|0.2|0.2|0.2|Malignant|201|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|7.2|7.5|7.3|Benign/Borderline|7716|109527150|Male|Tumors of the Meninges|2010|6.9|7.2|7.0
20+|0.1|0.2|0.2|Malignant|161|109527150|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|7.1|7.5|7.3|Benign/Borderline|7899|110839824|Male|Tumors of the Meninges|2011|7.0|7.3|7.1
20+|0.1|0.2|0.2|Malignant|190|110839824|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|7.2|7.6|7.4|Benign/Borderline|8168|112210327|Male|Tumors of the Meninges|2012|7.1|7.4|7.3
20+|0.1|0.2|0.2|Malignant|184|112210327|Male|Tumors of the Meninges|2012|0.1|0.2|0.2
20+|7.5|7.8|7.7|Benign/Borderline|8627|113464572|Male|Tumors of the Meninges|2013|7.4|7.8|7.6
20+|0.2|0.2|0.2|Malignant|202|113464572|Male|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|7.5|7.8|7.7|Benign/Borderline|8816|114723581|Male|Tumors of the Meninges|2014|7.5|7.8|7.7
20+|0.2|0.2|0.2|Malignant|218|114723581|Male|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|7.8|8.1|8.0|Benign/Borderline|9412|115951558|Male|Tumors of the Meninges|2015|8.0|8.3|8.1
20+|0.1|0.2|0.2|Malignant|198|115951558|Male|Tumors of the Meninges|2015|0.1|0.2|0.2
20+|8.0|8.2|8.1|Benign/Borderline|49231|584748560|Male|Tumors of the Meninges|2015-2019|8.3|8.5|8.4
20+|0.1|0.2|0.2|Malignant|980|584748560|Male|Tumors of the Meninges|2015-2019|0.2|0.2|0.2
20+|7.8|8.2|8.0|Benign/Borderline|9602|117114889|Male|Tumors of the Meninges|2016|8.0|8.4|8.2
20+|0.1|0.2|0.2|Malignant|206|117114889|Male|Tumors of the Meninges|2016|0.2|0.2|0.2
20+|8.1|8.5|8.3|Benign/Borderline|10184|118165836|Male|Tumors of the Meninges|2017|8.5|8.8|8.6
20+|0.1|0.2|0.2|Malignant|203|118165836|Male|Tumors of the Meninges|2017|0.1|0.2|0.2
20+|7.9|8.2|8.1|Benign/Borderline|10015|117962778|Male|Tumors of the Meninges|2018|8.3|8.7|8.5
20+|0.1|0.2|0.2|Malignant|200|117962778|Male|Tumors of the Meninges|2018|0.1|0.2|0.2
20+|8.0|8.3|8.1|Benign/Borderline|10258|118814607|Male|Tumors of the Meninges|2019|8.5|8.8|8.6
20+|0.1|0.2|0.1|Malignant|179|118814607|Male|Tumors of the Meninges|2019|0.1|0.2|0.2
20+|0.6|0.8|0.7|Benign/Borderline|653|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|619|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|831|103190694|Male|Unclassified Tumors|2005|0.8|0.9|0.8
20+|0.6|0.7|0.7|Malignant|613|103190694|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|858|104488268|Male|Unclassified Tumors|2006|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|577|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|859|105697783|Male|Unclassified Tumors|2007|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|574|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|946|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.9
20+|0.6|0.7|0.7|Malignant|626|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1054|108197539|Male|Unclassified Tumors|2009|0.9|1.0|1.0
20+|0.6|0.7|0.7|Malignant|650|108197539|Male|Unclassified Tumors|2009|0.6|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1125|109527150|Male|Unclassified Tumors|2010|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|614|109527150|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1145|110839824|Male|Unclassified Tumors|2011|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|625|110839824|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|1225|112210327|Male|Unclassified Tumors|2012|1.0|1.2|1.1
20+|0.6|0.7|0.6|Malignant|631|112210327|Male|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1209|113464572|Male|Unclassified Tumors|2013|1.0|1.1|1.1
20+|0.5|0.6|0.6|Malignant|624|113464572|Male|Unclassified Tumors|2013|0.5|0.6|0.5
20+|1.0|1.1|1.0|Benign/Borderline|1151|114723581|Male|Unclassified Tumors|2014|0.9|1.1|1.0
20+|0.6|0.7|0.6|Malignant|676|114723581|Male|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1099|115951558|Male|Unclassified Tumors|2015|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|640|115951558|Male|Unclassified Tumors|2015|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|4929|584748560|Male|Unclassified Tumors|2015-2019|0.8|0.9|0.8
20+|0.5|0.6|0.5|Malignant|3185|584748560|Male|Unclassified Tumors|2015-2019|0.5|0.6|0.5
20+|0.8|0.9|0.9|Benign/Borderline|1011|117114889|Male|Unclassified Tumors|2016|0.8|0.9|0.9
20+|0.5|0.6|0.6|Malignant|646|117114889|Male|Unclassified Tumors|2016|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|998|118165836|Male|Unclassified Tumors|2017|0.8|0.9|0.8
20+|0.4|0.5|0.5|Malignant|575|118165836|Male|Unclassified Tumors|2017|0.4|0.5|0.5
20+|0.7|0.8|0.8|Benign/Borderline|956|117962778|Male|Unclassified Tumors|2018|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|666|117962778|Male|Unclassified Tumors|2018|0.5|0.6|0.6
20+|0.7|0.8|0.7|Benign/Borderline|878|118814607|Male|Unclassified Tumors|2019|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|684|118814607|Male|Unclassified Tumors|2019|0.5|0.6|0.6
20+|0.1|0.1|0.1|Benign/Borderline|101|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|115|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|139|104488268|Male|Unique astrocytoma variants|2006|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|124|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|150|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|161|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|38|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|109527150|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109527150|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|191|110839824|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|32|110839824|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|177|112210327|Male|Unique astrocytoma variants|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|112210327|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|171|113464572|Male|Unique astrocytoma variants|2013|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|39|113464572|Male|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|180|114723581|Male|Unique astrocytoma variants|2014|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|114723581|Male|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|178|115951558|Male|Unique astrocytoma variants|2015|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|115951558|Male|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1005|584748560|Male|Unique astrocytoma variants|2015-2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|158|584748560|Male|Unique astrocytoma variants|2015-2019|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|201|117114889|Male|Unique astrocytoma variants|2016|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|117114889|Male|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|194|118165836|Male|Unique astrocytoma variants|2017|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|42|118165836|Male|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|117962778|Male|Unique astrocytoma variants|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|117962778|Male|Unique astrocytoma variants|2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|221|118814607|Male|Unique astrocytoma variants|2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|28|118814607|Male|Unique astrocytoma variants|2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|226142851|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|32|226142851|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|228745012|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|45|228745012|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|33|231376184|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|231376184|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|233788709|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|49|233788709|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|236247131|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|49|236247131|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|238618584|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|54|238618584|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|368|1202925164|Male and Female|All other|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|1023|1202925164|Male and Female|All other|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|77|240910318|Male and Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|240910318|Male and Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|74|243007764|Male and Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|54|243007764|Male and Female|All other|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|90|242606754|Male and Female|All other|2018|0.0|0.0|0.0
20+|0.1|0.2|0.2|Malignant|390|242606754|Male and Female|All other|2018|0.1|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|83|244322258|Male and Female|All other|2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|473|244322258|Male and Female|All other|2019|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1238|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1215|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1211|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1204|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1213|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1217|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|1286|226142851|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1278|228745012|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1341|231376184|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1439|233788709|Male and Female|Anaplastic astrocytoma|2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.6|0.6|Malignant|1413|236247131|Male and Female|Anaplastic astrocytoma|2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1483|238618584|Male and Female|Anaplastic astrocytoma|2015|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Anaplastic astrocytoma|2015-2019|~|~|~
20+|0.6|0.6|0.6|Malignant|7048|1202925164|Male and Female|Anaplastic astrocytoma|2015-2019|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.6|0.6|0.6|Malignant|1474|240910318|Male and Female|Anaplastic astrocytoma|2016|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Anaplastic astrocytoma|2017|~|~|~
20+|0.6|0.6|0.6|Malignant|1456|243007764|Male and Female|Anaplastic astrocytoma|2017|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Anaplastic astrocytoma|2018|~|~|~
20+|0.5|0.6|0.6|Malignant|1416|242606754|Male and Female|Anaplastic astrocytoma|2018|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Anaplastic astrocytoma|2019|~|~|~
20+|0.5|0.5|0.5|Malignant|1252|244322258|Male and Female|Anaplastic astrocytoma|2019|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|396|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|378|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|353|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|346|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|361|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|338|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|331|226142851|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|341|228745012|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|356|231376184|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.2|Malignant|379|233788709|Male and Female|Anaplastic oligodendroglioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|359|236247131|Male and Female|Anaplastic oligodendroglioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.2|Malignant|356|238618584|Male and Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Anaplastic oligodendroglioma|2015-2019|~|~|~
20+|0.1|0.2|0.2|Malignant|1847|1202925164|Male and Female|Anaplastic oligodendroglioma|2015-2019|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.2|Malignant|369|240910318|Male and Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Anaplastic oligodendroglioma|2017|~|~|~
20+|0.2|0.2|0.2|Malignant|424|243007764|Male and Female|Anaplastic oligodendroglioma|2017|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Anaplastic oligodendroglioma|2018|~|~|~
20+|0.1|0.2|0.1|Malignant|338|242606754|Male and Female|Anaplastic oligodendroglioma|2018|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Anaplastic oligodendroglioma|2019|~|~|~
20+|0.1|0.2|0.2|Malignant|369|244322258|Male and Female|Anaplastic oligodendroglioma|2019|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1209|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1198|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1191|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1164|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1125|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1056|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.5|0.5|Malignant|1100|226142851|Male and Female|Astrocytoma, NOS|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|1049|228745012|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|1052|231376184|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.5|0.4|Malignant|1023|233788709|Male and Female|Astrocytoma, NOS|2013|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.5|0.5|Malignant|1097|236247131|Male and Female|Astrocytoma, NOS|2014|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.5|0.5|Malignant|1208|238618584|Male and Female|Astrocytoma, NOS|2015|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Astrocytoma, NOS|2015-2019|~|~|~
20+|0.5|0.5|0.5|Malignant|6143|1202925164|Male and Female|Astrocytoma, NOS|2015-2019|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Astrocytoma, NOS|2016|~|~|~
20+|0.5|0.6|0.5|Malignant|1272|240910318|Male and Female|Astrocytoma, NOS|2016|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Astrocytoma, NOS|2017|~|~|~
20+|0.5|0.5|0.5|Malignant|1213|243007764|Male and Female|Astrocytoma, NOS|2017|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Astrocytoma, NOS|2018|~|~|~
20+|0.5|0.6|0.5|Malignant|1277|242606754|Male and Female|Astrocytoma, NOS|2018|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Astrocytoma, NOS|2019|~|~|~
20+|0.5|0.5|0.5|Malignant|1193|244322258|Male and Female|Astrocytoma, NOS|2019|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|64|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|76|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|68|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|91|218481776|Male and Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|78|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|74|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|85|226142851|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226142851|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|85|228745012|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|228745012|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|77|231376184|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|231376184|Male and Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|79|233788709|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|233788709|Male and Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|88|236247131|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|236247131|Male and Female|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|85|238618584|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|238618584|Male and Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|405|1202925164|Male and Female|Choroid plexus|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|1202925164|Male and Female|Choroid plexus|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|73|240910318|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|240910318|Male and Female|Choroid plexus|2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|93|243007764|Male and Female|Choroid plexus|2017|0.0|0.0|0.0
20+|~|~|~|Malignant|~|243007764|Male and Female|Choroid plexus|2017|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|83|242606754|Male and Female|Choroid plexus|2018|0.0|0.0|0.0
20+|~|~|~|Malignant|~|242606754|Male and Female|Choroid plexus|2018|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|73|244322258|Male and Female|Choroid plexus|2019|0.0|0.0|0.0
20+|~|~|~|Malignant|~|244322258|Male and Female|Choroid plexus|2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|394|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|420|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|395|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|421|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|424|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|432|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|442|226142851|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226142851|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|418|228745012|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228745012|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|446|231376184|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231376184|Male and Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|474|233788709|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233788709|Male and Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|435|236247131|Male and Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236247131|Male and Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|466|238618584|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238618584|Male and Female|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2318|1202925164|Male and Female|Craniopharyngioma|2015-2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1202925164|Male and Female|Craniopharyngioma|2015-2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|471|240910318|Male and Female|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|240910318|Male and Female|Craniopharyngioma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|489|243007764|Male and Female|Craniopharyngioma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|243007764|Male and Female|Craniopharyngioma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|455|242606754|Male and Female|Craniopharyngioma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|242606754|Male and Female|Craniopharyngioma|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|446|244322258|Male and Female|Craniopharyngioma|2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|244322258|Male and Female|Craniopharyngioma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|259|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|294|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|318|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|340|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|368|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|351|226142851|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|251|228745012|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|208|231376184|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|174|233788709|Male and Female|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|131|236247131|Male and Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|84|238618584|Male and Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Diffuse astrocytoma|2015-2019|~|~|~
20+|0.0|0.0|0.0|Malignant|176|1202925164|Male and Female|Diffuse astrocytoma|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|35|240910318|Male and Female|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Diffuse astrocytoma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|24|243007764|Male and Female|Diffuse astrocytoma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Diffuse astrocytoma|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|22|242606754|Male and Female|Diffuse astrocytoma|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Diffuse astrocytoma|2019|~|~|~
20+|~|~|~|Malignant|~|244322258|Male and Female|Diffuse astrocytoma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|166|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|190|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|217|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|213|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|237|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|199|226142851|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|187|228745012|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|173|231376184|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|187|233788709|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|181|236247131|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|169|238618584|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Embryonal/primitive/medulloblastoma|2015-2019|~|~|~
20+|0.1|0.1|0.1|Malignant|784|1202925164|Male and Female|Embryonal/primitive/medulloblastoma|2015-2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|181|240910318|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Embryonal/primitive/medulloblastoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|161|243007764|Male and Female|Embryonal/primitive/medulloblastoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Embryonal/primitive/medulloblastoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|143|242606754|Male and Female|Embryonal/primitive/medulloblastoma|2018|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Embryonal/primitive/medulloblastoma|2019|~|~|~
20+|0.1|0.1|0.1|Malignant|138|244322258|Male and Female|Embryonal/primitive/medulloblastoma|2019|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|246|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|270|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|311|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|251|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|261|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|277|226142851|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226142851|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|271|228745012|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|228745012|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|294|231376184|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|231376184|Male and Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|278|233788709|Male and Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|233788709|Male and Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|300|236247131|Male and Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|236247131|Male and Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|295|238618584|Male and Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|238618584|Male and Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1333|1202925164|Male and Female|Ependymoma variants|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|21|1202925164|Male and Female|Ependymoma variants|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|295|240910318|Male and Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|240910318|Male and Female|Ependymoma variants|2016|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|280|243007764|Male and Female|Ependymoma variants|2017|0.1|0.1|0.1
20+|~|~|~|Malignant|~|243007764|Male and Female|Ependymoma variants|2017|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|249|242606754|Male and Female|Ependymoma variants|2018|0.1|0.1|0.1
20+|~|~|~|Malignant|~|242606754|Male and Female|Ependymoma variants|2018|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|224|244322258|Male and Female|Ependymoma variants|2019|0.1|0.1|0.1
20+|~|~|~|Malignant|~|244322258|Male and Female|Ependymoma variants|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|597|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|604|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|587|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|587|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|635|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|687|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|226142851|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|629|226142851|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|228745012|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|595|228745012|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|631|231376184|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|580|233788709|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|29|236247131|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|567|236247131|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|27|238618584|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|586|238618584|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|112|1202925164|Male and Female|Ependymoma/anaplastic ependymoma|2015-2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|2805|1202925164|Male and Female|Ependymoma/anaplastic ependymoma|2015-2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|20|240910318|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|607|240910318|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|23|243007764|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|591|243007764|Male and Female|Ependymoma/anaplastic ependymoma|2017|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|21|242606754|Male and Female|Ependymoma/anaplastic ependymoma|2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|528|242606754|Male and Female|Ependymoma/anaplastic ependymoma|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|21|244322258|Male and Female|Ependymoma/anaplastic ependymoma|2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|501|244322258|Male and Female|Ependymoma/anaplastic ependymoma|2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|39|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|55|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|69|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|65|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|62|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|71|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|67|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|79|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|226142851|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226142851|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|228745012|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|69|228745012|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|65|231376184|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|231376184|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|52|233788709|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|233788709|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|236247131|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|69|236247131|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|238618584|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|238618584|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|280|1202925164|Male and Female|Germ Cell Tumors|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|340|1202925164|Male and Female|Germ Cell Tumors|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|240910318|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|76|240910318|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|54|243007764|Male and Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|66|243007764|Male and Female|Germ Cell Tumors|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|242606754|Male and Female|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|66|242606754|Male and Female|Germ Cell Tumors|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|244322258|Male and Female|Germ Cell Tumors|2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|72|244322258|Male and Female|Germ Cell Tumors|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9558|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.5|4.5|Malignant|9707|213511339|Male and Female|Glioblastoma|2005|4.5|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9799|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10197|218481776|Male and Female|Glioblastoma|2007|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10416|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.4|4.5|4.4|Malignant|10498|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Glioblastoma|2010|~|~|~
20+|4.4|4.5|4.4|Malignant|10745|226142851|Male and Female|Glioblastoma|2010|4.7|4.8|4.8
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10896|228745012|Male and Female|Glioblastoma|2011|4.7|4.9|4.8
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.6|4.5|Malignant|11396|231376184|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Glioblastoma|2013|~|~|~
20+|4.4|4.6|4.5|Malignant|11563|233788709|Male and Female|Glioblastoma|2013|4.9|5.0|4.9
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Glioblastoma|2014|~|~|~
20+|4.3|4.5|4.4|Malignant|11608|236247131|Male and Female|Glioblastoma|2014|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Glioblastoma|2015|~|~|~
20+|4.4|4.6|4.5|Malignant|12050|238618584|Male and Female|Glioblastoma|2015|5.0|5.1|5.0
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Glioblastoma|2015-2019|~|~|~
20+|4.4|4.5|4.5|Malignant|61710|1202925164|Male and Female|Glioblastoma|2015-2019|5.1|5.2|5.1
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Glioblastoma|2016|~|~|~
20+|4.5|4.6|4.5|Malignant|12443|240910318|Male and Female|Glioblastoma|2016|5.1|5.3|5.2
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Glioblastoma|2017|~|~|~
20+|4.4|4.6|4.5|Malignant|12597|243007764|Male and Female|Glioblastoma|2017|5.1|5.3|5.2
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Glioblastoma|2018|~|~|~
20+|4.4|4.5|4.4|Malignant|12545|242606754|Male and Female|Glioblastoma|2018|5.1|5.3|5.2
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Glioblastoma|2019|~|~|~
20+|4.3|4.4|4.3|Malignant|12443|244322258|Male and Female|Glioblastoma|2019|5.0|5.2|5.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|849|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|836|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|216055494|Male and Female|Glioma malignant, NOS|2006|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|845|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|878|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|927|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|25|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|974|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|21|226142851|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|819|226142851|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|29|228745012|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|948|228745012|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|231376184|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|933|231376184|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|31|233788709|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|930|233788709|Male and Female|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|40|236247131|Male and Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|955|236247131|Male and Female|Glioma malignant, NOS|2014|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|53|238618584|Male and Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1010|238618584|Male and Female|Glioma malignant, NOS|2015|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|224|1202925164|Male and Female|Glioma malignant, NOS|2015-2019|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|5226|1202925164|Male and Female|Glioma malignant, NOS|2015-2019|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|52|240910318|Male and Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1070|240910318|Male and Female|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|46|243007764|Male and Female|Glioma malignant, NOS|2017|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|1153|243007764|Male and Female|Glioma malignant, NOS|2017|0.4|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|36|242606754|Male and Female|Glioma malignant, NOS|2018|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1051|242606754|Male and Female|Glioma malignant, NOS|2018|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|37|244322258|Male and Female|Glioma malignant, NOS|2019|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|971|244322258|Male and Female|Glioma malignant, NOS|2019|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|462|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|520|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|499|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|475|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|534|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|513|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.3|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|535|226142851|Male and Female|Hemangioblastoma|2010|0.2|0.3|0.2
20+|~|~|~|Malignant|~|226142851|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|527|228745012|Male and Female|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|228745012|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|547|231376184|Male and Female|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|231376184|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|510|233788709|Male and Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233788709|Male and Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|496|236247131|Male and Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236247131|Male and Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|544|238618584|Male and Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238618584|Male and Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2684|1202925164|Male and Female|Hemangioblastoma|2015-2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|29|1202925164|Male and Female|Hemangioblastoma|2015-2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|553|240910318|Male and Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|240910318|Male and Female|Hemangioblastoma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|557|243007764|Male and Female|Hemangioblastoma|2017|0.2|0.2|0.2
20+|~|~|~|Malignant|~|243007764|Male and Female|Hemangioblastoma|2017|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|515|242606754|Male and Female|Hemangioblastoma|2018|0.2|0.2|0.2
20+|~|~|~|Malignant|~|242606754|Male and Female|Hemangioblastoma|2018|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|532|244322258|Male and Female|Hemangioblastoma|2019|0.2|0.2|0.2
20+|~|~|~|Malignant|~|244322258|Male and Female|Hemangioblastoma|2019|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|386|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|488|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|559|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|643|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|805|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.4
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|968|223491138|Male and Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1116|226142851|Male and Female|Hemangioma|2010|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226142851|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1231|228745012|Male and Female|Hemangioma|2011|0.5|0.6|0.5
20+|~|~|~|Malignant|~|228745012|Male and Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1243|231376184|Male and Female|Hemangioma|2012|0.5|0.6|0.5
20+|~|~|~|Malignant|~|231376184|Male and Female|Hemangioma|2012|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1252|233788709|Male and Female|Hemangioma|2013|0.5|0.6|0.5
20+|~|~|~|Malignant|~|233788709|Male and Female|Hemangioma|2013|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1189|236247131|Male and Female|Hemangioma|2014|0.5|0.5|0.5
20+|~|~|~|Malignant|~|236247131|Male and Female|Hemangioma|2014|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|1051|238618584|Male and Female|Hemangioma|2015|0.4|0.5|0.4
20+|~|~|~|Malignant|~|238618584|Male and Female|Hemangioma|2015|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|4829|1202925164|Male and Female|Hemangioma|2015-2019|0.4|0.4|0.4
20+|0.0|0.0|0.0|Malignant|21|1202925164|Male and Female|Hemangioma|2015-2019|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|983|240910318|Male and Female|Hemangioma|2016|0.4|0.4|0.4
20+|~|~|~|Malignant|~|240910318|Male and Female|Hemangioma|2016|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|955|243007764|Male and Female|Hemangioma|2017|0.4|0.4|0.4
20+|~|~|~|Malignant|~|243007764|Male and Female|Hemangioma|2017|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|955|242606754|Male and Female|Hemangioma|2018|0.4|0.4|0.4
20+|~|~|~|Malignant|~|242606754|Male and Female|Hemangioma|2018|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|898|244322258|Male and Female|Hemangioma|2019|0.3|0.4|0.4
20+|~|~|~|Malignant|~|244322258|Male and Female|Hemangioma|2019|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|50|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|45|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|53|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|55|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|53|226142851|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|43|228745012|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|47|231376184|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|46|233788709|Male and Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|52|236247131|Male and Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|41|238618584|Male and Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|1202925164|Male and Female|Local Extensions from Regional Tumors|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|175|1202925164|Male and Female|Local Extensions from Regional Tumors|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|41|240910318|Male and Female|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Local Extensions from Regional Tumors|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|36|243007764|Male and Female|Local Extensions from Regional Tumors|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Local Extensions from Regional Tumors|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|28|242606754|Male and Female|Local Extensions from Regional Tumors|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Local Extensions from Regional Tumors|2019|~|~|~
20+|0.0|0.0|0.0|Malignant|29|244322258|Male and Female|Local Extensions from Regional Tumors|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1340|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1439|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1436|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1378|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1477|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.7|0.6|Malignant|1429|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1502|226142851|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1522|228745012|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1461|231376184|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1468|233788709|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.6|Malignant|1633|236247131|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1580|238618584|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|~|~|~
20+|0.6|0.6|0.6|Malignant|8159|1202925164|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015-2019|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.7|0.6|Malignant|1657|240910318|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|~|~|~
20+|0.6|0.7|0.6|Malignant|1713|243007764|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|~|~|~
20+|0.6|0.6|0.6|Malignant|1655|242606754|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019|~|~|~
20+|0.5|0.6|0.6|Malignant|1590|244322258|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019|0.6|0.7|0.7
20+|8.9|9.2|9.0|Benign/Borderline|19221|211050944|Male and Female|Meningioma|2004|9.0|9.2|9.1
20+|0.2|0.2|0.2|Malignant|445|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|10.0|10.2|10.1|Benign/Borderline|21860|213511339|Male and Female|Meningioma|2005|10.1|10.4|10.2
20+|0.2|0.2|0.2|Malignant|436|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.5|10.7|10.6|Benign/Borderline|23321|216055494|Male and Female|Meningioma|2006|10.7|10.9|10.8
20+|0.2|0.2|0.2|Malignant|405|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.8|11.1|11.0|Benign/Borderline|24544|218481776|Male and Female|Meningioma|2007|11.1|11.4|11.2
20+|0.2|0.2|0.2|Malignant|444|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|11.4|11.7|11.6|Benign/Borderline|26447|220975702|Male and Female|Meningioma|2008|11.8|12.1|12.0
20+|0.1|0.2|0.2|Malignant|366|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|12.2|12.5|12.4|Benign/Borderline|28708|223491138|Male and Female|Meningioma|2009|12.7|13.0|12.8
20+|0.1|0.2|0.2|Malignant|353|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|11.9|12.1|12.0|Benign/Borderline|28381|226142851|Male and Female|Meningioma|2010|12.4|12.7|12.6
20+|0.1|0.2|0.1|Malignant|331|226142851|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|11.9|12.2|12.1|Benign/Borderline|29047|228745012|Male and Female|Meningioma|2011|12.6|12.8|12.7
20+|0.1|0.2|0.1|Malignant|329|228745012|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|12.1|12.4|12.3|Benign/Borderline|30100|231376184|Male and Female|Meningioma|2012|12.9|13.2|13.0
20+|0.1|0.2|0.1|Malignant|356|231376184|Male and Female|Meningioma|2012|0.1|0.2|0.2
20+|12.3|12.6|12.5|Benign/Borderline|31100|233788709|Male and Female|Meningioma|2013|13.2|13.5|13.3
20+|0.1|0.2|0.2|Malignant|382|233788709|Male and Female|Meningioma|2013|0.1|0.2|0.2
20+|12.5|12.8|12.7|Benign/Borderline|32232|236247131|Male and Female|Meningioma|2014|13.5|13.8|13.6
20+|0.1|0.2|0.1|Malignant|385|236247131|Male and Female|Meningioma|2014|0.1|0.2|0.2
20+|12.9|13.2|13.1|Benign/Borderline|33935|238618584|Male and Female|Meningioma|2015|14.1|14.4|14.2
20+|0.1|0.1|0.1|Malignant|350|238618584|Male and Female|Meningioma|2015|0.1|0.2|0.1
20+|13.2|13.3|13.2|Benign/Borderline|176558|1202925164|Male and Female|Meningioma|2015-2019|14.6|14.7|14.7
20+|0.1|0.1|0.1|Malignant|1597|1202925164|Male and Female|Meningioma|2015-2019|0.1|0.1|0.1
20+|13.1|13.4|13.2|Benign/Borderline|34879|240910318|Male and Female|Meningioma|2016|14.3|14.6|14.5
20+|0.1|0.1|0.1|Malignant|332|240910318|Male and Female|Meningioma|2016|0.1|0.2|0.1
20+|13.3|13.6|13.5|Benign/Borderline|36308|243007764|Male and Female|Meningioma|2017|14.8|15.1|14.9
20+|0.1|0.1|0.1|Malignant|328|243007764|Male and Female|Meningioma|2017|0.1|0.2|0.1
20+|13.1|13.4|13.2|Benign/Borderline|35877|242606754|Male and Female|Meningioma|2018|14.6|14.9|14.8
20+|0.1|0.1|0.1|Malignant|310|242606754|Male and Female|Meningioma|2018|0.1|0.1|0.1
20+|13.1|13.3|13.2|Benign/Borderline|36425|244322258|Male and Female|Meningioma|2019|14.8|15.1|14.9
20+|0.1|0.1|0.1|Malignant|287|244322258|Male and Female|Meningioma|2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|492|211050944|Male and Female|Mixed glioma|2004|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|566|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|639|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|590|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|601|220975702|Male and Female|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|680|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|614|226142851|Male and Female|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|636|228745012|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|575|231376184|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Mixed glioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|618|233788709|Male and Female|Mixed glioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Mixed glioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|467|236247131|Male and Female|Mixed glioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|277|238618584|Male and Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Mixed glioma|2015-2019|~|~|~
20+|0.0|0.0|0.0|Malignant|482|1202925164|Male and Female|Mixed glioma|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.0|Malignant|107|240910318|Male and Female|Mixed glioma|2016|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Mixed glioma|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|59|243007764|Male and Female|Mixed glioma|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Mixed glioma|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|21|242606754|Male and Female|Mixed glioma|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Mixed glioma|2019|~|~|~
20+|0.0|0.0|0.0|Malignant|20|244322258|Male and Female|Mixed glioma|2019|0.0|0.0|0.0
20+|0.5|0.6|0.6|Benign/Borderline|1201|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1315|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1499|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1324|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1424|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1288|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1430|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1218|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1452|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1369|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1538|223491138|Male and Female|Neoplasm, unspecified|2009|0.7|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1422|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1500|226142851|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1247|226142851|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1479|228745012|Male and Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1254|228745012|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|1592|231376184|Male and Female|Neoplasm, unspecified|2012|0.7|0.7|0.7
20+|0.5|0.5|0.5|Malignant|1275|231376184|Male and Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1491|233788709|Male and Female|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1279|233788709|Male and Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1533|236247131|Male and Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1407|236247131|Male and Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1504|238618584|Male and Female|Neoplasm, unspecified|2015|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1368|238618584|Male and Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|0.5|0.5|0.5|Benign/Borderline|6425|1202925164|Male and Female|Neoplasm, unspecified|2015-2019|0.5|0.5|0.5
20+|0.5|0.5|0.5|Malignant|6455|1202925164|Male and Female|Neoplasm, unspecified|2015-2019|0.5|0.5|0.5
20+|0.5|0.6|0.5|Benign/Borderline|1378|240910318|Male and Female|Neoplasm, unspecified|2016|0.5|0.6|0.6
20+|0.4|0.5|0.5|Malignant|1249|240910318|Male and Female|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|0.5|0.5|0.5|Benign/Borderline|1327|243007764|Male and Female|Neoplasm, unspecified|2017|0.5|0.6|0.5
20+|0.4|0.5|0.5|Malignant|1250|243007764|Male and Female|Neoplasm, unspecified|2017|0.5|0.5|0.5
20+|0.4|0.5|0.5|Benign/Borderline|1217|242606754|Male and Female|Neoplasm, unspecified|2018|0.5|0.5|0.5
20+|0.5|0.5|0.5|Malignant|1304|242606754|Male and Female|Neoplasm, unspecified|2018|0.5|0.6|0.5
20+|0.4|0.4|0.4|Benign/Borderline|1018|244322258|Male and Female|Neoplasm, unspecified|2019|0.4|0.4|0.4
20+|0.5|0.5|0.5|Malignant|1329|244322258|Male and Female|Neoplasm, unspecified|2019|0.5|0.6|0.5
20+|2.2|2.4|2.3|Benign/Borderline|4919|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5544|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|53|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5648|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|5758|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|5853|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6203|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|38|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6040|226142851|Male and Female|Nerve sheath, benign and malignant|2010|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|45|226142851|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6393|228745012|Male and Female|Nerve sheath, benign and malignant|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|38|228745012|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|6796|231376184|Male and Female|Nerve sheath, benign and malignant|2012|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|51|231376184|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.8|2.9|2.9|Benign/Borderline|7060|233788709|Male and Female|Nerve sheath, benign and malignant|2013|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|43|233788709|Male and Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.9|3.0|3.0|Benign/Borderline|7460|236247131|Male and Female|Nerve sheath, benign and malignant|2014|3.1|3.2|3.2
20+|0.0|0.0|0.0|Malignant|39|236247131|Male and Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.9|3.0|3.0|Benign/Borderline|7555|238618584|Male and Female|Nerve sheath, benign and malignant|2015|3.1|3.2|3.2
20+|0.0|0.0|0.0|Malignant|39|238618584|Male and Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|36025|1202925164|Male and Female|Nerve sheath, benign and malignant|2015-2019|3.0|3.0|3.0
20+|0.0|0.0|0.0|Malignant|200|1202925164|Male and Female|Nerve sheath, benign and malignant|2015-2019|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|7430|240910318|Male and Female|Nerve sheath, benign and malignant|2016|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|50|240910318|Male and Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7396|243007764|Male and Female|Nerve sheath, benign and malignant|2017|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|43|243007764|Male and Female|Nerve sheath, benign and malignant|2017|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|7141|242606754|Male and Female|Nerve sheath, benign and malignant|2018|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|30|242606754|Male and Female|Nerve sheath, benign and malignant|2018|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|6656|244322258|Male and Female|Nerve sheath, benign and malignant|2019|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|38|244322258|Male and Female|Nerve sheath, benign and malignant|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226142851|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|51|228745012|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|54|231376184|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|48|233788709|Male and Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|57|236247131|Male and Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|70|238618584|Male and Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|39|1202925164|Male and Female|Neuroepithelial|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|194|1202925164|Male and Female|Neuroepithelial|2015-2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|47|240910318|Male and Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Neuroepithelial|2017|~|~|~
20+|0.0|0.0|0.0|Malignant|34|243007764|Male and Female|Neuroepithelial|2017|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Neuroepithelial|2018|~|~|~
20+|0.0|0.0|0.0|Malignant|22|242606754|Male and Female|Neuroepithelial|2018|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Neuroepithelial|2019|~|~|~
20+|0.0|0.0|0.0|Malignant|22|244322258|Male and Female|Neuroepithelial|2019|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|317|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|377|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|54|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|388|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|44|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|392|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|46|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|422|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|442|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|482|226142851|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|226142851|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|433|228745012|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|39|228745012|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|423|231376184|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|42|231376184|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|399|233788709|Male and Female|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|233788709|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|464|236247131|Male and Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|236247131|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|499|238618584|Male and Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|238618584|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2386|1202925164|Male and Female|Neuronal/glial, neuronal|2015-2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|170|1202925164|Male and Female|Neuronal/glial, neuronal|2015-2019|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|483|240910318|Male and Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|48|240910318|Male and Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|514|243007764|Male and Female|Neuronal/glial, neuronal|2017|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|243007764|Male and Female|Neuronal/glial, neuronal|2017|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|452|242606754|Male and Female|Neuronal/glial, neuronal|2018|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|242606754|Male and Female|Neuronal/glial, neuronal|2018|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|451|244322258|Male and Female|Neuronal/glial, neuronal|2019|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|36|244322258|Male and Female|Neuronal/glial, neuronal|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|830|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|803|213511339|Male and Female|Oligodendroglioma|2005|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|854|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|816|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|779|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|841|223491138|Male and Female|Oligodendroglioma|2009|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|804|226142851|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|767|228745012|Male and Female|Oligodendroglioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|679|231376184|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|720|233788709|Male and Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Oligodendroglioma|2014|~|~|~
20+|0.3|0.3|0.3|Malignant|723|236247131|Male and Female|Oligodendroglioma|2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Oligodendroglioma|2015|~|~|~
20+|0.3|0.3|0.3|Malignant|720|238618584|Male and Female|Oligodendroglioma|2015|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1202925164|Male and Female|Oligodendroglioma|2015-2019|~|~|~
20+|0.3|0.3|0.3|Malignant|3525|1202925164|Male and Female|Oligodendroglioma|2015-2019|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Oligodendroglioma|2016|~|~|~
20+|0.3|0.3|0.3|Malignant|741|240910318|Male and Female|Oligodendroglioma|2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Oligodendroglioma|2017|~|~|~
20+|0.3|0.3|0.3|Malignant|727|243007764|Male and Female|Oligodendroglioma|2017|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Oligodendroglioma|2018|~|~|~
20+|0.3|0.3|0.3|Malignant|663|242606754|Male and Female|Oligodendroglioma|2018|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|244322258|Male and Female|Oligodendroglioma|2019|~|~|~
20+|0.3|0.3|0.3|Malignant|693|244322258|Male and Female|Oligodendroglioma|2019|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|152|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|58|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|154|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|64|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|157|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|165|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|78|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|209|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|99|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|202|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|76|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|176|226142851|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|226142851|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|164|228745012|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|77|228745012|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|201|231376184|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|71|231376184|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|179|233788709|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|86|233788709|Male and Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|183|236247131|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|83|236247131|Male and Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|202|238618584|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|88|238618584|Male and Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|868|1202925164|Male and Female|Other mesenchymal|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|473|1202925164|Male and Female|Other mesenchymal|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|161|240910318|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|81|240910318|Male and Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|192|243007764|Male and Female|Other mesenchymal|2017|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|111|243007764|Male and Female|Other mesenchymal|2017|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|172|242606754|Male and Female|Other mesenchymal|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|103|242606754|Male and Female|Other mesenchymal|2018|0.0|0.1|0.0
20+|0.0|0.1|0.1|Benign/Borderline|145|244322258|Male and Female|Other mesenchymal|2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|93|244322258|Male and Female|Other mesenchymal|2019|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|279|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|306|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|305|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|308|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|290|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|273|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226142851|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|331|226142851|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228745012|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|337|228745012|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231376184|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|272|231376184|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233788709|Male and Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|305|233788709|Male and Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236247131|Male and Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|299|236247131|Male and Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238618584|Male and Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|297|238618584|Male and Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|1202925164|Male and Female|Pilocytic astrocytoma|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|1412|1202925164|Male and Female|Pilocytic astrocytoma|2015-2019|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|240910318|Male and Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|299|240910318|Male and Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|243007764|Male and Female|Pilocytic astrocytoma|2017|~|~|~
20+|0.1|0.1|0.1|Malignant|270|243007764|Male and Female|Pilocytic astrocytoma|2017|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|242606754|Male and Female|Pilocytic astrocytoma|2018|~|~|~
20+|0.1|0.1|0.1|Malignant|274|242606754|Male and Female|Pilocytic astrocytoma|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|21|244322258|Male and Female|Pilocytic astrocytoma|2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|279|244322258|Male and Female|Pilocytic astrocytoma|2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|51|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|46|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|69|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|47|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|55|226142851|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226142851|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|228745012|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|228745012|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|231376184|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|231376184|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|233788709|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|70|233788709|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|236247131|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|236247131|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|63|238618584|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|59|238618584|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|275|1202925164|Male and Female|Pineal parenchymal|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|260|1202925164|Male and Female|Pineal parenchymal|2015-2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|240910318|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|63|240910318|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|55|243007764|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|53|243007764|Male and Female|Pineal parenchymal|2017|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|55|242606754|Male and Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|242606754|Male and Female|Pineal parenchymal|2018|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|41|244322258|Male and Female|Pineal parenchymal|2019|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|46|244322258|Male and Female|Pineal parenchymal|2019|0.0|0.0|0.0
20+|3.5|3.7|3.6|Benign/Borderline|7675|211050944|Male and Female|Pituitary|2004|3.6|3.7|3.6
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|8730|213511339|Male and Female|Pituitary|2005|4.0|4.2|4.1
20+|0.0|0.0|0.0|Malignant|37|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9497|216055494|Male and Female|Pituitary|2006|4.3|4.5|4.4
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|10119|218481776|Male and Female|Pituitary|2007|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|10995|220975702|Male and Female|Pituitary|2008|4.9|5.1|5.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|5.2|5.4|5.3|Benign/Borderline|11943|223491138|Male and Female|Pituitary|2009|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|24|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|5.3|5.4|5.3|Benign/Borderline|12181|226142851|Male and Female|Pituitary|2010|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|32|226142851|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|12516|228745012|Male and Female|Pituitary|2011|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|33|228745012|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|13535|231376184|Male and Female|Pituitary|2012|5.8|5.9|5.8
20+|0.0|0.0|0.0|Malignant|35|231376184|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|13550|233788709|Male and Female|Pituitary|2013|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|41|233788709|Male and Female|Pituitary|2013|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|13830|236247131|Male and Female|Pituitary|2014|5.8|6.0|5.9
20+|0.0|0.0|0.0|Malignant|33|236247131|Male and Female|Pituitary|2014|0.0|0.0|0.0
20+|5.9|6.1|6.0|Benign/Borderline|14479|238618584|Male and Female|Pituitary|2015|6.0|6.2|6.1
20+|0.0|0.0|0.0|Malignant|30|238618584|Male and Female|Pituitary|2015|0.0|0.0|0.0
20+|5.9|6.0|5.9|Benign/Borderline|72691|1202925164|Male and Female|Pituitary|2015-2019|6.0|6.1|6.0
20+|0.0|0.0|0.0|Malignant|109|1202925164|Male and Female|Pituitary|2015-2019|0.0|0.0|0.0
20+|5.9|6.1|6.0|Benign/Borderline|14688|240910318|Male and Female|Pituitary|2016|6.0|6.2|6.1
20+|0.0|0.0|0.0|Malignant|24|240910318|Male and Female|Pituitary|2016|0.0|0.0|0.0
20+|6.1|6.3|6.2|Benign/Borderline|15240|243007764|Male and Female|Pituitary|2017|6.2|6.4|6.3
20+|0.0|0.0|0.0|Malignant|20|243007764|Male and Female|Pituitary|2017|0.0|0.0|0.0
20+|5.8|6.0|5.9|Benign/Borderline|14693|242606754|Male and Female|Pituitary|2018|6.0|6.2|6.1
20+|0.0|0.0|0.0|Malignant|22|242606754|Male and Female|Pituitary|2018|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|13940|244322258|Male and Female|Pituitary|2019|5.6|5.8|5.7
20+|~|~|~|Malignant|~|244322258|Male and Female|Pituitary|2019|~|~|~
20+|16.4|16.8|16.6|Benign/Borderline|35292|211050944|Male and Female|Total|2004|16.5|16.9|16.7
20+|9.0|9.3|9.1|Malignant|19402|211050944|Male and Female|Total|2004|9.1|9.3|9.2
20+|18.5|18.9|18.7|Benign/Borderline|40268|213511339|Male and Female|Total|2005|18.7|19.0|18.9
20+|9.0|9.3|9.1|Malignant|19744|213511339|Male and Female|Total|2005|9.1|9.4|9.2
20+|19.3|19.6|19.5|Benign/Borderline|42627|216055494|Male and Female|Total|2006|19.5|19.9|19.7
20+|8.9|9.2|9.0|Malignant|19835|216055494|Male and Female|Total|2006|9.1|9.3|9.2
20+|19.9|20.2|20.1|Benign/Borderline|44652|218481776|Male and Female|Total|2007|20.2|20.6|20.4
20+|8.9|9.2|9.0|Malignant|20179|218481776|Male and Female|Total|2007|9.1|9.4|9.2
20+|21.0|21.4|21.2|Benign/Borderline|47881|220975702|Male and Female|Total|2008|21.5|21.9|21.7
20+|9.0|9.2|9.1|Malignant|20626|220975702|Male and Female|Total|2008|9.2|9.5|9.3
20+|22.3|22.7|22.5|Benign/Borderline|51710|223491138|Male and Female|Total|2009|22.9|23.3|23.1
20+|8.9|9.1|9.0|Malignant|20844|223491138|Male and Female|Total|2009|9.2|9.5|9.3
20+|21.9|22.3|22.1|Benign/Borderline|51639|226142851|Male and Female|Total|2010|22.6|23.0|22.8
20+|8.7|8.9|8.8|Malignant|20760|226142851|Male and Female|Total|2010|9.1|9.3|9.2
20+|22.2|22.6|22.4|Benign/Borderline|53031|228745012|Male and Female|Total|2011|23.0|23.4|23.2
20+|8.6|8.8|8.7|Malignant|20882|228745012|Male and Female|Total|2011|9.0|9.3|9.1
20+|22.9|23.3|23.1|Benign/Borderline|55717|231376184|Male and Female|Total|2012|23.9|24.3|24.1
20+|8.5|8.8|8.7|Malignant|21192|231376184|Male and Female|Total|2012|9.0|9.3|9.2
20+|23.0|23.4|23.2|Benign/Borderline|56826|233788709|Male and Female|Total|2013|24.1|24.5|24.3
20+|8.5|8.8|8.7|Malignant|21563|233788709|Male and Female|Total|2013|9.1|9.3|9.2
20+|23.4|23.8|23.6|Benign/Borderline|58713|236247131|Male and Female|Total|2014|24.7|25.1|24.9
20+|8.5|8.7|8.6|Malignant|21748|236247131|Male and Female|Total|2014|9.1|9.3|9.2
20+|24.0|24.4|24.2|Benign/Borderline|61134|238618584|Male and Female|Total|2015|25.4|25.8|25.6
20+|8.4|8.7|8.6|Malignant|22039|238618584|Male and Female|Total|2015|9.1|9.4|9.2
20+|23.8|24.0|23.9|Benign/Borderline|309127|1202925164|Male and Female|Total|2015-2019|25.6|25.8|25.7
20+|8.2|8.3|8.3|Malignant|109766|1202925164|Male and Female|Total|2015-2019|9.1|9.2|9.1
20+|24.0|24.3|24.1|Benign/Borderline|61933|240910318|Male and Female|Total|2016|25.5|25.9|25.7
20+|8.4|8.6|8.5|Malignant|22367|240910318|Male and Female|Total|2016|9.2|9.4|9.3
20+|24.3|24.6|24.5|Benign/Borderline|63852|243007764|Male and Female|Total|2017|26.1|26.5|26.3
20+|8.3|8.5|8.4|Malignant|22468|243007764|Male and Female|Total|2017|9.1|9.4|9.2
20+|23.5|23.9|23.7|Benign/Borderline|62323|242606754|Male and Female|Total|2018|25.5|25.9|25.7
20+|8.0|8.3|8.2|Malignant|21986|242606754|Male and Female|Total|2018|8.9|9.2|9.1
20+|22.8|23.2|23.0|Benign/Borderline|61349|244322258|Male and Female|Total|2019|24.9|25.3|25.1
20+|7.8|8.0|7.9|Malignant|21505|244322258|Male and Female|Total|2019|8.7|8.9|8.8
20+|2.2|2.4|2.3|Benign/Borderline|4919|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.3|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|5547|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|53|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5650|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|5760|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|5857|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6210|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|38|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6044|226142851|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.6|2.7|2.7
20+|0.0|0.0|0.0|Malignant|45|226142851|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6398|228745012|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|38|228745012|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|6798|231376184|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|51|231376184|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.8|2.9|2.9|Benign/Borderline|7065|233788709|Male and Female|Tumors of Cranial and Spinal Nerves|2013|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|43|233788709|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.9|3.1|3.0|Benign/Borderline|7469|236247131|Male and Female|Tumors of Cranial and Spinal Nerves|2014|3.1|3.2|3.2
20+|0.0|0.0|0.0|Malignant|39|236247131|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.9|3.0|3.0|Benign/Borderline|7565|238618584|Male and Female|Tumors of Cranial and Spinal Nerves|2015|3.1|3.2|3.2
20+|0.0|0.0|0.0|Malignant|39|238618584|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.8|2.8|2.8|Benign/Borderline|36057|1202925164|Male and Female|Tumors of Cranial and Spinal Nerves|2015-2019|3.0|3.0|3.0
20+|0.0|0.0|0.0|Malignant|200|1202925164|Male and Female|Tumors of Cranial and Spinal Nerves|2015-2019|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|7440|240910318|Male and Female|Tumors of Cranial and Spinal Nerves|2016|3.0|3.2|3.1
20+|0.0|0.0|0.0|Malignant|50|240910318|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7401|243007764|Male and Female|Tumors of Cranial and Spinal Nerves|2017|3.0|3.1|3.0
20+|0.0|0.0|0.0|Malignant|43|243007764|Male and Female|Tumors of Cranial and Spinal Nerves|2017|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|7144|242606754|Male and Female|Tumors of Cranial and Spinal Nerves|2018|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|30|242606754|Male and Female|Tumors of Cranial and Spinal Nerves|2018|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|6660|244322258|Male and Female|Tumors of Cranial and Spinal Nerves|2019|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|38|244322258|Male and Female|Tumors of Cranial and Spinal Nerves|2019|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|834|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.7|7.5|Malignant|16036|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|974|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16263|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1048|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16438|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|1015|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16821|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1080|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17103|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.9|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1111|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17381|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.7|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1197|226142851|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
20+|7.3|7.5|7.4|Malignant|17392|226142851|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.6|7.8|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1182|228745012|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17493|228745012|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.5|7.8|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1185|231376184|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|17827|231376184|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1144|233788709|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.5|0.5|0.5
20+|7.2|7.4|7.3|Malignant|18147|233788709|Male and Female|Tumors of Neuroepthelial Tissue|2013|7.6|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1282|236247131|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|18016|236247131|Male and Female|Tumors of Neuroepthelial Tissue|2014|7.5|7.7|7.6
20+|0.5|0.6|0.6|Benign/Borderline|1321|238618584|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.6
20+|7.1|7.3|7.2|Malignant|18461|238618584|Male and Female|Tumors of Neuroepthelial Tissue|2015|7.6|7.8|7.7
20+|0.5|0.6|0.5|Benign/Borderline|6378|1202925164|Male and Female|Tumors of Neuroepthelial Tissue|2015-2019|0.5|0.5|0.5
20+|6.9|7.0|7.0|Malignant|92134|1202925164|Male and Female|Tumors of Neuroepthelial Tissue|2015-2019|7.6|7.7|7.7
20+|0.5|0.6|0.6|Benign/Borderline|1312|240910318|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.5|0.6|0.5
20+|7.1|7.3|7.2|Malignant|18830|240910318|Male and Female|Tumors of Neuroepthelial Tissue|2016|7.7|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1317|243007764|Male and Female|Tumors of Neuroepthelial Tissue|2017|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|18878|243007764|Male and Female|Tumors of Neuroepthelial Tissue|2017|7.7|7.9|7.8
20+|0.5|0.5|0.5|Benign/Borderline|1240|242606754|Male and Female|Tumors of Neuroepthelial Tissue|2018|0.5|0.5|0.5
20+|6.8|7.0|6.9|Malignant|18432|242606754|Male and Female|Tumors of Neuroepthelial Tissue|2018|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1220|244322258|Male and Female|Tumors of Neuroepthelial Tissue|2019|0.5|0.5|0.5
20+|6.5|6.7|6.6|Malignant|18038|244322258|Male and Female|Tumors of Neuroepthelial Tissue|2019|7.3|7.5|7.4
20+|3.7|3.9|3.8|Benign/Borderline|8069|211050944|Male and Female|Tumors of Sellar Region|2004|3.7|3.9|3.8
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|9150|213511339|Male and Female|Tumors of Sellar Region|2005|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|39|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|9892|216055494|Male and Female|Tumors of Sellar Region|2006|4.5|4.7|4.6
20+|0.0|0.0|0.0|Malignant|33|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|10540|218481776|Male and Female|Tumors of Sellar Region|2007|4.7|4.9|4.8
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|5.1|5.2|5.2|Benign/Borderline|11419|220975702|Male and Female|Tumors of Sellar Region|2008|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|16|220975702|Male and Female|Tumors of Sellar Region|2008|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|12375|223491138|Male and Female|Tumors of Sellar Region|2009|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|25|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|12623|226142851|Male and Female|Tumors of Sellar Region|2010|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|32|226142851|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|12934|228745012|Male and Female|Tumors of Sellar Region|2011|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|35|228745012|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.9|6.1|6.0|Benign/Borderline|13981|231376184|Male and Female|Tumors of Sellar Region|2012|5.9|6.1|6.0
20+|0.0|0.0|0.0|Malignant|35|231376184|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.8|6.0|5.9|Benign/Borderline|14024|233788709|Male and Female|Tumors of Sellar Region|2013|5.9|6.1|6.0
20+|0.0|0.0|0.0|Malignant|42|233788709|Male and Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.9|6.1|6.0|Benign/Borderline|14265|236247131|Male and Female|Tumors of Sellar Region|2014|5.9|6.1|6.0
20+|0.0|0.0|0.0|Malignant|37|236247131|Male and Female|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|6.1|6.3|6.2|Benign/Borderline|14945|238618584|Male and Female|Tumors of Sellar Region|2015|6.2|6.4|6.3
20+|0.0|0.0|0.0|Malignant|31|238618584|Male and Female|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|6.1|6.2|6.1|Benign/Borderline|75009|1202925164|Male and Female|Tumors of Sellar Region|2015-2019|6.2|6.3|6.2
20+|0.0|0.0|0.0|Malignant|112|1202925164|Male and Female|Tumors of Sellar Region|2015-2019|0.0|0.0|0.0
20+|6.1|6.3|6.2|Benign/Borderline|15159|240910318|Male and Female|Tumors of Sellar Region|2016|6.2|6.4|6.3
20+|0.0|0.0|0.0|Malignant|25|240910318|Male and Female|Tumors of Sellar Region|2016|0.0|0.0|0.0
20+|6.3|6.5|6.4|Benign/Borderline|15729|243007764|Male and Female|Tumors of Sellar Region|2017|6.4|6.6|6.5
20+|0.0|0.0|0.0|Malignant|21|243007764|Male and Female|Tumors of Sellar Region|2017|0.0|0.0|0.0
20+|6.0|6.2|6.1|Benign/Borderline|15148|242606754|Male and Female|Tumors of Sellar Region|2018|6.1|6.3|6.2
20+|0.0|0.0|0.0|Malignant|22|242606754|Male and Female|Tumors of Sellar Region|2018|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|14386|244322258|Male and Female|Tumors of Sellar Region|2019|5.8|6.0|5.9
20+|~|~|~|Malignant|~|244322258|Male and Female|Tumors of Sellar Region|2019|~|~|~
20+|9.2|9.5|9.3|Benign/Borderline|19835|211050944|Male and Female|Tumors of the Meninges|2004|9.3|9.5|9.4
20+|0.2|0.3|0.2|Malignant|504|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|10.3|10.6|10.4|Benign/Borderline|22534|213511339|Male and Female|Tumors of the Meninges|2005|10.4|10.7|10.6
20+|0.2|0.3|0.2|Malignant|503|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.8|11.0|10.9|Benign/Borderline|23977|216055494|Male and Female|Tumors of the Meninges|2006|11.0|11.2|11.1
20+|0.2|0.2|0.2|Malignant|469|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|11.1|11.4|11.3|Benign/Borderline|25184|218481776|Male and Female|Tumors of the Meninges|2007|11.4|11.7|11.5
20+|0.2|0.3|0.2|Malignant|529|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.8|12.1|11.9|Benign/Borderline|27190|220975702|Male and Female|Tumors of the Meninges|2008|12.2|12.5|12.3
20+|0.2|0.2|0.2|Malignant|471|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|12.5|12.8|12.7|Benign/Borderline|29423|223491138|Male and Female|Tumors of the Meninges|2009|13.0|13.3|13.2
20+|0.2|0.2|0.2|Malignant|432|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|12.2|12.4|12.3|Benign/Borderline|29092|226142851|Male and Female|Tumors of the Meninges|2010|12.7|13.0|12.9
20+|0.2|0.2|0.2|Malignant|404|226142851|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|12.2|12.5|12.4|Benign/Borderline|29738|228745012|Male and Female|Tumors of the Meninges|2011|12.9|13.1|13.0
20+|0.2|0.2|0.2|Malignant|407|228745012|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|12.4|12.7|12.6|Benign/Borderline|30848|231376184|Male and Female|Tumors of the Meninges|2012|13.2|13.5|13.3
20+|0.2|0.2|0.2|Malignant|427|231376184|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|12.6|12.9|12.8|Benign/Borderline|31789|233788709|Male and Female|Tumors of the Meninges|2013|13.4|13.7|13.6
20+|0.2|0.2|0.2|Malignant|472|233788709|Male and Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|12.8|13.1|12.9|Benign/Borderline|32911|236247131|Male and Female|Tumors of the Meninges|2014|13.8|14.1|13.9
20+|0.2|0.2|0.2|Malignant|475|236247131|Male and Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|13.2|13.5|13.4|Benign/Borderline|34681|238618584|Male and Female|Tumors of the Meninges|2015|14.4|14.7|14.5
20+|0.2|0.2|0.2|Malignant|443|238618584|Male and Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|13.5|13.6|13.5|Benign/Borderline|180110|1202925164|Male and Female|Tumors of the Meninges|2015-2019|14.9|15.0|15.0
20+|0.2|0.2|0.2|Malignant|2099|1202925164|Male and Female|Tumors of the Meninges|2015-2019|0.2|0.2|0.2
20+|13.4|13.7|13.5|Benign/Borderline|35593|240910318|Male and Female|Tumors of the Meninges|2016|14.6|14.9|14.8
20+|0.1|0.2|0.2|Malignant|421|240910318|Male and Female|Tumors of the Meninges|2016|0.2|0.2|0.2
20+|13.6|13.9|13.8|Benign/Borderline|37057|243007764|Male and Female|Tumors of the Meninges|2017|15.1|15.4|15.2
20+|0.2|0.2|0.2|Malignant|445|243007764|Male and Female|Tumors of the Meninges|2017|0.2|0.2|0.2
20+|13.4|13.6|13.5|Benign/Borderline|36564|242606754|Male and Female|Tumors of the Meninges|2018|14.9|15.2|15.1
20+|0.1|0.2|0.2|Malignant|421|242606754|Male and Female|Tumors of the Meninges|2018|0.2|0.2|0.2
20+|13.3|13.6|13.5|Benign/Borderline|37102|244322258|Male and Female|Tumors of the Meninges|2019|15.0|15.3|15.2
20+|0.1|0.2|0.1|Malignant|382|244322258|Male and Female|Tumors of the Meninges|2019|0.1|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|1593|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.8
20+|0.6|0.7|0.6|Malignant|1328|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1992|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1337|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1993|216055494|Male and Female|Unclassified Tumors|2006|0.9|1.0|0.9
20+|0.6|0.6|0.6|Malignant|1304|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2079|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|1229|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|2266|220975702|Male and Female|Unclassified Tumors|2008|1.0|1.1|1.0
20+|0.6|0.6|0.6|Malignant|1393|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2509|223491138|Male and Female|Unclassified Tumors|2009|1.1|1.2|1.1
20+|0.6|0.7|0.6|Malignant|1440|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2621|226142851|Male and Female|Unclassified Tumors|2010|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1268|226142851|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|2715|228745012|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1275|228745012|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|2836|231376184|Male and Female|Unclassified Tumors|2012|1.2|1.3|1.2
20+|0.5|0.6|0.5|Malignant|1292|231376184|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2750|233788709|Male and Female|Unclassified Tumors|2013|1.1|1.2|1.2
20+|0.5|0.5|0.5|Malignant|1293|233788709|Male and Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2725|236247131|Male and Female|Unclassified Tumors|2014|1.1|1.2|1.2
20+|0.5|0.6|0.6|Malignant|1427|236247131|Male and Female|Unclassified Tumors|2014|0.6|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|2559|238618584|Male and Female|Unclassified Tumors|2015|1.0|1.1|1.1
20+|0.5|0.6|0.5|Malignant|1384|238618584|Male and Female|Unclassified Tumors|2015|0.5|0.6|0.6
20+|0.9|0.9|0.9|Benign/Borderline|11277|1202925164|Male and Female|Unclassified Tumors|2015-2019|0.9|1.0|0.9
20+|0.5|0.5|0.5|Malignant|6547|1202925164|Male and Female|Unclassified Tumors|2015-2019|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|2364|240910318|Male and Female|Unclassified Tumors|2016|0.9|1.0|1.0
20+|0.4|0.5|0.5|Malignant|1267|240910318|Male and Female|Unclassified Tumors|2016|0.5|0.6|0.5
20+|0.9|0.9|0.9|Benign/Borderline|2288|243007764|Male and Female|Unclassified Tumors|2017|0.9|1.0|0.9
20+|0.4|0.5|0.5|Malignant|1266|243007764|Male and Female|Unclassified Tumors|2017|0.5|0.6|0.5
20+|0.8|0.9|0.8|Benign/Borderline|2179|242606754|Male and Female|Unclassified Tumors|2018|0.9|0.9|0.9
20+|0.5|0.5|0.5|Malignant|1332|242606754|Male and Female|Unclassified Tumors|2018|0.5|0.6|0.5
20+|0.7|0.8|0.7|Benign/Borderline|1919|244322258|Male and Female|Unclassified Tumors|2019|0.8|0.8|0.8
20+|0.5|0.5|0.5|Malignant|1343|244322258|Male and Female|Unclassified Tumors|2019|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|155|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|158|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|189|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|187|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|210|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|238|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|256|226142851|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|46|226142851|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|272|228745012|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|62|228745012|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|279|231376184|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|58|231376184|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|268|233788709|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|69|233788709|Male and Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|281|236247131|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|78|236247131|Male and Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|285|238618584|Male and Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|50|238618584|Male and Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1544|1202925164|Male and Female|Unique astrocytoma variants|2015-2019|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|308|1202925164|Male and Female|Unique astrocytoma variants|2015-2019|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|314|240910318|Male and Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|240910318|Male and Female|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|294|243007764|Male and Female|Unique astrocytoma variants|2017|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|72|243007764|Male and Female|Unique astrocytoma variants|2017|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|321|242606754|Male and Female|Unique astrocytoma variants|2018|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|62|242606754|Male and Female|Unique astrocytoma variants|2018|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|335|244322258|Male and Female|Unique astrocytoma variants|2019|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|57|244322258|Male and Female|Unique astrocytoma variants|2019|0.0|0.0|0.0
